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Arboviruses are blood-borne pathogens that threaten half of the world’s 
population. The recent outbreak of Zika virus (ZIKV) in Brazil has highlighted the 
importance of developing new strategies to limit virus spread. While vaccines are in 
development, one way to immediately suppress viral transmission is through biocontrol 
of mosquito vector. Novel biocontrol strategies utilize microbe – mosquito interactions to 
inhibit the transmission of pathogens. A powerful tool under investigation is the 
intracellular bacteria, Wolbachia pipientis, which are maintained in insect populations 
through maternal transmission. The Wolbachia strain wMel can be trans-infected into 
mosquitos limiting ZIKV transmission. However, thermal stress can hinder maternal 
transmission of the wMel strain of Wolbachia. For Wolbachia-based technologies of 
vector control, it is important to have additional strains with viral suppression capabilities 
available. 
We characterized alternative Wolbachia strains in A. albopictus mosquito cell 
lines and the underlying mechanisms of these interactions. We identified two novel 
Wolbachia strains with robust arbovirus repression. wAlbB, native to mosquitos blocked 
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90% of ZIKV growth. More strikingly, wStri, a nonnative symbiont, ablated ZIKV 
growth in A. albopictus cells below the limit of detection. After showing that ZIKV 
growth is rescued in wStri infected A. albopictus cells by the pharmacological removal of 
Wolbachia, we established these cells as an in vitro model for mechanistic studies. Using 
novel labeling and reporter techniques, we isolate a block in virus growth by Wolbachia 
at two stages of viral growth, entry and translation. We further show that cholesterol, 
which can partially rescue viral growth in Wolbachia wStri infected cells, aids in viral 
entry but does not promote viral growth post entry. 
Beyond our Wolbachia studies, we further investigated the limited arbovirus 
growth observed in many A. aegypti cell lines and identified two insect–specific viruses 
which interfere with arbovirus growth. To address the limited biocontrol tools in C. 
pipiens mosquitos, we characterized commensal microbiota that may be used as a direct 
competitor of viruses or as a tool to genetically enhance an antiviral response in the 
mosquito gut. Together this work expands our understanding of Wolbachia-mediated 
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CHAPTER 1: BIOLOGICAL CONTROL OF ARBOVIRUSES 
1.1 Mosquitos transmit pathogenic human viruses 
Arboviruses are zoonotic pathogenic viruses transmitted by arthropod vectors 
such as mosquitos, ticks, and fleas. Arboviruses are maintained in enzootic (sylvatic) and 
epidemic (urban) cycles (Vasilakis et al. 2014, Vasilakis and Weaver 2017). Enzootic 
infections regularly cycle across an animal (reservoir) population when a mosquito 
infects an animal and the animal becomes viremic. A new mosquito may then bite the 
viremic animal and become able to transmit the virus after the virus has disseminated and 
grown in the mosquito. Organisms involved in an enzootic cycle can cause spillover into 
epizootic or epidemic cycles when virus is transmitted in a zone of emergence cohabited 
by a susceptible animal or human population, respectively.  
Mosquitos are an effective vector for disseminating disease because of their 
regular contact with many mammals and the female’s requirement of a blood meal to 
make eggs. Of the 3,500 known species of mosquitos, fewer than 100 species require 
blood meals (Harbach and Besansky 2014). These lone species are sufficient to 
perpetuate the transmission of human disease. Ninety percent of all vector borne diseases 
are transmitted by mosquitos (McGraw and O'Neill 2013) emphasizing the need to study 
mosquitos and their competency to transmit disease. 
Mosquitos are geographically limited by abiotic factors including temperature, 
precipitation, and wind. These abiotic limitations cause niches that lead to divergence of 
mosquito species. Mosquitos do not travel far and are thus limited to transmission cycles 




virus in different zones. These zone are termed sylvatic, emergence, or urban zones 
(Vasilakis and Weaver 2017) (Figure 1.1, Table 1.1). Mosquito behavior is a prominent 
indicator of which zone a mosquito may inhabit. Highly adaptive species such as Aedes 
aegypti and Aedes albopictus mosquitos transcend zones making these mosquitos 
efficient vectors of human disease. 
 
Figure 1.1 Arbovirus vectors depend on sylvatic or urban cycling 
YFV, DENV, and ZIKV are vectored by various mosquito species, which vary within 
sylvatic or urban cycling. Arbovirus spread is further maintained by transovarial 






Table 1.1 Arboviruses & their vectors 
 
Arbovirus  Family Genus Primary mosquito vector 
Zika virus Flaviviridae flavivirus Aedes sp. (A. aegypti, A. albopictus, A. 
africanis, etc.) 
Dengue virus Flaviviridae flavivirus Aedes sp. (A. aegypti, A. albopictus, A. 
africanis, etc.) 
Yellow fever virus Flaviviridae flavivirus Aedes sp. (A. aegypti, A. albopictus, A. 
africanis, etc.) 
West Nile virus Flaviviridae flavivirus Culex sp. (C. pipiens, C. nigripalpus Theo, C. 
bahamensis Dyar and Knab, C. 
quinquefasciatus), limited transmission in 
Aedes sp.  (Aedes taeniorhynchus) 
Japanese 
Encephilitis virus 




Togaviridae alphavirus Aedes sp. (A. aegypti, A. albopictus, A. 
africanis, etc.) 
Sindbis virus Togaviridae alphavirus Culex sp. (C. pipiens, C. quinquefascitatus, C. 
torrentium) 
La crosse virus Bunyaviridae bunyavirus Aedes triseriatus,limited transmission in Culex 
sp. (C. restuans, C. pipiens) 
Vesicular 
stomatitis virus  
(livestock 
pathogen) 
Rhabdoviridae vesiculovirus Sandfly (phlebotomine), limited transmission 
in Aedes sp. (A. ageypti) 
 
 
1.1.1 Arboviruses are a global burden 
Global climate change and urbanization has allowed mosquito species to become 
invasive. The Aedes genus, which transmits many arboviruses (Table 1.1), perseveres in 
different environments, which facilitates the outbreak of disease. The mosquito habitat 
range has expanded allowing the vectors of arboviruses to reach new areas. A. aegypti 




temperate climates. In 2016, A. aegypti mosquitos were identified as far north as New 
York, U.S.A. and A. albopictus mosquitos reached Maine, U.S.A. (CDC 2017). The 
expansion of these vectors is aided by global warming suggesting that spread will 
continue (Jetten and Focks 1997, Rochlin et al. 2013). 
The global threat of arbovirus disease is exemplified by the relentless 
transmission of the flavivirus and alphavirus genus. Flaviviruses including dengue virus 
(DENV), Zika virus (ZIKV), West Nile virus (WNV), and Yellow fever virus (YFV) as 
well as Chikungunya virus (CHIKV, alphavirus) cases have increased in subtropic and 
temperate climates enabled by increasing mosquito geographic range, increased travel, 
and high urban mosquito density (Gubler 2004, Fares et al. 2015, Couto-Lima et al. 
2017). Several of these viruses can be found in overlapping regions consistent with their 
transmission by the same species of mosquito species (Table 1.1) (Figure 1.2). For 
example, CHIKV, DENV, and ZIKV are currently transmitted throughout the Americas 
where they infect the same human and mosquito populations. 
Consistent with the geographic overlap of these diseases, co-infections with more 
than one virus often occurs in mosquitos. DENV and CHIKV can be simultaneously 
transmitted by the same mosquito (Göertz et al. 2017). Recent studies have shown 
CHIKV and DENV can even infect the same patient in 13 of 98 countries where both 
CHIKV and DENV circulate (Furuya-Kanamori et al. 2016). These and other reports 
show that arboviruses are co-circulating and expanding their geographic overlap in the 




2017, Vallejos-Paras and Cabrera-Gaytan 2017) emphasizing the importance of 
understanding concurrent and sequential infections. 
 




ZIKV, DENV, and CHIKV transmission are distributed throughout five 
continents where their vector, Aedes sp. mosquitos, are present. Significant overlap of all 
three of these viruses is present in North and South America as well as Southeast Asia. 
Figure adapted from (Rückert et al. 2017). 
 
1.1.2 Arbovirus disease 
The genus flavivirus is comprised of over 70 viruses including a multitude of 
important human pathogens (Kuno et al. 1998). Flavivirus infection is up to 80% 
asymptomatic (Cleton et al. 2012). Symptomatic disease presents as an acute mild febrile 




arthralgia, myalgia, and a rash. Mosquito borne flaviviruses display a range of tissue 
tropism resulting in differential secondary symptoms. These flaviviruses can be separated 
into encephalitic and hemorrhagic viruses by the secondary symptoms they cause. 
Encephalitic flaviviruses include WNV, Japanese encephalitis virus (JEV), and Eastern 
Equine encephalitis virus (EEE). Hemorrhagic flaviviruses include YFV and DENV. 
Additionally, much of this work will investigate ZIKV, which has a unique fetal 
neurotropism.  
YFV is a hemorrhagic fever virus and with severe consequences of infection 
including delirium, bleeding from the eyes, nose, and mouth, yellowing of the skin and 
eyes (jaundice), indicative of liver disease (Monath and Vasconcelos 2015). YFV disease 
was wide spread in Africa in the late 19th century and into the early 1900s before the 
causative agent was identified and vaccine became available in 1938 (Norrby 2007, 
Frierson 2010). The availability of a vaccine has kept YFV cases isolated to Africa for 
many years. However, in the past three years, YFV cases have emerged in major cities of 
Brazil and across South America (Barrett 2016, Barrett 2017). 
Two and a half billion people live in DENV endemic regions of the world 
(Messina et al. 2014). Disease ranges from asymptomatic to severe DENV characterized 
by dengue hemorrhagic fever/dengue shock syndrome (DHF/DSS). Severe DENV 
symptoms parallel YFV infection. DENV can be delineated into four different serotypes: 
DENV-1-4. Infection with any one of the four strains induces both serotype-specific and 




doubled every decade since 1900 and continues to increase (Messina et al. 2014, Fares et 
al. 2015, Sharp et al. 2017).  
Most recently, ZIKV made its way into the Americas causing significant 
morbidity. Zika fever is described as a febrile illness which causes a rash, fever, and 
requires a recovery time of approximately one month (Simpson 1964). Zika fever 
symptoms resemble a mild (non-severe) DENV illness. The surge of cases in Brazil in 
2015 highlighted the secondary severe symptoms ZIKV can cause. Severe ZIKV 
symptoms include Guillen Barre syndrome and birth defects, most notably, microcephaly 
(Fauci and Morens 2016) emphasizing a risk to pregnant women. ZIKV was first 
identified in monkeys in 1947 in West Africa (Dick et al. 1952) and caused sporadic 
illness throughout south east Asia and Sub-Saharan Africa until 2007. Prior to 2015, 
ZIKV had not been reported in Brazil, yet by the end of the year, 18 of the 27 Brazilian 
states reported autochthonous (local transmission) (WHO 2015). ZIKV is now 
recognized as a global threat, although case numbers in 2017 are much less than in 2015-
2016 (Baud et al. 2017).  
In contrast to YFV, DENV, and ZIKV, WNV is naturally transmitted by Culex sp. 
mosquitos (Reisen et al. 2005), although it can be found and replicate in Aedes mosquitos 
(Colpitts et al. 2012). Like other flaviviruses, WNV causes a mild febrile illness. 
However, unlike the hemorrhagic group of flavivirus, severe WNV infection is 
characterized by encephalitis. Consistent with the geographic distribution of Culex 
mosquitos, WNV circulation is widespread across the United States (Plante et al. 2014), 




can be maintained in an avian reservoir, its target host. In addition to WNV, other Culex 
transmitted viruses such as JEV and Usutu virus (USUV) (Nikolay 2015) are ongoing 
and emerging, respectively. 
For the past 20 years, flavivirus circulation has been coupled with circulation of a 
second family of viruses, Togaviridae, most notably, CHIKV in the genus alphavirus. 
CHIKV illness is most prominently characterized by arthralgia similar to DENV 
infection. However, this illness can be prolonged or chronic (Bautista-Reyes et al. 2017). 
Aedes sp. mosquitos transmit CHIKV, similar to the hemorrhagic flaviviruses.  CHIKV is 
vastly diverse with heterotypic strains circulating in Asia and South America (Pybus et 
al. 2015).  
 
1.2 Positive sense RNA replication  
Flaviviruses and alphaviruses are positive sense RNA virus genera. These viruses 
are defined by their genome structure and sequence. For both flaviviruses and 
alphaviruses, the viral genome is the minimal unit needed to produce an infection. 
Genomic RNA is directly translated by host machinery similar to host mRNA to initiate 
infection. The structure, genes, and replication methods of this positive sense RNA 
differs between flaviviruses and alphaviruses. In this section, we will review flavivirus 
and alphavirus replication strategies.   
Flaviruses enter mosquito and mammalian cells through an unknown or 
promiscuous receptor. Over thirteen putative entry receptors have been described for 




receptor, promoting uptake through clatharin-mediated endocytosis. Then, by a pH 
dependent mechanism, the viral envelope fuses with the endosomal membrane releasing 
the infectious genome into the cytoplasm of the cell (Smit et al. 2011). Upon entry into a 
cell, the viral genome undergoes an initial round of translation to produce the structural 
and nonstructural proteins (NS) including the RNA-dependent RNA-polymerase (NS5) 
necessary to replicate the viral genome. From here, cyclic amplification increases protein 
and viral genome production in the endoplasmic reticulum (Figure 1.3). This 
amplification occurs in the endoplasmic reticulum in replication factories that are 
cholesterol rich (Apte-Sengupta et al. 2014). The virus assembles in the endoplasmic 
reticulum after sufficient amplification has occurred and then is matured through the 
cleavage of pr from the M protein. Matured virions exit the cell through the secretory 
pathway (Fernandez-Garcia et al. 2009). 
Flaviviruses have three structural proteins. Structural proteins make up the outside 
of the virion that is exported from an infected cell. The majority of the virion is coated 
with Envelope protein (E). E protein is a 53 kDa protein which encapsulates the virion in 
a dimer conformation. Under acidic pHs, the E protein undergoes a conformational 
change from a dimer into a trimer facilitating membrane fusion. Capsid protein (C) 
directs the virion to the endoplasmic reticulum for replication but also has divergent 
function across flavivirus species. Lastly, the membrane glycoprotein (prM) protein is 
cleaved from immature particles at the end of the secretory pathway facilitating the 




Seven NS aid replication and pathogenesis of flaviviruses. NS proteins are not 
present in the infectious virion and instead must be produced upon entry into a cell. Some 
functions of NS proteins have been identified but additional functions specific to 
flavivirus species remain elusive. These proteins are NS1, NS2A, NS2B, NS3, NS4A, 
NS4B, and NS5 (Fields et al. 2013). NS1 plays an essential role in RNA synthesis but is 
also an immunogenic secreted factor that can promote vascular leakage in DENV 
infection (Beatty et al. 2015). NS2A suppresses the mammalian immune response 
(Cumberworth et al. 2017) while NS2B functions to anchor the viral protease (NS3). 
NS4A promotes membrane rearrangement and complexes with NS1 in RNA synthesis 
(Fields et al. 2013). NS4B supports NS3 functional while simultaneously repressing a 
host immune (interferon) response (Zou et al. 2015, Cumberworth et al. 2017). NS5 is 
RNA dependent RNA polymerase, which synthesizes new RNA, a methyltransferase, 
which caps the 5’ UTR stabilizing and protecting viral RNA from host RNases, and 
immune antagonist (Best 2017). 
Like flaviviruses, alphaviruses enter host cells through promiscuous cell-type 
dependent receptors. Under low pH’s the alphavirus envelope protein dimer (E1-E2) is 
destabilized exposing a fusion domains that promotes envelope and endosomal fusion 
(Fields et al. 2013). The viral genome is released and primary translation produces the 
virus’ six structural proteins and four NS proteins. Importantly, alphaviruses produce a 
subgenomic RNA to independently express structural and NS genes as two polyproteins 




NS proteins (nsP1-nsP4) carry out methyltransferease and proteolytic as well as RNA 
synthesis and immune antagonism (Fields et al. 2013). 
 




Positive sense RNA viruses enter the host cell and uncoat an infectious unit of 
RNA. This RNA is then translated and amplified throughout viral RNA replication and 
further rounds of translation. Virus is then assembled along the secretory pathway where 
it is matured and released as a new infectious unit. Figure adapted from (Rodenhuis-





1.3 Methods of Arbovirus control 
There are three distinct opportunities to control arbovirus transmission in its 
natural cycle (Figure 1.4). One opportunity is through vaccination, a method protecting 
the population by training the adaptive immune system. A second, common approach is 
through vector population control (i.e limiting or reducing the mosquito population). 
Most recently, a third approach has been to target the ability for mosquitos to replicate 
and transmit viruses. The following sections discuss the advancements and challenges of 
each approach. 
 
Figure 1.4 Mosquito transmitted virus control strategies 
 
Arboviruses in the epidemic cycle can be targeted at three stages of the virus transmission 
cycle. Infected humans and mosquitos are shown in orange and opportunities to block 






1.3.1 Vaccines design and challenges 
Flavivirus vaccine design has been a long and arduous challenge. The only 
approved vaccine for mosquito borne flaviviruses is the YFV YF-17D vaccine. This 
vaccine is safe but costly to produce. YF-17D is an attenuated isolate identified through 
extensive subculturing resulting in 14 key amino acid substitutions and reduced genetic 
diversity of the virus. This vaccine has been available since 1938. Yet, limited vaccine 
supply and compliance has allowed diseases to spread in Angola (Kupferschmidt 2016) 
and Brazil (Barrett 2016) where it has caused fatality between 20-60% (Monath and 
Vasconcelos 2015). The limited availability has caused governments to administer 1/5 
doses in many parts of the world. This dosing offers only short-term protection. 
YF-17D is one of the oldest and most reliable vaccines distributed. As such, 
several studies have aimed to use the YF-17D backbone as a platform for live attenuated 
vaccines against other flaviviruses (Bonaldo et al. 2014). A vaccine incorporating YF 
17D immunogenicity coupled with a humoral immune response to other flaviviruses 
would have bivalent potential decreasing cost and broadly decreasing arbovirus disease. 
Thus far, in addition to the tetravalent CYD-TDV DENV vaccine developed by Sanofi 
Pasteur (Guy et al. 2010), a YF-DENV chimeric vaccine proposed by Halstead et al has 
been shown to elicit strong DENV protection (Halstead and Russell 2016). However, 
these vaccines have increased hospitalization and secondary-dengue like symptoms in 
immune naïve populations (Ferguson et al. 2016).  
DENV vaccine development has been complicated by the cross reactivity of the 




dependent enhancement (ADE). ADE occurs when low concentrations of neutralizing or 
sub-neutralizing antibodies bind to virus forming infectious immune complexes which 
are then capable of infecting Fc receptor bearing cells (Guzman et al. 2013) expanding 
the repertoire of DENV permissive cells in a host. This phenomenon was first described 
in 1976 where peripheral Simian leukocytes could only be infected with DENV upon 
secondary exposure suggesting a humoral immune response was facilitating infection 
(Marchette et al. 1976). The enhanced infection of leukocytes by sera from DENV 
exposed individuals was confirmed in human and primate cells in vitro (Halstead et al. 
1976, Halstead and O'Rourke 1977). The infection of leukocytes by DENV was shown to 
disseminate virus increasing infection in the liver of mice (Zellweger et al. 2010) and 
ultimately lead to DHF/DSS (Guzman et al. 2013, Halstead 2014). Sequential heterotypic 
infection with two of the four serotypes of DENV has been shown to cause ADE in vitro 
and in vivo (Halstead 2014). Prior exposure to DENV has been identified as the highest 
risk factor for DHF/DSS in human populations because of ADE (Gubler 1998, 
Katzelnick et al. 2017). Without treatment DHF/DSS has an increased fatality up to 4 % 
(Moraes et al. 2013).  
The close antigenic overlap between DENV and ZIKV allows for cross-reactive 
immune responses when sequentially infected with these two viruses. Indeed, after the 
outbreak of ZIKV in 2015, where DENV was cocirculating, ZIKV was quickly shown to 
worsen DENV infection and to itself be worsened by previous exposure to DENV 




there are no vaccines shown not to induce ADE. Thus, further research is needed to 
broadly target and reduce arbovirus infection in addition to vaccine development. 
 
1.3.2 Mosquito population control 
Targeting the mosquito limits total disease spread and is appealing to the 
immediate need to stop the spread of these viruses. Controlling arboviruses by limiting 
the mosquito vector has been a long attempted strategy with mixed results. One approach 
to target mosquitos is the use of insecticides to kill extant populations. Insecticides are 
widely effective at reducing mosquito populations when resistance is not evident. 
Applications of pyrethroids and organophospates using space spray to control mosquito 
populations is fraught with high cost, low community support, ineffective timing, and 
low efficacy and/or residual effect (Esu et al. 2010, Horstick et al. 2010, George et al. 
2015). This has weakened the effectiveness of a chemical based population reduction.  
Alternative strategies for vector control block male reproduction in a mosquito 
population by a method known as sterile insect technique (SIT) (Figure 1.4). SIT 
sterilizes males or makes the offspring of males improperly develop leading to death 
effectively crashing a population. This is accomplished by irradiation of males 
(Rodriguez et al. 2013, Yamada et al. 2014, Dandalo et al. 2017) and genetic 
modification of reproductive genes (Catteruccia et al. 2009). Companies exploiting these 
technologies, such as Oxitec, are active in Europe and North and South America (Qsim et 
al. 2017). The greatest drawback to these strategies is a costly need to annually release 




1.3.3 Targeting mosquito vector competency to limit virus transmission 
Vector competency is defined by the capacity for a vector to become infected 
with a microbe and for that microbe to replicate to infectious titers sufficient to induce 
disease in a second host. When a mosquito takes up a blood meal, saliva is ejected into 
the human or animal being fed on. Saliva release and blood feeding are not anatomically 
connected (Rozeboom 1960). Thus, in order to be infectious to novel host, the virus must 
make its way from the gut where it originated in a blood meal to the hemolymph of the 
mosquito. Once in the hemolymph, virus is disseminated throughout the body including 
the saliva, legs, and head of the mosquito (Figure 1.5).  
Symbiotic bacteria and pre-existing viruses pose significant barriers to a virus 
invading a mosquito. Virus in the blood meal is first exposed to the gut environment. 
This is a range of different pHs and heavily colonized by bacteria (Boudko et al. 2001, 
Chandel et al. 2013, Coon et al. 2014). The extracellular resident microbes currently in 
the digestive tract of the mosquito may release antiviral compounds to prime an immune 
response (Ramirez et al. 2014). Mosquitos have a robust innate immune response guided 
by the Toll and IMD pathways (Shin et al. 2003, Xi et al. 2008). If the virus evades this 
response and successfully infects the cells surrounding the gut epithelium, it now faces a 
second challenge, intracellular viruses and bacteria (Jupatanakul et al. 2014). The use of 
these diverse microbes to control arbovirus transmission is a broad and exciting area of 






Figure 1.5 Viral uptake and replication in the mosquito 
 
Female mosquitos are infected with pathogenic viruses taken up during a blood meal. The 
virus enters the mosquito gut and then must escape to become infectious to a new 
recipient of mosquito saliva. The virus must replicate in either the gut epithelium, the 
hemolymph (mosquito “blood”), or salivary glands. Mosquitos have an open circulatory 
system disseminating the virus throughout the body after replication. This process takes 
7-14 days. Thus, for a mosquito to become an infectious vector competent to transmit 





1.4 Wolbachia pipientis co-infection has strong potential to limit mosquito 
population and disease transmission 
Wolbachia pipientis are intracellular bacteria that affect host reproduction by 
infecting the gonads of its host (Werren et al. 2008). Wolbachia were first identified in 
wild mosquito populations (Hertig 1936). Infecting naïve mosquitos with Wolbachia has 
potential to limit arbovirus disease by two methods accomplished by either male or 
female mosquitos. Infecting male mosquitos has the potential to decrease mosquito 
populations. Infecting female mosquitos has a direct impact on the capacity for a 
mosquito to transmit disease.  
Certain strains of Wolbachia can induce cytoplasmic incompatibility (CI) (Zabalou 
et al. 2004). CI occurs when a male is unable to produce offspring with the female. The 
embryos die early in embryogenesis. Wolbachia infection induces CI when Wolbachia is 
present in the male but not the female mosquito (Yen and Barr 1973). Thus, releasing 
Wolbachia infected males has the potential to decrease the mosquito population.  
CI was first utilized to eradicate Culex pipiens fatigans mosquito populations in the 
late 1960s (Laven 1967), although it was not yet known that Wolbachia infection was the 
cause or how CI was induced. It was recently shown that Wolbachia dysregulate two 
deubiquinating proteins carried by the male sperm causing CI (Beckmann et al. 2017).  
This strategy has given rise to several companies employing Wolbachia for A. aegypti 
SIT-like control (Sinkins 2004). The drawback to this strategy is the constant need to 




approach. A self-renewing strategy would benefit areas that cannot maintain release or 
control costs.  
In contrast to the SIT approaches utilizing Wolbachia infection in males, female 
mosquitos carrying Wolbachia also limit arbovirus transmission through a novel 
mechanism. Wolbachia-infected female mosquitos have reduced capacity to transmit 
pathogens because of the hindrance of viral growth (reviewed by (Caragata et al. 2016)). 
Wolbachia infection was first shown to protect its host from pathogenic virus infection in 
Drosophila melanogaster.  Within a year, Wolbachia was also shown to block pathogenic 
virus growth in other host including mosquitos (Moreira et al. 2009).   
Some mosquitos including A. albopictus (Armbruster et al. 2003), A. fluviatilis 
(Baton et al. 2013), and C. pipiens (Hertig 1936) are naturally infected with strains of 
Wolbachia (Table 1.2). These native infections have been shown to limit virus replication 
(Glaser and Meola 2010, Mousson et al. 2012, Raquin et al. 2015). However, not all 
mosquitos are naturally infected with Wolbachia causing a need to introduce Wolbachia 
to naïve vector competent mosquitos. A. aegypti, a prominent vector of DENV, CHIKV, 
and ZIKV is naturally devoid of Wolbachia. Wolbachia infected A. aegypti mosquitos 







Table 1.2 Native Wolbachia hosts and their respective Wolbachia strain 
 
Wolbachia strain  Natural host Host description 
wMel D. melanogaster fruit fly  
wMelPOP D. melanogaster fruit fly  
wAlbB A. albopictus mosquito 
wAlbA A. albopictus mosquito 
wFlu A. fluviatilis  mosquito 
wPip C. pipiens mosquito 
wPip C. quinquefasciatus mosquito 
wStri L. striatellus leafhopper 
 
Wolbachia consists of divergent strains which coevolved with their hosts. 
Wolbachia strains can be a range of parasitic or mutualistic depending on their host. 
Figure 1.6 (Werren et al. 2008) demonstrates the divergence of Wolbachia phylogeny by 
host (arthropod, nematode, etc.) and the supergroups which form distinct clades aligning 
with these hosts. The most well studied Wolbachia strains are in supergroup A and are 
symbionts of the model organism D. melanogaster: wMel and wMelPOP. These 
Wolbachia strains were the first to be implicated in the direct repression of virus growth 
(Hedges et al. 2008, Moreira et al. 2009).  
wMelPOP is a pathogenic strain of Wolbachia which grows to high densities in A. 
aegypti (McMeniman et al. 2009, Suh et al. 2017). wMelPOP was first introduced to A. 
aegypti mosquitos through serial passaging in A. aegypti cell culture (McMeniman et al. 
2008) and then into live animals (McMeniman et al. 2009). wMelPOP was shown to be a 
potent inhibitor of DENV (Moreira et al. 2009), CHIKV (Moreira et al. 2009, Van Den 




(Table 1.3). However, as a pathogenic strain, wMelPOP is a detriment to host fitness 
limiting natural incorporation into a population (Nguyen et al. 2015). Thus, the release of 
wMelPOP infected A. aegypti mosquitos would not be sustainable and a less pathogenic 
strain is required for self-sustaining biocontrol of mosquito-borne viruses.  
wMel is a sister strain of wMelPOP which is also native to D. melanogaster. In 
contrast to wMelPOP, wMel resides at lower densities in Drosophila (Toomey and 
Frydman 2014) and mosquitos (Voronin et al. 2010). wMel has also been described to 
inhibit DENV (Walker et al. 2011, Blagrove et al. 2012, Ye et al. 2015), ZIKV (Aliota et 
al. 2016, Dutra et al. 2016), CHIKV (Blagrove et al. 2013, Aliota et al. 2016), and WNV 
(Joubert and O'Neill 2017) (Table 1.3). However, wMel does not limit YFV in A. aegypti 
(Van Den Hurk et al. 2012). wMel causes far fewer fitness costs to the mosquito host 
(Blagrove et al. 2013). Further, wMel induces CI in mosquitos which and is thus 
favorable to promote itself into a population.  
1.4.1 A call for novel Wolbachia strains to reduce arboviruses  
Studies and models project wMel to successfully integrate into a population 
(Ferguson et al. 2015). However, more recent studies demonstrate that supergroup A 
Wolbachia including wMel have reduced maternal transmission and CI when grown at 
cycling temperatures that are naturally observed (Ross et al. 2017). In contrast, a 
supergroup B Wolbachia, wAlbB, was unaffected by cycling temperatures suggesting a 





Wolbachia from supergroup B have been investigated for their ability to suppress 
mosquito-borne viruses in Aedes mosquitos. wAlbB, the natural resident of A. albopictus, 
resides at low densities causing moderate inhibition of DENV (Lu et al. 2012, Mousson 
et al. 2012) and CHIKV (Mousson et al. 2010, Raquin et al. 2015) (Table 1.3). However, 
wAlbB causes a more pronounced repression of DENV in a non-native host: A. aegypti 
(Bian et al. 2010, Joubert et al. 2016). Studies have also shown that superinfection of 
wMel with wAlbB can suppress DENV and potentially help sustain overall Wolbachia 
titers in A. aegypti mosquitos (Joubert et al. 2016). wAlbB has also been shown to repress 
WNV in A. aegypti (Joubert and O'Neill 2017) but in contrast enhances WNV in C. 
tarsalis mosquitos (Dodson et al. 2014). Taken together, these studies suggest wAlbB 







Figure 1.6 Wolbachia phylogeny and supergroups 
 
(A) Wolbachia are intracellular gram-negative bacteria in the Anaplasmataceae family. 
There is only one accepted species of Wolbachia. However, many strains of Wolbachia 
have been identified. (B) Wolbachia strains form distinct phylogenetic clades in 
alignment with their native co-evolved host. Wolbachia’s relationship with its host can 
vary from mutualism to parasitism depending on the host and Wolbachia strain. Figure by 















Table 1.3 Wolbachia effect on arbovirus growth by strain and host 
wMelPOP DENV ZIKV YFV WNV CHIKV 
A. aegypti Inhibits DV2 
(Moreira et al. 2009) 
(Frentiu et al. 2010)* 
(Walker et al. 2011) 
(Rancès et al. 2013) 
(Geoghegan et al. 2017)* 
N.d. Inhibits 
(Van Den Hurk et al. 
2012) 
Inhibits 
(Hussain et al. 2013) 
Inhibits 
(Moreira et al. 2009) 
      
A. albopictus DV2 (Frentiu et al. 2010)*   N.d. N.d. N.d. N.d. 
      
wMel DENV ZIKV YFV WNV CHIKV 
A. aegypti Inhibits 
DV2 (Bian et al. 2010)  
DV2 (Walker et al. 2011)  
DV1, DV2 (Frentiu et al. 
2014)  
DV3 (Ye et al. 2015)  
DV3 (Amuzu and McGraw 
2016)  
DV2 (Joubert et al. 2016)  
DV2 (Terradas et al. 2017)*  
Inhibits 
(Dutra et al. 
2016) 




(Van Den Hurk et al. 
2012) 
No effect   
(Hussain et al. 2013) 
Inhibits 
(Aliota et al. 2016) 
(Van Den Hurk et al. 
2012) 
      
A. albopictus Inhibits 
DV2 (Blagrove et al. 2012)  
N.d. N.d. N.d. Inhibits 
(Blagrove et al. 2013) 




DV2 (Rancès et al. 2012) 
N.d. N.d. Inhibits 
(Glaser and Meola 
2010) 
No effect 










wAlbB DENV ZIKV YFV WNV CHIKV 
A. aegypti Inhibits DV2 
(Lu et al. 2012) * 
(Pan et al. 2012) 
(Joubert et al. 2016)  
(Joubert and O'Neill 2017) 
N.d. N.d. Inhibits 
(Joubert and O'Neill 2017) 
N.d. 
      
A. albopictus Inhibits DV2 
(Lu et al. 2012)* 
(Mousson et al. 2012)  
N.d. N.d.  N.d. Inhibits 
(Mousson et al. 2010) 
(Raquin et al. 2015)* 
      
C. tarsalis N.d. N.d. N.d. Enhances replication 
(Dodson et al. 2014) 
N.d. 
      
wPip DENV ZIKV YFV WNV CHIKV 
C. quinquefasciatus N.d. 
 
N.d. N.d. Inhibits 




N.d.= Not determined 
 
 
       *in vitro 




1.4.2 Putative mechanisms of Wolbachia-virus suppression 
The expansion of Wolbachia studies has allowed for the development of multiple 
in vitro and in vivo models to investigate the mechanism of Wolbachia-mediated viral 
repression. These studies have resulted in three overarching hypotheses. (1) Wolbachia 
primes the host innate immune system. (2) Wolbachia sequesters key host nutrients that 
the virus requires to infect and replicate at a cellular level. (3) Wolbachia upregulates 
proteins that can have an antiviral or suppressive effect of viral genome replication such 
as methylation. It is likely that a combination of these mechanisms inhibits viral growth 
in mosquito cells. In this section, we will review these mechanisms and their supporting 
data. 
Wolbachia stimulates innate defenses which in turn represses viruses (Rancès et 
al. 2012). Mosquito innate immunity consists of three main pathways: IMD, Toll, and 
small interfering RNAs (RNAi) (Guo and Wang 2015). The IMD pathway is not required 
for Wolbachia mediated viral repression (Rancès et al. 2013). Conflicting data negates 
(Rancès et al. 2013) or implicates (Pan et al. 2012) Toll-mediated virus protection by the 
stimulation of reactive oxygen species to repress virus growth. RNAi is not required 
(Hedges et al. 2012) but may play a small part in enhancing virus repression (Terradas et 
al. 2017). Together these studies show innate immunity may promote some viral 
protection but that there are additional mechanisms by which Wolbachia block virus 
growth.  
Competition between Wolbachia and the virus for host nutrients has also been 




host for amino acids and cholesterol (Caragata et al. 2014), and to alter host lipid 
metabolism profiles (Molloy et al. 2016). Cholesterol and lipids are important for virus 
entry, replication, and assembly (Stiasny et al. 2003, Mazzon and Mercer 2014) thus may 
be demand by both Wolbachia and the virus. In the model system, D. melanogaster, 
feeding flies with cholesterol has been shown to rescue Drosophila C virus (DCV) 
growth in the presence of Wolbachia, implying that Wolbachia were sequestering 
cholesterol from DCV (Caragata et al. 2013). It was recently shown that free and 
esterified cholesterol as well as lipid transport proteins are dysregulated in Wolbachia 
wMelPOP infected A. aegypti cells (Geoghegan et al. 2017). However, the authors did 
not observe a rescue in viral growth when free cholesterol was supplemented in 
Wolbachia infected cells. Further research is needed to delineate how cholesterol or lipids 
may be involved in Wolbachia mediated viral repression. 
The final and most recent mechanism proposed is that Wolbachia modulate 
methylation to suppress viral pathogens. Wolbachia disrupts global methylation of its 
host genome and RNA (Ye et al. 2013). RNA methylation is a means to control viral 
translation and genome replication (Lichinchi et al. 2016). Dnmt2 is an RNA 
methyltransferase which is dysregulated by Wolbachia. Dnmt2 has been shown to be 
upregulated by Wolbachia to repress Sindbis virus (SINV) (alphavirus) growth 
(Bhattacharya et al. 2017) in D. melanogaster. However, in A. aegypti, Dnmt2 has been 
shown to be down regulated by Wolbachia limiting the growth of DENV (Zhang et al. 
2013). These contradicting results may be due to different methylation control of 




different host organisms. Further studies are needed to elucidate how these mechanisms 
work individually and in conjunction to suppress viral growth in Wolbachia infected 
cells. 
1.4.3 Field implementation of Wolbachia mediated arbovirus control  
Field trials are testing Wolbachia mediated virus control in Australia, Brazil, and 
Southeast Asia. Optimizing when and how many Wolbachia infected mosquitos are 
needed to release to successfully incorporate Wolbachia into a population was a key first 
step in implementation and has been determined (Schmidt et al. 2017). Wolbachia are 
maternally transmitted from mother to offspring. Maternal transmission coupled with CI 
(discussed under population control) provides a fitness advantage to Wolbachia infected 
mosquitos. This advantage allows Wolbachia-infected mosquitos to efficiently overtake a 
population of Wolbachia-free mosquitos. The Wolbachia infection is then self-sustained 
in a population (Ferguson et al. 2015). Trials have shown that wMel infected A. aegypti 
laboratory and wild mosquitos which are fed viremic blood from a DENV infected 
patient have reduced DENV titers and prolonged dissemination (Carrington et al. 2017). 
However, epidemiological data of DENV transmission in regions with Wolbachia 
infected mosquitos compared to areas without Wolbachia infected mosquitos are not yet 
available. Future efforts will assess the efficacy of this strategy through annual disease 
occurrence in arbovirus endemic areas.  
Additional efforts are needed to address and understand Wolbachia mediated 
virus control in additional mosquito genera, especially Culex sp. Unlike Aedes sp. 




(Wimberly et al. 2014) and Europe (Rizzoli et al. 2015). Culex mosquitos transmit 
human pathogens including WNV, JEV, St. Louis encephalitis virus (SLEV), and USUV 
(Mackenzie et al. 2004, Nikolay 2015). There are currently no Wolbachia based 
strategies to control Culex mosquito transmitted viruses. The contradictory enhancing and 
repressive effect of Wolbachia strains wAlbB and wPip, respectively (Table 1.3), suggest 
that additional studies and perhaps alternative strategies are needed to block viral growth 
in Culex sp. mosquitos.  
1.5 Insect specific viruses interfere with viral growth 
Insect specific virus (ISVs) are viruses which infect only an insect and not a 
mammalian cell. ISV interference is a suggested alternative strategy to impede mosquito 
vector competence. ISVs have been identified in the Birnaviridae, Bunyaviridae, 
Flaviviridae (flavivirus), Mesoniviridae, Negeviruses, Nodaviridae, Reoviridae, 
Rhabdoviridae, Togaviridae, and Tymoviridae families (Bolling et al. 2015). The 
majority of these viruses have not been purified and have only been identified through 
metagenomics sequencing (Bolling et al. 2015). The most well characterized family 
including ISVs is the flavivirus family, termed Insect specific flaviviruses (ISfVs) 
(Blitvich and Firth 2015). Several of these viruses such as Culex flavivirus and Palm 
Creek virus (PCV) have been studied in cell lines and mosquitos to better understand 
their growth kinetics (Blitvich and Firth 2015). Other ISVs such as Eilat virus in the 





An established ISV infection can limit arbovirus infection. PCV, an ISfV impedes 
WNV growth in mosquito cell culture (Hobson-Peters et al. 2013). Other ISfVs detected 
in mosquito laboratory colonies (Bolling et al. 2012) or wild mosquitos (Blitvich and 
Firth 2015, McLean et al. 2015, Hall et al. 2016) have been shown to also restrict 
arbovirus growth. However, this repression is not universal. Some ISfV have been shown 
to enhance the growth of arbovirus growth, specifically DENV (Zhang et al. 2017). 
Further investigation of ISV repression of direct interference or engineered (Erasmus et 
al. 2017) interference with arboviruses will offer alternative strategies to limit disease. 
1.6 Gut microbiota are the initial line of defense blocking virus infection in the 
mosquito host. 
Mosquito guts are the first opportunity for a mosquito to eliminate an arbovirus 
pathogen (Hegde et al. 2015). After an infectious blood meal is consumed, the virus must 
infiltrate epithelial cells lining the mosquito gut. From here, virus amplifies in the 
mosquito midgut epithelium and escapes to the hemolymph (Salazar et al. 2007). 
Mosquitos have an open circulatory system facilitating dissemination of the virus. Virus 
may reach the salivary glands to perpetuate transmission (Salazar et al. 2007) seven to 
fourteen days post blood feeding, depending on host genotype (Bennett et al. 2005) and 
virus species. 
Mosquito guts are host to a range microbial communities with conserved 
dominant bacteria such as Enterobacteriaceae and also may include up to 20 unique 
species depending on the population and environment (Chandel et al. 2013, Duguma et 




correlated with an increase in the transmission of infectious diseases (Keesing et al. 
2010). Recent studies have investigated the composition and application of gut 
microbiota to limit arbovirus disease. Several symbiotic bacteria (Serratia, Asaia) 
directly impede the vector competency of mosquitos to transmit human pathogens such as 
DENV, CHIKV, and WNV (Hedges et al. 2008, Moreira et al. 2009, Glaser and Meola 
2010, Weiss and Aksoy 2011) suggesting that engineering gut microbiota may be a 
promising approach to arbovirus control.  
1.7 Dissertation rationale  
  The biocontrol of arboviruses is a broad and rapidly expanding field with the 
potential to limit the global arbovirus disease burden. When I applied to graduate school, 
I was interested in coupling my experience in flavivirus virology with the promising 
biocontrol strategy of co-infecting mosquitos with Wolbachia. Large collaborations had 
been in place since my early undergraduate career to establish Wolbachia to drive out 
endemic DENV in Brazil, Australia, and Thailand with all of the emphasis of Wolbachia 
mediated control by the strain wMel. It was curious to me why and if this strain from D. 
melanogaster was the best choice for biocontrol of arbovirus threats. 
I sought out Horacio Frydman’s lab at Boston University to address this question. 
The Frydman lab studies how Wolbachia alters and interacts with its host in a tissue and 
strain specific manner. Wolbachia strains that are closely related (i.e. strains within 
supergroup A) are highly genetically divergent (Ishmael et al. 2009) and have been 
argued to be independent species (Ramirez-Puebla et al. 2015, Lindsey et al. 2016, 




colonized by different strains of Wolbachia (Toomey et al. 2013) and the density of that 
colonization (Toomey and Frydman 2014) depends primarily on the strain of Wolbachia, 
rather than the host. I was interested to understand how this strain specific effect 
translated to arbovirus control.   
Additional studies supported the exploration of Wolbachia strains other than 
wMel.  Supergroup A Wolbachia including wMel were shown to have temperature 
dependent maternal transmission compromising their ability to integrate into some 
populations (Ross et al. 2017). This directed my interest towards supergroup B 
Wolbachia. Supergroup B Wolbachia had previously been implicated in CHIKV and 
DENV control (Mousson et al. 2012, Raquin et al. 2015) but it had not been determined 
if this strain would also repress the most recent arbovirus threat, ZIKV. Cell line 
adaptation is the first step towards using a new Wolbachia strain to block arboviruses. 
Consequently, I strategized a list of sources of supergroup B Wolbachia strains in 
mosquito cell lines. I found wAlbB established in A. aegypti and A. albopictus from 
Zhiyong Xi and wStri infected A. albopictus cells from Ann Fallon. These researchers 
kindly shared their cells allowing me to investigate arbovirus interactions. My efforts to 
investigate the effect of supergroup B Wolbachia strains wAlbB and wStri are described 
in Chapter 3. 
Wolbachia studies are often carried out in complex in vivo systems. However, a 
few in vitro systems where molecular interactions can more easily be studied have been 
established. Wolbachia’s robust four log repression of DENV observed in vivo by each 




wMel (Aag2wMel) (Terradas et al. 2017) or wAlbB (w-Aag2) (Lu et al. 2012). These 
cell lines were previously used to characterize the role of innate immunity in Wolbachia 
mediated virus repression. Aag2wMel cells have approximately 1 log reduction of DENV 
(Terradas et al. 2017) while wAlbB infected Aag2 cells repressed DENV by 3 to 6 logs 
indicating high variability (Lu et al. 2012). This low inhibition and high variability 
suggested I study my strains in cells other than A. aegypti. 
A. albopictus is a close relative of A. aegypti and a vector of ZIKV. Although the 
feeding behavior of A. aegypti provides more opportunity to transmit ZIKV, A. 
albopictus and A. aegypti are equally competent and permissive of ZIKV (Chouin-
Carneiro et al. 2016). I investigated ZIKV growth in A. albopictus cells with supergroup 
B Wolbachia, wAlbB (Aa23wAlbB) and wStri (CwStri) to determine if supergroup B 
Wolbachia repress ZIKV. Interestingly, the results from CwStri cells suggested that these 
cells may provide a promising model system for future studies investigating Wolbachia-
arbovirus interactions. To further characterize this system, I assessed if CwStri cell 
repression was representative of other model Wolbachia systems by comparing 
Wolbachia density (Lu et al. 2012), virus inhibition early in viral growth (Rainey et al. 
2016, Bhattacharya et al. 2017), and rescue of viral growth by cholesterol 
supplementation (Caragata et al. 2013) or TET treatment (Lu et al. 2012). 
Characterization of the CwStri model to investigate ZIKV repression in vitro is discussed 
in Chapter 3. 
After establishing that wStri prevented ZIKV growth in Aedes cells, I was 




Wolbachia interference with arboviruses was largely restricted to positive sense RNA 
viruses in the flavivirus and alphavirus family. Repression of Rift Valley fever virus and 
La Crosse virus (LACV) (negative sense RNA viruses) in their natural urban mosquito 
vector, Aedes sp. (Pepin et al. 2010) had not yet been studied. However, some studies in 
Culex sp. suggested that Wolbachia do not repress negative sense RNA viruses (Glaser 
and Meola 2010, Dodson et al. 2017). With the help of our collaborators in the lab of 
Sharon Isern and Scott Michael at Florida Gulf Coast University, we tested positive and 
negative sense RNA viruses to better understand the range of wStri mediated arbovirus 
repression. The range of host protection by supergroup B Wolbachia strain wStri is 
described in Chapter 4. 
Following these experiments, I was interested in exploring mechanisms of 
Wolbachia virus interaction. Mechanistic studies of Wolbachia mediated virus control 
have thus far been viewed from the prospective of the host. These studies look at host 
factors such as immune system activators in the Aedes mosquito to decipher how 
Wolbachia represses viral growth. These candidate gene approaches suggested that 
Wolbachia impede viral growth through immune priming, nutrient competition, or lipid 
dysregulation yet lack a specific connection to viral infection. I wanted to take a different 
approach to understanding Wolbachia mediated virus restriction by virus inhibition from 
the prospective of the viral lifecycle.  
Isolating the different stages of viral infection required significant troubleshooting 
and innovation. Isolation of viral entry was most difficult. I initially tried to directly 




lacked the resolution needed to quantify entry events suggesting amplification of virus 
signal was needed. Amplification of viral infection is naturally reported by viral genome 
replication and growth. To uncouple entry from viral replication, the amplification of an 
entry reporter that was not dependent on viral machinery was needed. Pseudotyped virus 
with Vesicular stomatitis virus (VSV) expressing the ZIKV envelope protein on their 
outer surface and internally encoding a GFP reporter has been shown to induce ZIKV 
specific antibodies and can be repressed by ZIKV antibodies (Betancourt et al. 2017). 
However, after producing high quantities of Envelope expressing VSV, no ZIKV 
dependent entry was observed in Aedes cells with or without Wolbachia. As a result, I 
turned back to imaging using native ZIKV but amplifying the signal with a bright 
fluorescent conjugate, BODIPY which allowed me to assess entry inhibition. Beyond 
entry, virus genome replication could independently be altered by Wolbachia. I bypassed 
entry using transfection techniques to quantify post entry blocks and align Wolbachia 
inhibition with specific stages of virus infection. 
As suggested in section 1.3.2, one way that Wolbachia interferes with virus 
growth is through cholesterol and lipid dysregulation in Wolbachia infected cells. 
Wolbachia resides in a triple membrane derived from the host (Cho et al. 2011) and the 
requirement of lipids for flaviviruses has been well established (Stiasny et al. 2003, Smit 
et al. 2011). I was interested to see if cholesterol or lipid supplement would rescue viral 
growth at one of the specific blocks I determined. These results, discussed in Chapter 4, 




 I next wanted to assess if wStri inhibits ZIKV in A. aegypti cells so that this strain 
could be directly compared to the currently used wMel/A.aegypti strategy. I found ZIKV 
growth in A. aegypti Aag2 cells with or without Wolbachia to be highly variable, 
consistent with previous reports of DENV growth in these cells. To better understand the 
limitations of A. aegypti cells, I focused on cells devoid of Wolbachia to limit the number 
of variables impacting viral growth. Shortly after I characterized ZIKV growth in the 
Aag2 cells, a timely report showing that Wolbachia interferes with ISVs in Aag2 cells 
shed light on the dual infection of Aag2 cells with Cell fusing agent virus (CFAV) and 
Phasi Charoen like virus (PCLV) (Schnettler et al. 2016). I recreated this dual infection in 
A. albopictus cells to determine if ISV dual infection could interfere with arbovirus 
growth in Aag2 cells. The characterization of ZIKV growth and effect of ISV dual 
infection in Aedes cells on arbovirus growth is discussed in Chapter 5.  
 As part of my dissertation, I also include a characterization of the C. pipiens gut 
microbiota. Current studies showing a Wolbachia strain specific enhancement of WNV in 
C. tarsalis mosquitos (Dodson et al. 2014) suggest that Wolbachia may not be as 
successful at repressing viruses in Culex sp. as it is in Aedes sp. mosquitos. Because gut 
microbiota are the first interaction for a virus inside a mosquito host, studies have 
suggested the engineering of mosquito extracellular gut microbiota to block arbovirus 
infection. C. pipiens are prominent vectors of several viruses including WNV. This 
strategy has not been expanded to C. pipiens perhaps because the gut microbiota has not 
yet been cultured and studied. I characterized the gut microbiota by 16S profiling and 




sequenced the full genome of each isolate.  I also assessed the metabolic capacity of each 
isolate providing additional tools to aid future arbovirus control strategies in C. pipiens 
mosquitos.   
 Together these studies provide important tools and understanding to advance to 
the biocontrol of arboviruses in the mosquito vector. I identified Wolbachia strains to aid 
ZIKV control in Aedes sp. mosquitos and uncovered specific blocks in viral growth 
caused by Wolbachia. I show a role for cholesterol in the impotence of viral infection in 
Wolbachia infected cells. I determined a lack of permissivity in A. aegypti cells to be 
caused by dual ISV infection facilitating a more thorough understanding of the variability 
of these cells. Lastly, I expanded the understanding of microbial communities in C. 
pipiens mosquitos. The microbial interactions defined here increase the reservoir of tools 





CHAPTER 2: Materials & Methods 
2.1 Insect cell culture 
A. albopictus C710 W- and CwStri cells were provided by Ann Fallon. CwStri 
cells were derived from C710 cells which were transinfected with Wolbachia pipientis 
wStri from the planthopper, Laodelphax striatellus (Fallon et al. 2013). C710 and CwStri 
cells were grown at 28°C with 5% CO2 and subcultured weekly at a 1:5 dilution in E-5 
media as previously described (Fallon et al. 2013). All experiments in C710 W- and 
CwStri cells described here used E-5 media. However, these cells were readily adapted to 
Schneider’s media with 10% tetracycline (TET) tested fetal bovine serum (FBS). 
A. albopictus Aa23 cells with and without a stable Wolbachia pipientis wAlbB 
infection were provided by Zhiyong Xi. Aa23 are derived from A. albopictus with a 
natural Wolbachia pipientis wAlbB infection. Aa23 W- were treated with TET to remove 
Wolbachia (Lu et al. 2012). wAlbB infected cells were subcultured weekly at a 1:5 
dilution. Cells were grown in Schneider’s media with 10% TET-tested fetal bovine serum 
and 50ug/mL penicillin and 50ug/mL streptomycin at 28°C with 5%CO2. 
A. albopictus C6/36 cells were cultured in Minimal Essential Media (MEM) with 
10% FBS, 1X nonessential amino acids, and 2mM glutamine. C6/36 cells were 
subcultured weekly at a 1:10 dilution.  
A. aegypti Aag2 cells were cultured in Schneider’s media with 10% FBS and 
50ug/mL penicillin and 50ug/mL streptomycin at 28°C with 5% CO2. Cells were split 
1:10 weekly. CCL-125 cells were grown in MEM with 20% FBS as recommended by 




were provided by Zhiyong Xi and Tonya Colpitts. CCL-125 cell lines were obtained from 
Marshall Bloom and the ATCC.  
2.2 Mammalian cell culture 
Macaca mulatta kidney LLC-MK2 (ATCC CCL-7) cells were cultured in 
Dulbecco's Modified Eagle Medium (DMEM) with 10% fetal bovine serum and 2mM 
glutamine at 37°C with 5% CO2. African green monkey (Cercopithecus aethiops) Vero 
E6 (ATCC CRL-158) cells were grown in MEM with 10% fetal bovine serum. African 
green monkey (Cercopithecus aethiops) kidney epithelial cells, Vero (ATCC CCL-81, 
American Type Culture Collection, Manassas, VA), were cultured in DMEM 
supplemented with 10% (v/v) fetal bovine serum, 2 mM Glutamax, 100 U ml− 1 penicillin 
G, 100 μg ml− 1 streptomycin and 0.25 μg ml− 1 amphotericin B at 37 °C with 5% (v/v) 
CO2. LLC-MK2, Vero, and Vero E6 cells were subcultured biweekly at a 1:10 dilution.  
2.3 Phylogenetic analysis of Wolbachia strains 
Phylogenetic analysis was by generating a concatenated sequence using five 
multilocus sequence-typing genes (coxA, fbpA, ftsZ, gatB and hcpA)(Baldo et al. 2006). 
wMel sequences were identified in the assembled genome are available on NCBI 
(accession number AE017196.1). All other genes were identified by BLAST search of 
unassembled genome sequence contigs. wStri sequences were identified from GenBank 
accession numbers LRUH01000003.1 (coxA, gatB),  LRUH01000022.1 (ftsZ), 
LRUH01000049.1 (fbpA), and LRUH01000065.1 (hcpA). wAlbB sequences were 
identified from GenBank accession numbers CAGB01000095.1 (coxA, gatB),  




wMelPop sequences were identified from GenBank accession numbers 
AQQE01000026.1 (coxA), AQQE01000016.1  (gatB),  AQQE01000047.1 (ftsZ), 
AQQE01000005.1 (fbpA), and AQQE01000033.1 (hcpA). wPip sequences were 
identified from GenBank accession numbers CACK01000072.1 (coxA), 
CACK01000072.1 and CACK01000085.1 (gatB),  CACK01000123.1 (ftsZ), 
CACK01000089.1 (fbpA), and CACK01000050.1 (hcpA). Sequences were aligned by 
MUSCLE and the Tamura-Nei model to produce a maximum likelihood tree by in 
MEGA6 (Tamura et al. 2013). 
2.4 Virus stocks 
The following strains were used in this study: DENV-2 NGC, ZIKV PRVABC59, 
YFV 17D, CHIKV 131/25, LACV H78, and VSV Indiana. DENV and ZIKV were 
propagated in C6/36 cells at an MOI of 0.01 for 6 days. ZIKV strain MR766 and 
PRVABC were obtained from Biodefense and Emerging Infections Research Resources 
Repository. DENV-2 NGC was obtained from the lab of Scott Michael and Sharon Isern. 
YFV 17D was recovered from a molecular clone obtained from Charles Rice at 
Rockefeller Institute. YFV 17D was propagated in Vero cells at an MOI of 0.001 for 3 
days.  CHIKV was provided by Robert Tesh at the University of Texas at Galveston. 
Lyophilized CHIKV was reconstituted in serum free DMEM media and propagated in 
Vero cells for 2 days. LACV and VSV were grown in Vero E6 cells at a starting MOI of 
0.01 and harvested when cytopathic effect showed greater than 50% lethality 
(approximately 24-36 hours). Harvested supernatants were pelleted at 4000 RCF, 




To concentrate virus for high MOI experiment, 8% polyethylene glycol 8000 was 
incubated with virus overnight at 4 °C. Virus was pelleted at 30,000 RCF and 
resuspended in NTE (NaCl-Tris-EDTA) buffer. Infectious virus units were quantified by 
focus forming assay. 
2.5 Determining Infectious virus production 
2.5.1 Plaque Assay 
Infectious units of ZIKV, CHIKV, LACV, and VSV were quantified by plaque 
assay. Briefly, Vero cells or Vero E6 cells were plated at ~90% confluency. Serial 
dilutions of virus were incubated with cells for 1 hour followed by removal of the viral 
inoculum and 1.4% Avicel in MEM with 10% FBS was added. Cells were incubated at 
37°C with 5% CO2 for the following durations: ZIKV-5 days, CHIKV-2 days, LACV-3 
days, VSV-1 day. After incubation, overlay was removed by aspiration and cells were 
fixed with 4% formaldehyde for 1 hour at room temperature. Crystal violet was incubated 
with cells for 10 minutes, rinsed in water, and counted. 
2.5.2 Focus Forming Assay 
DENV titer was determined by focus forming assay. Briefly, LLC-MK2 cells 
were incubated with serially diluted virus for 1 hour. Virus was removed and cells were 
rinsed one time before adding 1.4% Avicel in MEM with 10% FBS. Plates were 
incubated for 72 hours, followed by fixation in 10% formalin for 1 hour at room 
temperature then permeabilized with 70% ethanol for 30 minutes. Cell were stained with 




tween 20 and 5% NFDM followed by goat anti-human HRP. Foci were developed with 
0.5mg/mL diaminobenzidine in 25mM Tris-HCl, pH 7.2. Foci were counted and graphed 
in GraphPad Prism 
YF 17D titer was determined by focus forming assay. Vero cells were seeded at a 
density of 5 x105 cells in per well of a 12-well plate 24 hours prior to infection. Serial 
dilutions of virus were incubated with cells for 1 hour followed by removal of the viral 
inoculum, and 1.4% Avicel in MEM with 10% FBS was added. Cells were incubated at 
37°C with 5% CO2 for 48 hours followed by fixation in Formalde-Fresh Solution for 1 
hour at room temperature then permeabilized with 70% ethanol for 30 minutes. Cells 
were stained with flavivirus anti-Envelope protein antibody (1.6D) (Costin et al. 2013) in 
PBS with 0.01% tween 20 and 5% NFDM followed by goat anti-human HRP. Foci were 
visualized by the addition of 3,3-diaminobenzidine tetrahydrochloride. Foci were counted 





Figure 2.1 Focus forming assay method 
 
 
Diagram of focus forming assay technique. Only mature virions produced and released 
by infected cells are detected. 
 
2.6 Tetracycline treatment to reduce Wolbachia density 
Cells were infected at an MOI of 0.01 for 1 hour at 28 ºC. Virus inoculum was 
removed and complete medium with either 0.0235, 0.25, 2.5 µg/mL TET was added to 
each well. Cells were incubated at 28 ºC with 5% CO2 for 5 days. After incubation, 
medium was removed and cells were rinsed one time with PBS. Cellular RNA was 
extracted by Qiagen RNeasy kit per manufacturer recommendations. Quantitative RT-




2.7 Fluorescent in situ hybridization to detect Wolbachia 
Fluorescent in situ hybridization was performed with minor modification to 
previously described (Toomey et al. 2013). Briefly, cells were fixed with 4% 
paraformaldehyde in serum-free media with 0.1% trition and 0.1% Tween 20 for 1 hour. 
Cells were then incubated in hybridization buffer (50% formamide, 5X SSC, 250mg/l 
salmon sperm DNA, 0.5X Denhardt's solution, 20mM Tris HCl, 0.1% SDS) at 37 ºC for 
1 hour. Probes were added in in situ buffer at a concentration of 1ng/µL (probe 1) or 
7.5pg/uL (probe 2). Fluorescent in situ hybridization utilized two Wolbachia 16S rRNA 
probes: Probe 1: 5'Cy3 - ATCTTGCGACCGTAGTCC - 3' and Probe 2: 
5’Alexafluor488-ACATGCTCCACCGCTTGTGCGGGTCCCCGTCAATT-3’. Probes 
were incubated with cells for a minimum of 3 hours at 37 ºC then washed in buffer 1 (1X 
SSC, 20mM Tris-HCl, and 0.1% SDS) followed by wash buffer 2 (0.5XSSC, 20mM Tris-
HCl, and 0.1% SDS) at 37 ºC for 15 minutes each. Cells were stained with Hoechst at 
0.5ug/mL in wash buffer 2 for 30 min at room temperature. Finally, cells were rinsed 
with wash buffer 2 twice and mounted in prolong gold for imaging on an Olympus 
FV100 fluoview confocal microscope. 
2.8 Quantitative RT-PCR  
Cells were infected at an MOI of 0.01 for 1 hour at 28 ºC in serum free medium 
(MEM or Schneider’s Drosophila media). Virus inoculum was removed and complete 
media (with FBS supplement described above) was added to each well. Cells were 
incubated at 28 ºC with 5% CO2 for 5 days. After incubation, medium was removed and 




per manufacturer recommendations. Quantitative RT-PCR was carried out with Roche 
One-Step SYBR green kit. ZIKV primers were previously published (Faye et al. 2008). 
wStri primers and wAlbB primers were made against Wolbachia surface protein . All 









Table 2.1 Primers for quantitative and end point reverse transcription PCR 
 
Target Forward Reverse Application 
annexin x TGATCCAGATCTTGCTGTGC GATGGTACGTCCGGTCAGTT RT-qRTPCR 
apolipoprotein D 1 CCCTTTGACCTCAGCATCAT ATTCACGGCATACTCGAACC RT-qRTPCR 
apolipoprotein D 2 TTCTCCTGTTCGGGACAATC ATCCTCCAGCTCGACATCAT RT-qRTPCR 










RTPCR (end point) 
CFAV CTGATGTGCGTGCAGTTCTT CACAACGGTAGCGAGAGACA RT-qRTPCR 
fatty acid synthase CGGTTTGGTGTTGGAGAACT GAATCGGACACGTTCTTGGT RT-qRTPCR 
fatty acid synthase CGGTTTGGTGTTGGAGAACT GAATCGGACACGTTCTTGGT RT-qRTPCR 
juvenile hormone inducible 
protein 
ATCTTCTGCACGGTCGAAGT TGCCTCTTGATGTCTGCTTG RT-qRTPCR 
lipid depleted protein AACCTTGCGGACAACAAATC CTCCTTCAGACGCTTTTTGG RT-qRTPCR 
Lipophorin receptor GCGTTGATCCGTCTCTTAGC ATTTGGCAGGAGTGTTCCAC RT-qRTPCR 
Lipophorin receptor GCGTTGATCCGTCTCTTAGC ATTTGGCAGGAGTGTTCCAC RT-qRTPCR 
LSD-1 (perilipin 1) CCGATCATCAAGGAACAACC CAGTAGACGCTCGGCCAGT RT-qRTPCR 
LSD-1 (perilipin 1) CCGATCATCAAGGAACAACC CAGTAGACGCTCGGCCAGT RT-qRTPCR 
LSD-2 (perilipin 2) TGGAAGAAAGCCAACGAAG AGGGCTGGATCTTCCTTGA RT-qRTPCR 





RTPCR (end point) 








phospholipase D GTCGGTGGTGCTAGTGGAAT CAGCAATCAACAGCTTGGAA RT-qRTPCR 













steroid dehydrogenase GATGGAATTGGCAAAGCCTA GTTTCGTAGATTTCCGGTCC RT-qRTPCR 

















2.9 Western Blots 
Cells were infected with ZIKV at an MOI of 10 for 1 hour at 28 ºC in serum free 
medium. Virus inoculum was removed and complete medium was added to each well. 
Cells were incubated at 28 ºC with 5% CO2 for 24, 48, or 72 hours. After incubation, 
medium was removed and cells were rinsed one time with PBS. Protein was extracted by 
NP-40 buffer with protease inhibitor on ice for 5 minutes. 15 µg of protein was loaded 
per well in a 10% sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS 
PAGE) TGX mini gel and subsequently transferred to low-fluorescence polyvinylidene 
fluoride membrane (Biorad). After blocking for 1 hour in Odyssey phosphate buffered 
saline (PBS) blocking buffer, proteins were probed for with Genetex polyclonal Rabbit 
anti-Zika NS5 (GTX133312), Abcam mouse anti-Hsp60 LK-2 (ab59458), and Millipore 
mouse anti-actin (MAB1501) in Odyssey Blocking buffer with 0.01% Tween 20 
overnight at 4 ºC. Blots were then incubated with Licor secondary antibodies, IRDye® 
680LT Donkey anti-Mouse IgG (H + L),and IRDye® 800CW Donkey anti-Rabbit IgG 
(H + L) were incubated at 1:5000 in Odyssey blocking buffer with 0.01% Tween 20 and 
0.01% SDS. Membranes were visualized with the Licor Odyssey Clx. Quantitation of 
band intensity was performed with Image studio and graphed in in GraphPad Prism. To 
determine the appropriate statistical test, we consulted a computational 
biologist/statistician (Tom Kepler, Microbiology, Mathematics & Statistics, Boston 
University) who advised us to log-transform the intensity ratios, which typically produces 




2.10 High MOI infections of positive and negative sense RNA viruses in CwStri 
and C710 W- cells 
CwStri and C710 W- cells were seeded at 2 x 105 cells per well in a 12-well plate 
and incubated at 28°C with 5% CO2 for 24 hours. Cells were infected with one of the six 
viruses described above at an MOI of 10 in serum free media (MEM) at 28°C with 5% 
CO2. After 1 hour, virus inoculum was carefully removed and 1mL of E-5 media was 
added per well. Infections were incubated at 28°C with 5% CO2 for 72 hours. Cell 
supernatant was collected and infectious virus was quantified as described above. 
2.11 Assessment of a soluble Wolbachia induced factor to repress Zika virus 
 CwStri and C710 W- cells were seeded at 1 x 105 cells in a total volume of 5mL 
per T-25 flask and incubated at 28°C with 5% CO2 for 5 days. Conditioned media was 
collected and pelleted at 4000 RCF to remove any cells and cell debris. CwStri and C710 
W- cells were seeded at 2 x 105 cells per well in 12 well dish. Cells were infected at an 
MOI of 10 with ZIKV PRVABC59 in serum free media (MEM) for 1 hour at 28°C with 
5% CO2. Post virus absorption, 1mL of conditioned media from either C710 W- or 
CwStri cells was added to cells. Infected cells were incubated at 28°C with 5% CO2 for 3 
days. Supernatant was harvested and infectious virus production was assayed as 
described above.  
2.12 Determining the effect of Wolbachia infection frequency on Zika virus 
growth  
CwStri and C710 W- cells were seeded in varying ratios of CwStri/C710 W- cells 




CO2 for 24 hours. Cells were infected with ZIKV PRVABC59 for 1 hour at 28°C with 
5% CO2 in serum free media (MEM). Virus inoculum was removed and 0.5mL of E-5 
media was added per well. Cells were incubated for 72 hours at 28°C with 5% CO2. Post 
incubation, cell supernatant was collected to determine the production of infectious virus 
as described above and cells were processed for immunofluorescence as described below.  
 Cells were fixed with 4% paraformaldehyde with 0.1% Triton and 0.1% Tween 
20 for 1 hour at room temperature. Cells were then incubated in 70% ethanol for 30 
minutes to further permeabilize the cells. Primary antibody to detect ZIKV Envelope 
protein (D11C) was added at 1 µg/mL in PBS with 0.1% Tween 20. Cells were incubated 
overnight at 4°C. After removing and rinsing primary antibody, cells were incubated for 
30 minutes with 1:500 goat anti-human AlexaFluor 568 (secondary antibody). Secondary 
antibody was removed and rinsed three times with PBS and cells were fixed with 4% 
paraformaldehyde a second time to stabilize the antibody complex during fluorescent in 
situ hybridization. Fluorescent in situ hybridization is described above. 
2.13 BODIPY labelling & Entry assay 
 VSV and ZIKV PRVABC59 were grown in five 150 cm2 flasks in Vero E6 or 
C6/36 cells, respectively. VSV was grown at a low MOI of 0.01 for 24 hours. ZIKV 
PRVABC59 was grown in C6/36 cells for six days. Supernatant was pelleted at 4000 
RCF to remove cell debris and filtered through a 0.2uM PES filter. Virus was pelleted at 
32,000 RPM in a SW32Ti rotor in a Beckman Coulter Optima L-90K Ultracentrifuge. 
Virus pellets were resuspended in 1 mL of PBS with 10 µg/mL BODIPY 650/665.Virus 




was collected and dialyzed in an 8000 dalton molecular weight cut off membrane to 
remove unbound probe for three days in three L of PBS at 4 °C. PBS was exchanged for 
fresh solution each day. After dialysis, virus was collected and aliquoted. Infectious virus 
titer was determined through plaque assay as described above. Virus labelling was 
confirmed on a 10% SDS-PAGE gel. BODIPY 650/665 incorporation was determined 
through imaging on a Licor Odyssey in the 700nm channel. 
 C710 W- and CwStri cells were plated at 3 x 105 cells per chamber on a 
ChamberSlide (LabTekII cat#154526) and incubated at 28 °C with 5% CO2 for 24 hours. 
Cells were infected with VSV-BODIPY or ZIKV-BODIPY at an MOI of 10 for 1 hour at 
28 °C with 5% CO2 in either serum free media (MEM) or serum free media (MEM) with 
cholesterol-lipid supplement at 2X concentration (Schultz et al. 2017). Virus inoculum 
was removed and cells were rinsed three times with PBS. Cells were fixed in 4% 
paraformaldehyde for 1 hour at room temperature and mounted in prolong gold with 
DAPI. Virus absorption was measured by mean BODIPY fluorescence per cell in ImageJ. 
2.14 Cholesterol supplementation in Zika virus infected CwStri cells 
CwStri and C710 W- cells were infected at an MOI of 0.01 for 1 hour at 28 ºC in 
serum free medium. Virus inoculum was removed and complete medium with or without 
cholesterol lipid concentrate (Thermo-fisher cat #12531018). Incubation took place at 28 
ºC with 5% CO2 for 5 days. Supernatant was removed. Cells were rinsed one time with 
PBS and then lysed with Qiagen RLT buffer. RNA was extracted by RNeasy kit per 





2.15 Transfection efficiency of C710 W- and CwStri cells 
 An Alexafluor 568 conjugated probe adhered to the 5’ end of the partial ZIKV 
5’UTR sequence: 5’CTACTCCGCGTTTTAGCATATTGACAATCCGGAATCCT 
CCGG 3’ to make a reporter probe to determine transfection efficiency. CwStri and C710 
cells were seeded at 3.5 x 105 cells per well in 0.5 mL in a 24 well plate and incubated for 
24 hours at 28 °C with 5% CO2. Per well, 1 µg of probe was diluted in 100 µL of 
Optimem with 1 µL of Mirus Bio mRNA boost and 1 µL of Mirus Bio mRNA TransIT 
reagent (MIR 2225), allowed three minutes for lipid complexes to assemble and added to 
cells on top of the media present. Control transfections lacking the DNA probe or 
transfection boost and reagent were conducted simultaneously. Cells were incubated at 
28°C with 5% CO2 for 24 hours. Supernatant was then removed and cells were either 
fixed for imaging analysis or rinsed three times with PBS for plate reader analysis. To 
image probe incorporation into cells, cells were fixed in 4% paraformaldehyde for 1 hour 
at room temperature. Cells were rinsed one time with PBS and mounted in prolong gold 
with DAPI. To quantify probe entry into cells by plate reader analysis, cells were lysed in 
NP40 lysis buffer and 100 µL of cell lysate was transferred to a clear bottom plate. A 
Tecan Spark plate reader was used to determine fluorescence in the 568nm channel.  
2.16 Isolation of infectious RNA and virus genome transfection 
 To isolate infectious viral RNA, five 150cm2 flasks of C6/36 cells were infected 
with ZIKV at an MOI of 0.01. Six days post infection supernatant was pelleted at 4000 
RCF to remove cell debris and filtered through a 0.2uM PES filter. Virus was pelleted at 




Virus pellets were resuspended in 500 µL of Trizol. Trizol RNA extraction was carried 
out per manufacturer’s protocol. Viral RNA was resuspended in 100 µL of RNase free 
water and quantified by a Thermoscientific Nano Drop 2000.  CwStri and C710 cells 
were plated at 3.5 x 105 cells per well in 0.5 mL in a 24 well plate and incubated for 24 
hours at 28 °C with 5% CO2. Each well was transfected with 0.5 µg or 1µg of infectious 
RNA diluted in 100 µL of Optimem with 1 µL of Mirus Bio mRNA boost and 1 µL of 
Mirus Bio mRNA TransIT reagent. Three minutes was allowed for lipid complexes to 
assemble before being added to cells. Cells were incubated for four days at 28 °C with 
5% CO2. 24 hours post transfection cell supernatant was replaced with fresh complete 
media (E-5). At the end of the four day incubation, supernatant was collected and 
infectious virus was assessed by plaque assay as described above. RNA isolation by a 
Qiagen RNeasy extraction did not yield infectious RNA when transfected. 
2.17 Zika virus translation reporter construction 
 A gene block with the 5’ and 3’UTR of ZIKV flanking Firefly luciferase was 
designed and purchased from Integrated DNA Technologies. The 5’ and 3’UTR of ZIKV 
was derived from ZIKV strain FSS13025 [GenBank accession number KU955593.1]. 
The gene block was cloned into a TOPO cloning vector and amplified with the primers in 
Table 2.1. To amplify, the PCR reaction was subjected to 40 cycles of 95°C for 30 
seconds, 60°C for one minute, 72°C for three minutes. DNA was quantified by a 
Thermoscientific Nano Drop 2000. 1 µg of DNA was in vitro transcribed by mMessenger 
mMachine T7 kit by thermofisher scientific (AM1344). Capped RNA was isolated by 




plated at 3.5 x 105 cells per well in 0.5 mL in a 24 well plate and incubated for 24 hours 
at 28 °C with 5% CO2. Each well was transfected with 1 µg of RNA reporter construct 
diluted in 100uL of Optimem with 1uL of Mirus Bio mRNA boost and 1uL of Mirus Bio 
mRNA TransIT reagent. Three minutes was allowed for lipid complexes to assemble 
before being added to cells. Transfected cells were incubated at 28°C with 5% CO2 for 24 
hours. Cell supernatant was removed and cells were lysed in 100 µL of NanoGlo Firefly 
luciferase reagent (Promega N1110). Luminescence was determined on a Tecan Spark 
Plate reader.  
2.18 35S Methionine pulse treatment to assess translation in C710 W- and CwStri 
cells 
 C710 W- and CwStri cells were seeded at 5 x 105 cells/well in a 12 well plate and 
incubated for 24 hours at 28°C with 5% CO2. Cells were methionine starved in Grace’s 
Insect media (-Met) supplemented with 1X non-essential amino acids for 1 hour. 25µCi 
of EasyTag L-[35S]-Methionine was added per well in Grace’s insect media (-Met) for 30 
minutes. To isolate Wolbachia versus host translation, 22.5 µM TET, 10 µM 
Cyclohexamide or both was added to cells throughout starvation and [35S]-Methionine 
pulse. After Methionine pulse, cell supernatant was removed and cells were lysed in 100 
µL NP40 lysis buffer with protease inhibitor for five minutes. Lysate was pelleted at 
10,000 RCF to remove nuclei and supernatant was collected. Supernatant was diluted in 
Sodium dodecyl sulfate (SDS) loading buffer and heated to 95 °C for five minutes. 
Protein lysate was run through a 10% SDS-PAGE gel and stained with coomassie R-250 




Licor Odyssey in the 700nm channel. The gel was dried at 80 °C for three hours on a 
vacuum drier. The dried gel was exposed to a phosphorimager for 2.5 hours and 
radioactive decay was ready on a Biorad imager.  
2.19 Reverse Transcription PCR (end-point) for ISV detection 
1.0 x105 cells were collected for RNA extraction. RNA was extracted by Qiagen 
RNeasy kit per manufacturer recommendations. RT-PCR was carried out with 
Superscript III One-step Reverse transcription PCR kit per manufacturer’s 
recommendations. PCLV primers were previously published (Schnettler et al. 2016) 
(Table 2.1). Rps6 primers used target a conserved region of A. aegypti and A. albopictus 
Rps6 gene (Lee et al. 2012) (Table 2.1). Products were visualized by SYBR green 
nucleic acid dye after running on a 1% agarose gel in Tris-acetate EDTA (TAE). 
2.20 Zika virus Growth curves in Aedes cells 
Aag2, Aa23, and C6/36 cells were plated in a 24 well plate at 5 x 104 cells/well. 
One day post plating, cells were infected with ZIKV MR766 or PRVABC59 at an MOI 
of 0.01 for 1 hour at 28°C in serum-free Schneider’s Drosophila media (Aa23 and Aag2) 
or MEM (C6/36). Virus inoculum was removed and complete media was added to each 
well. Cells were incubated at 28 °C with 5% CO2 and supernatant time points were taken 
from a fresh well every day for 6 days. Supernatant RNA was extracted by Qiagen Viral 
RNA extraction kit per manufacturer recommendations. Quantitative RT-PCR was 




2.21 Generation of Aa23 cells persistently infected with Phasi Charoen like virus 
 PCLV containing supernatant from confluent Aag2 cells was collected and 
centrifuged at maximum speed, filtered through a 0.2uM filter, and aliquoted. A. 
albopictus Aa23 cells were infected with the PCLV stock at a 1:10 dilution. As a control 
for nutrient deprivation, PCLV-free Aa23 cells were incubated with 1:10 dilution of 
Aa23 spent media. Media was replaced at 24 hours post infection. Six days post 
infection, cells were observed for cytopathic effect and plated in 12 well plates at 
1x105cells per well. One day post plating, PCLV and CFAV infection was determined by 
RT PCR (above) in cells and supernatant. A 1:10 dilution of PCLV stock was UV-treated 
at 100µJ/cm2 for 10 minutes rocking every 3.3 minutes to inactivate infectious virus. 
2.22 Arbovirus infection of Aa23 with dual Insect specific virus infection 
Post infection with PCLV or nutrient deprivation (above), Aa23 cells were 
infected at a low (MOI 0.1) or high (MOI 10) of ZIKV PRVABC59, LACV H78, or 
DENV-2 NGC for 1 hour at 28ºC with 5% CO2. After incubation, cells were rinsed one 
time with PBS and 1 mL of Schneider’s media with 10% FBS was added.  Cells were 
incubated for 6 days at 28 ºC with 5% CO2. Supernatant was collected for focus forming 
or plaque assay to determine infectious virus as described above. 
2.23 Sequencing and Phylogenetic analysis 
Virus genome was sequenced by Sanger sequencing using primers in Table 2.2. 
Primers were designed against PCLV Bristol Aag2 sequences (Accession numbers: 
KU936057.1, KU936056.1, and KU936055.1) Sequences were assembled in DNA 




Tamura-Nei model to produce a maximum likelihood tree by in MEGA6 (Tamura et al. 
2013). Resulting sequences were deposited in NCBI GenBank. 
 
Table 2.2 Genome sequencing primers Phasi Charoen like virus 
  
forward reverse 
1 GTTGGACATGAAGCAGTGGC TTTCGCCAGTTCAGACTGCT 
2 AATTAAGATGTCCACTTTGCTCAAT TTCAGTTGCATCTTCTGGCA 
3 AGCAGTCTGAACTGGCGAAA AGTGTGGATGCGTTTCTGGT 
4 AACAAGCTGTTTGGAGGAGAGA ACTGAGCGCAAAAACATGAAGT 
5 ACTTCATGTTTTTGCGCTCAGT TCCCTGCATCATTCCTGTGG 
6 GAGCAGGGAGCCCTTACATT CGCCATTCTTGGTCAACATTCA 
7 ACCCATAACCCTGACAGATGC TCACTTTCTGATGCTGTGTGA 
8 ACACTGATATCATGACTCCCCG AACCCAGCCCATGTTCTCAAT 
9 ATTGAGAACATGGGCTGGGTT GTCTCCCCCAGCTAATTCACA 
10 GTCGATTTCGAAGAAGTAGGTGC TGCTAAACAATACCCTTCTACGTT 
11 TGATATATGCAGCGGCGAGT AAGCCGTAATGAGAGTGAGC 
12 AAGAAACCATAGACCCGGAGTT TGTTTTCCCCTGGATGGAGC 
13 CAACGGTGTTGACTGTGACAA TTCCCCTTACCATCGCTTCTG 
14 ACTGCAGGCTGATAGACGAAC GTGCAACCATGAAACCCTGC 
15 GCCTGTCCCATCTGCGAATA GCACAGCCTCTCAGTTTCCT 
16 GGAAACTGAGAGGCTGTGCT AGCCCCACCATTGGAAAACA 
17 CAGAATTACTGCGCTCAGAAACATA TCACAAAGACCAGCCCCAAA 
 
2.24 Mosquito rearing 
Culex pipiens pipiens were conventionally reared in the insectary at 28° C, ~60% 
relative humidity (RH), and 12 h light: 12 h dark photoperiod. Larvae were fed a standard 
diet consisting of finely rabbit pellets: fish flakes: yeast extract (2:2:1) in plastic covered 
rearing pans with 1 inch of distilled water. Pupae were transferred to plastic cages where 




Females were blood fed defibrinated chicken blood once a week promoting egg laying. 
100-400 eggs were laid 4-10 days post feeding and collected to a larvae pan.  
2.25 C. pipiens gut microbiota cultivation and analysis 
C. pipiens mosquitos were collected and submerged in 10% household bleach for 
one minute under gentle agitation. Mosquitos were then rinsed three times in sterile water 
to dilute out any bleach prior to homogenization. DNA extraction for 16S ribosomal 
profiling was carried out with a Qiagen DNA Blood and Tissue kit per manufacturer’s 
recommendations with additional lysozyme treatment for the extraction of gram positive 
bacteria. Extracted DNA was sequenced as previously described (Simhadri et al. 2017). 
Rama Simhadri prepared DNA for ribosomal profiling and analyzed the Illumina 
sequencing reads in Qiime. 
Mosquito extracts were homogenized in sterile PBS for the cultivation of gut 
microbiota. Supernatant was serially diluted and plated on Tryptic Soy Agar (TSA) or 
Brain and Heart infused agar (BHI) with or without 5% defibrinated chicken blood. After 
48-120h growth at 25 ºC, 25 bacteria with different morphologies were selected. 
Bacterial DNA was extracted as described above. Using the 8F and 1492R primer set, the 
16S rDNA was amplified and sequenced by Sanger sequencing. Seven bacterial colonies 
were chosen based on divergence of their 16S rDNA sequence. A working stock of each 





2.26 C. pipiens gut microbiota genome sequencing and annotation 
PacBio SMRT sequencing was used to determine the full genome of the seven 
isolated bacteria. To prepare samples for PacBio sequencing, bacterial genomic DNA 
was isolated and sheered to ~10,000bp fragments using Covaris spin tubes (catalog no. 
520079). The resulting double stranded DNA fragment ends were ligated with adapters to 
form a single stranded plasmid that is half sense, and half antisense (Figure 2.2). After the 
PacBio polymerase was bound to the ligation adapters, the DNA-polymerase complex is 
bound to magnetic beads and washed over a SMRT cell. A SMRT cell contains 150,000 
Zero Mode Waveguides (ZMWs). Each ZMW is a few angstroms apart allowing for only 
one bound polymerase to enter each well. During the sequencing reaction, the polymerase 
will add fluorescently tagged dNTPs, cleaving the fluorescent probe as each base is 
incorporated. The camera at the bottom of each ZMW reports the fluorescent signal and 
converts that information to a DNA sequence. Since the sequencing reaction is being 
performed on a circular template, each fragment in a single well is sequenced many fold 
over, effectively reducing errors in the process. PacBio sequencing results in 100 to 400X 
coverage of most bacterial genomes.  
A minimum of 100X coverage was obtained for all seven of the bacterial genomes 
and were thus optimal for Hierarchical genome-assembly process (HGAP). HGAP 
assemblies are most reliable when 50X or more coverage is available for de novo 
assembly (Chin et al. 2013). HGAP was used to assemble the genome into large 
segments of DNA with uniform overlapping coverage, called contigs. The contigs were 




realigned to this reference to confirm coverage and correct variants. The completed 
sequence were then annotated by RAST.  
 
Figure 2.2 Pacific Bioscience Single Molecule Real Time Sequencing library 
preparation and SMRT cell technology overview 
 
 
2.27 Biochemical assessment of microbial metabolism 
Genome sequences were deposited in RAST and KEGG for metabolic modeling. 
To further validate these results, pure cultures of each bacteria were subject to various 
mediums for analysis. All tests were conducted via broth mediated inoculation followed 
by incubation at 25ºC for 24-48 hours. For protease production, 120 hour incubation was 
allowed upon negative result. Sulfur Indole Motility (SIM) agar was inoculated to assess 




and Smith 2015). Protease production was assessed by gelatin and casein hydrolysis as 
described (Brown and Smith 2015). Phenylalanine deaminase, nitrate production, citrate 
(Simmons) were previously described. Glucose, lactose, and mannitol fermentation were 
determined as previously described (Brown and Smith 2015). 
Table 2.3 Species-specific primer for Culex gut microbiota 
 
Gene Organism Forward Reverse 




























CHAPTER 3: Group B Wolbachia strains wAlbB and wStri inhibit the growth of 
Zika virus in vitro 
3.1 Preamble 
As was mentioned in the introduction, one promising alternative strategy is to limit 
arbovirus transmission and spread through the use of endosymbiotic bacteria such as 
Wolbachia pipientis (Bourtzis et al. 2014). It is estimated that up to 40% of all insects are 
infected with diverse strains of Wolbachia (Zug and Hammerstein 2012). Wolbachia 
strains which have been investigated for the ability to inhibit arboviruses span two major 
phylogenetic clades (supergroup A and supergroup B) (Kittayapong et al. 2000). 
Wolbachia strains from both clades cultured in Aedes mosquito cells have been shown to 
inhibit the replication of viral pathogens (Moreira et al. 2009, Bian et al. 2010, Frentiu et 
al. 2010, Walker et al. 2011, Hussain et al. 2013, Nguyen et al. 2015). 
Wolbachia-infected Aedes mosquitos have a strong resistance to infection with 
various arboviruses. wMelPop is a pathogenic strain of Wolbachia native to Drosophila 
melanogaster resides at an extreme density with too large of a fitness cost on the 
mosquito to successfully integrate into the mosquito population (Nguyen et al. 2015). 
Wolbachia strain wMel, also indigenous to D. melanogaster, does not have the fitness 
costs caused by wMelPop (Blagrove et al. 2012, Blagrove et al. 2013, Ferguson et al. 
2015). While some models predict successful control of arboviruses by Wolbachia wMel 
strain (Ferguson et al. 2015), concerns have been raised that over time ongoing 
evolutionary adaptations of Wolbachia/vector/virus interactions may undermine the long-




example, recent studies suggest that wMel may struggle to integrate into large mosquito 
populations (Ross et al. 2017). This is due to a loss of maternal transmission, density, and 
reduced ability to induce cytoplasmic compatibility at tropical cyclic temperatures 
simulated in laboratory experiments (Ross et al. 2017). As a result, strategies employing 
alternative Wolbachia strains, which effectively reduce viral titer without large host 
fitness costs, have been suggested to improve the efforts of a Wolbachia-mediated 
suppression strategy (Joubert et al. 2016). 
Here we investigate two Wolbachia strains belonging to the supergroup B, wAlbB 
and wStri, to determine if they effectively inhibit ZIKV in vitro. wAlbB has been reported 
to have opposing phenotypes for different viruses in different mosquito hosts (Mousson 
et al. 2012, Dodson et al. 2014, Raquin et al. 2015, Joubert and O’Neill 2017), making it 
an interesting Wolbachia strain for study.  wStri of leafhopper Laodelphax striatella has 
also been established in A. albopictus culture (Fallon et al. 2013), making it potentially 
useful towards future vector suppression approaches, yet never been studied in the 
context of arboviruses. Our results show both Wolbachia strains inhibit ZIKV in A. 
albopictus cells. Using wStri-infected cells, our data demonstrate the early inhibition of 
virus infection prior to or at transcription and translation of virus. We also provide 
evidence that competition for cholesterol and/or other lipids plays a partial role in the 
suppression of viral infection in Aedes cells harboring the endosymbiont Wolbachia. We 
conclude that wStri and wAlbB are effective inhibitors of ZIKV. This led to the 




3.2 Phylogenetically distinct Wolbachia strains, wStri and wAlbB, successfully 
established in mosquito cell culture inhibit Zika virus in vitro. 
Previous work show Wolbachia wMel strain, belonging to the supergroup A 
(Baldo et al. 2006), inhibit ZIKV in vivo (Aliota et al. 2016, Dutra et al. 2016). To 
increase the repertoire of Wolbachia strains available for ZIKV control and to develop an 
in vitro system amenable to high-throughput approaches, we investigated whether wAlbB 
and wStri strains of Wolbachia were capable of restricting ZIKV infection in mosquito 
cells. These strains are phylogenetically distant from the wMel and wMelPop strains 
(Figure 3.1A). wStri and wAlbB form a clade with wPip, consistent with previous reports 
defining each of these strains as group B Wolbachia strains (Van Meer et al. 1999) 
(Figure 3.1A). Because wAlbB and wStri are adapted to Aedes cell culture, we 
investigated them further to determine if they are candidates for ZIKV control. 
While no investigations have pursued wStri, wAlbB has been shown to inhibit 
DENV, a relative of ZIKV, in Aedes mosquitos (Joubert et al. 2016). Group B Wolbachia 
have been shown to have inhibitory effect on DENV growth in A. albopictus (Bian et al. 
2010, Caragata et al.). Thus, we hypothesized wAlbB and wStri may inhibit ZIKV. To 
investigate this hypothesis, we utilized A. albopictus cells with persistent Wolbachia 
infection. wAlbB infected cells, their respective Wolbachia free cell line (Aa23), as well 
as wStri infected cells, and their respective Wolbachia-free line (C710) were infected 
with ZIKV at a low multiplicity of infection (MOI 0.01). After five days of incubation, 
titers were determined by focus forming assay. Wolbachia strain wAlbB significantly 




mean of 3.5x105 to 2.4x104 focus forming units (FFU) per mL (Figure 3.1B). wAlbB-
containing mosquito cells were also resistant to infection with a clinical isolate of the 
Asian lineage of ZIKV.  Puerto Rican strain PRVABC59, isolated in 2016, produced 
fewer infectious virions in wAlbB-infected cells compared to wAlbB-free cells, from 
7.6x107 to 4.4x103 FFU/mL (Figure 3.1C). Cells infected with Wolbachia strain wStri 
also showed significantly less replication of ZIKV MR766, with titer from wStri-free 
cells of 2.0x105 compared to titers of 7.3x102 from cells containing wStri (Figure 3.1B). 
There was a similar decrease in replication of ZIKV PRVABC from 7.8x105 in wStri-free 
cells to 4.9x102 in cells containing wStri (Figure 1C). Three independent experiments 
show ZIKV titers in wStri-infected cells of ~102, representing repression close to or at the 
limit of detection in this assay. wStri consistently reduced titers below the limit of 
detection while wAlbB cells always grew low levels of virus (Figure 1B and 1C).  
We confirmed this finding by quantitative RT PCR of cells to determine the 
production of viral genome copies. We first looked at viral genome copies by infecting 
Wolbachia-free and Wolbachia-infected cells with ZIKV at a low multiplicity of 
infection (MOI   0.01). After five days of incubation, cell lysates were collected and 
analyzed by quantitative RT-PCR. ZIKV MR766 was only not significantly reduced from 
a CT of ~19 in Wolbachia-free Aa23 cells to a CT of ~22 in Aa23 cell infected with 
wAlbB consistent with the 1 log reduction observed by focus forming assay (Figure 3.1B 
and 1D). ZIKV MR766 RNA was significantly reduced from a CT of ~17 in Wolbachia-
free C710 cells to a CT of 27 or undetectable (CT equivalent to no template control) in 




CwStri cells compared to C710 W- cells consistent with focus forming assay reduction 
(Figure 3.1B and 3.1D). Wolbachia wAlbB and wStri had a robust inhibitory effect on 
ZIKV PRVABC59 (Figure 3.1E). ZIKV PRVABC59 RNA was significantly reduced 
from a CT of ~17 in Aa23 cells to a CT of ~25 in wAlbB infected cells. Likewise, a 
reduction of CT of ~16 in C710 cells to CT of 29 or undetectable in CwStri cells was 
observed (Figure 3.1E).  Both wAlbB infected cells and wStri infected cells significantly 
reduced ZIKV PRVABC59 viral genome copies below the limit of detection showing a 
viral-strain specific effect (Figure 3.1C and 31E). Overall, the data suggest that wStri is 






Figure 3.1 Phylogenetically distinct Wolbachia strains, wStri and wAlbB 
significantly inhibit Zika virus production of infectious virions in A. albopictus cells 
 
(A) Phylogenetic analysis was performed on five concatenated multilocus 
sequence typing genes (coxA, fbpA, ftsZ, gatB and hcpA) (Baldo et al. 2006) by 
MUSCLE alignment and the Tamura-Nei model to produce a maximum likelihood tree 




produced >105 infectious units/mL after initial infection at MOI 0.01. Wolbachia strain 
wAlbB significantly reduced ZIKV MR766 in each experiment (p<0.013 for each 
experiment). Wolbachia strain wStri inhibited ZIKV MR766 in each experiment 
(p<0.016 for each experiment). Statistical significance determined using the Holm-Sidak 
method, with alpha   0.05. Each experiment was analyzed individually, without assuming 
a consistent standard deviation. Statistical tests were calculated by GraphPad Prism. Data 
shown are means and standard deviation of three independent experiments with a 
minimum of two technical replicates each.  (C) Wolbachia strain wAlbB significantly 
reduced ZIKV PRVABC in each experiment (p<0.05 for each experiment). Wolbachia 
strain wStri significantly inhibited ZIKV PRVABC in each experiment (p<0.01 for each 
experiment). Statistical significance determined using the Holm-Sidak method, with 
alpha   0.05. Each experiment was analyzed individually, without assuming a consistent 
standard deviation. Statistical tests were calculated by GraphPad Prism. Data shown are 
means and standard deviation of three independent experiments with a minimum of two 
technical replicates each. The dotted line represents the limit of detection. (D) After 
infection at MOI 0.01, cells were incubated for five days. Cells were assayed for viral 
genome by qRTPCR. Limit of detection was determined based on a no input control. 
wAlbB did not significantly reduce ZIKV MR766 viral genome copies (p>0.05). wStri 
reduces ZIKV MR766 genome copies to undetectable levels (p<0.05 for C710 compared 
to CwStri). Statistical significance was determined by a ratio paired T test. Statistics 
were calculated on the collective of three independent experiments. Statistical tests were 




with no less than two technical replicates each. (E) After infection with PRVABC59 at 
an MOI 0.01, cells were incubated for five days and assayed for viral genome by 
qRTPCR. wAlbB and wStri significantly reduced ZIKV PRVABC59 below the limit of 
detection (dotted line) determined by a no input control (p<0.05 for both strains 
compared to their respective Wolbachia-free lines. Statistical significance was 
determined by a ratio paired T test. Statistics were calculated on the collective of three 
independent experiments. Statistical tests were calculated by GraphPad Prism. Data 
shown are means of three independent experiments with no less than two technical 
replicates each. 
 
3.3 Wolbachia wAlbB and wStri cell lines are infected at similar frequencies yet 
different densities 
To better characterize the Wolbachia wAlbB and wStri infected cells, we 
determined frequency of Wolbachia infection in each cell line by imaging. Fluorescent in 
situ hybridization by two different probes show each Wolbachia strain infected 94% or 
more cells in each cell line (Table 3.1, Figure 3.2A). Wolbachia density has been 
demonstrated to be a determinant of DENV inhibition (Lu et al. 2012). Thus, we 
hypothesized that the stronger inhibition by wStri might therefore be attributed to the 
higher density of this Wolbachia strain compared with wAlbB in cells. We quantitated 
Wolbachia density by Hsp60 band intensity (Figure 3.2B and 3.2C). wAlbB infected cells 
at 2-3 times lower density relative to wStri density (Figure 3.2C). Wolbachia density in a 




therefore hypothesize that Wolbachia strain density caused by strain-specific interactions 
with their host confers an antiviral phenotype. Reduction of wStri density may reduce 
viral protection while increasing wAlbB density may increase the antiviral phenotype 
observed in wStri infected cells.  
 
Table 3.1 Wolbachia wAlbB and wStri infection frequency 
 Using the DIC channel to delineate cell membranes, cells were counted and recorded as 
Wolbachia-infected or Wolbachia-free to determine the frequency of Wolbachia infection 
in each cell line. Two different Wolbachia 16S rRNA probes were used to confirm the 
reliability of this technique across two independent experiments. 
 
Probe 1 % Probe 2 % 
CwStri 125/129 96.9 48/51 94.1 












(A) Fluorescent in situ hybridization of Aa23 cells with and without wAlbB and C710 
cells with and without wStri. Using the DIC channel to delineate cell barriers, cells were 
counted and recorded as Wolbachia-infected or Wolbachia-free to determine the 
frequency of Wolbachia infection in each cell line. Data is recorded in Table 1. (B) 
Western Blot to quantitate Wolbachia density (Hsp60) relative to host (Actin) proteins. 
(C) Hsp60 normalized to Actin band intensity was quantified for of three independent 
experiments to compare wStri density to wAlbB density in A. albopictus cells 
(significant, p<0.05). wStri density is normalized to 1 for each experiment to compare 
wAlbB density. Statistical significance determined by paired T Test one-tailed, alpha  
0.05 on the natural log of the (hsp60/actin) ratio accounting for non-normal distribution 
of fluorescent intensities. Statistical tests were calculated by GraphPad Prism. 
 
 
3.4 TET treatment reduces Wolbachia titer rescuing Zika virus growth 
To further investigate the role of Wolbachia, we asked if the rescue of ZIKV 
growth is dependent on the density of Wolbachia present in ZIKV-challenged cells. 
Treatment of wStri containing cells with increasing concentrations of TET demonstrated 
a reduction in Wolbachia titers from a mean of six copies of Wolbachia surface protein 
(wsp) per host ribosomal protein (Rps6) to less than one copy of wsp per 20 copies of 
Rps6 (Figure 3.3A). When these cells were infected with ZIKV, there was an inverse 
dose-dependent increase in ZIKV replication rescue (Figure 3.3A and 3.3B). ZIKV RNA 
copies in CwStri cells treated with TET increased from undetectable concentrations to 




Thus, ZIKV inhibition in the CwStri line is due to the presence of Wolbachia directly, 
rather than a result of epigenetic or genetic changes caused by Wolbachia that altered the 
cells permissiveness. 
 




(A) TET dose response treatment of Wolbachia titer assayed by Wolbachia surface 
protein by qRT-PCR. Wolbachia concentration was normalized to non-treated conditions. 
Data shown are means of three independent experiments with no less than two technical 
replicates each.  (B) TET dose response of CwStri cells treated with TET post infection 
with ZIKV PRVABC.  ZIKV infection is significantly reduced in wStri-infected cells at 0 
and 0.025ug/mL TET (p<0.001 and p<0.005, respectively). At TET concentrations of 
0.25ug/mL and 2.5ug/mL, ZIKV infection is not significantly different from W- 
comparable treatment (p>0.05). Statistical significance were independently calculated by 




each dose of TET. Discovery determined using the Two-stage linear step-up procedure of 
Benjamini, Krieger and Yekutieli, with Q   1%. Statistical tests were calculated by 
GraphPad Prism. Each TET concentration was analyzed individually, without assuming a 
consistent standard deviation. Data was normalized to C710 W- no treatment. Data 
shown are the mean and standard deviation of three independent experiments.  
 
 
3.5 Wolbachia wStri inhibits Zika virus early in viral infection 
We next wanted to investigate the stage of viral infection which is blocked by 
Wolbachia to gain mechanistic insight. Towards this goal, we chose the strain with the 
most robust effect on virus growth, wStri. We divided the virus lifecycle into two phases 
to investigate a stage of viral inhibition: (1) viral entry, transcription and translation, and 
(2) assembly and release of mature virions (Figure 3.4A). The previous results 
demonstrated Wolbachia inhibition of the production of viral genome and infectious 
particles at a low multiplicity of infection (MOI 0.01) (Figure 3.1). To determine if 
CwStri cells were highly resistant to ZIKV infection, we next infected cells at a high 
multiplicity of infection (MOI 10) and assayed the production of infectious units by FFA. 
We found a consistent significant reduction in FFU in CwStri cells compared to C710 
(p<0.05) (Figure 3.4B). We investigated differences in virus production upstream of the 
production of infectious particles to determine if there is an early block of virus 
production by infecting C710 and CwStri cells with ZIKV PRVABC59 at a high 




three days post infection. We observed a consistent significant reduction in viral genome 
copies from a CT of ~14 in C710 cells to a CT of ~26 in CwStri cells (Figure 3.4C). 
Viral RNA is replicated by nonstructural protein 5 (NS5), a viral protein not 
packaged in the infectious virion. We assessed early virus infection by analyzing NS5 
translation by western blot. Cells were infected with ZIKV PRVABC59 at a high MOI 
(MOI 10) restricting our analysis to fewer rounds of virus amplification, and collected 
after one, two, and three days. CwStri cells infected with ZIKV MR766 translated 
undetectable amounts of NS5 at all time points (Figure 3.4D). Their Wolbachia-free 
C710 cells produced significantly more NS5 with the most robust signal at three days 
post infection (Figure 3.4D). We repeated this analysis with both ZIKV strains MR766 
and PRVABC59 for three independent experiments to quantitate ZIKV NS5 in C710 and 
CwStri cells. Consistent with the time course, ZIKV NS5 was significantly reduced in 
CwStri cells (Figure 3.4E). Hsp60 indicates Wolbachia infection in the C710 cells 












 (A)  Isolation of ZIKV lifecycle: (1) viral entry, transcription and translation and (2) 
assembly and release of mature virions. Quantitative RTPCR and western blot were used 
to assess early infection. Focus forming assay assesses late infection. (B) Infectious virus 
was assayed by focus forming assay three days post infection at a high multiplicity of 
infection (MOI 10) (p<0.05) Statistical significance was determined by a paired T test. 
Statistics were calculated on the collective of three independent experiments. Statistical 
tests were calculated by GraphPad Prism. (C) After infection at MOI 10 cells were 
incubated for three days. Cells were assayed for viral genome by qRTPCR. wStri reduces 
ZIKV PRVABC59 genome copies to undetectable levels (p<0.05). Statistical 
significance was determined by a ratio paired T test on the collective of three independent 
experiments calculated by GraphPad Prism. Data shown are means of three independent 
experiments with no less than two technical replicates each. (D) C710 and CwStri cells 
were assayed for NS5 production by western blot one, two, and three days post infection 
at MOI 10.  (E) ZIKV MR766 and PRVABC NS5 expression is significantly reduced 
following high multiplicity of infection (MOI 10) in wStri infected cells (p<0.05 for both 
ZIKV strains). Statistical significance was determined by one tailed a ratio paired T test 
under the assumption that samples are from a population where the log of the ratios 
follows a Gaussian distribution. Statistics were calculated on the collective of three 
independent experiments. Statistical tests were calculated by GraphPad Prism. Data 
shown are mean and standard deviations of three independent experiments. Data shown 





Addition of cholesterol-lipid supplement partially rescues ZIKV growth in CwStri cells. 
 Wolbachia inhibition of Drosophila C virus (DCV) has been shown to be 
mediated by competition for cholesterol (Caragata et al. 2013). When cholesterol is 
added to the flies diet, DCV grows to lethal titers in the presence of Wolbachia (Caragata 
et al. 2013). Cholesterol is important for a several steps in flavivirus infection including 
entry early in virus infection (Smit et al. 2011). To determine if the Drosophila observed 
phenotype translates to a human pathogen, we investigated if the addition of cholesterol 
would rescue ZIKV growth in Wolbachia. We infected cells at an MOI of 0.01 with 
ZIKV PRVABC59 for one hour. Cholesterol-lipid supplement designed for cell culture 
was added in increasing concentration. After six days, we observed no change in 
Wolbachia density quantitated by qRT-PCR (Figure 3.5A). However, ZIKV RNA was 
increased >1log with the addition of the cholesterol-lipid solution (Figure 3.5B). This 
result strongly implicates a role for the competition for cholesterol and/or other lipids in 






Figure 3.5 Addition of cholesterol-lipid supplement partially rescues Zika virus 
growth in CwStri cells.  
 
 
(A) Wolbachia density quantitated by wsp is unchanged by the addition of cholesterol 
concentrate. Data is normalized to no treatment control. (B) ZIKV RNA is partially 
rescued in wStri-infected cells relative to Wolbachia-free (C710) cells. Statistical 
significance determined using the Holm-Sidak method, with alpha   0.05. Each 
experiment was analyzed individually, without assuming a consistent standard deviation. 
Statistical tests were calculated by GraphPad Prism. Data shown is the mean and standard 







The data presented here show that ZIKV replication is compromised by two 
different supergroup B Wolbachia strains. wAlbB reduced virus growth by 1 to 3-log 
titer. wStri was more effective consistently ablating growth below detection. This could 
be due to the different cell type the Wolbachia strains are transinfected into, C710 and 
Aa23. However, C710 and Aa23 cells are equally permissive to ZIKV growth suggesting 
a Wolbachia-strain specific phenotype. This is the first report to our knowledge of wStri 
inhibition of any flavivirus. 
An alternative hypothesis for the weaker inhibition by wAlbB is that wAlbB is 
native to A. albopictus. Non-native Wolbachia strains have been reported to be more 
effective at pathogen inhibition than native Wolbachia strains in the native host. wAlbB 
restricts DENV dissemination in its native host A. albopictus (Mousson et al. 2012, Bian 
et al. 2013), albeit to a lesser extent than wAlbB restricts DENV in A. aegypti, a non-
native host (Joubert et al. 2016). Consistent with this hypothesis, transinfection of non-
native wMel into A. albopictus or A. aegypti induces a strong antiviral phenotype 
(Blagrove et al. 2012). Our data show a similar trend such that wStri, a non-native 
Wolbachia strain to A. albopictus, is more effective at reducing ZIKV titer than wAlbB, a 
native Wolbachia endosymbiont of A. albopictus. 
Differences in the native versus non-native virus growth phenotype trends with 
different Wolbachia densities. wAlbB inhibition of DENV has been shown to be 
dependent on Wolbachia titer (Lu et al. 2012). wAlbB grows to a higher per cell density 




al. 2012). We observed reduced titers of wAlbB relative to wStri in A. albopictus 
consistent with a density-dependent phenotype. Higher densities, like that demonstrated 
by wMelPop (Caragata et al.), compared to wMel are more effective at reducing viral 
titer. Too high of a Wolbachia titer comes with a fitness cost (Nguyen et al. 2015). It is 
important to next investigate if wStri reduces ZIKV in vivo and with limited 
transinfection fitness cost. 
Mechanism of Action 
The stage of flavivirus lifecycle that is inhibited in Wolbachia-infected cells has 
not been identified. Our studies suggest that Wolbachia restriction of ZIKV occurs at an 
early step of infection. It is likely that many flaviviruses are restricted at this step based 
on flavivirus similarities. One study suggested that alphavirus, Semliki forest virus, is 
inhibited by Wolbachia early in viral inhibition (Rainey et al. 2016) consistent with our 
data. Thus, Wolbachia may block many positive RNA viruses by the same mechanism. 
Previous investigations into a mechanism of Wolbachia mediated virus 
suppression have focused on molecular pathways in the immune system (Pan et al. 2012, 
Rancès et al. 2013) and on metabolic competition (Caragata et al. 2013). We chose to 
look at the impact of cholesterol on virus growth in Wolbachia-infected cells because 
Wolbachia have been shown to compete with the host for cholesterol, lipids, and amino 
acids (Caragata et al. 2014, Molloy et al. 2016).  Wolbachia protection from Drosophila 
C virus is dependent on cholesterol in Drosophila(Caragata et al. 2013). We found an 
increase in ZIKV growth in Wolbachia-infected cells but not Wolbachia-free cells when 




on cholesterol and/or other lipids in Wolbachia-mediated virus inhibition. This 
competition may play a role in inhibiting viral entry since increased cholesterol has a 
strong impact on virus entry (Stiasny et al. 2003). However, additional mechanisms must 
also contribute to viral inhibition. 
3.6.1 In vitro studies 
Cell lines offer a valuable tool to dissect molecular aspects of virus – host 
interactions. While C6/36 mosquito cells are permissive to ZIKV, other mosquito cell 
lines such as CCL-125s do not allow ZIKV growth (Offerdahl et al. 2017). Often ZIKV 
is propagated in C6/36 cell lines, because they are defective in the antiviral RNA 
interference response (Brackney et al. 2010). However, this also renders them limited for 
vector competence and RNAi screens. Here we demonstrate two additional insect cell 
line are competent for ZIKV, Aa23 and C710. The availability of a cell line system to 
investigate Wolbachia ZIKV suppression offer a platform for future RNAi screens and 
other high-throughput approaches aimed at determining the mechanism and pathways of 
viral suppression by Wolbachia. This is the first evidence that Wolbachia block ZIKV in 
cell culture, showing that blockage occurs in cell autonomous manner independent of 
systemic immunity.  
3.6.2 In vivo application 
These results have implications for using Wolbachia to control arbovirus. The 
current Wolbachia-based strategy to inhibit arboviruses employs only wMel (Bourtzis et 




wMel control (Ferguson et al. 2015, Ye et al. 2015). Field trials are currently being 
investigated.  However, there are concerns that wMel will adapt to its new Aedes host 
(Zug and Hammerstein 2015). This may cause loss of virus inhibition (Zug and 
Hammerstein 2015). Investigation of additional strains will provide additional tools to 
wMel to improve upon disease control strategies. Our data suggest wStri and wAlbB to a 
lesser extent could also be used to inhibit ZIKV replication in mosquitos. Studies will 
need to be conducted to assess if wStri can successfully inhibit ZIKV in A. aegypti 
including the transinfection of wStri into A. aegypti in vitro to adapt to A. aegypti for 
future in vivo approaches. 
3.7 Future Directions 
This study highlights an important aspect towards improving the utilization of 
Wolbachia to limit ZIKV transmission. Understanding this mechanism of Wolbachia 
caused virus suppression may inform direct targeting approaches of arboviruses in vivo 
The robust inhibition of ZIKV by wStri is optimal for mechanistic investigation of 
Wolbachia-arbovirus interaction. The CwStri in vitro system demonstrates a robust anti-
viral phenotype and is fully permissive to ZIKV when Wolbachia are removed. The data 
presented here suggest that Wolbachia wStri blocks viral growth early in viral replication. 
Previous studies addressing mechanism have used a candidate gene approach to directly 
consider potential molecular intermediates of Wolbachia’s antiviral phenotype. 
Identification of an exact stage of viral block would focus future studies and candidate 
gene approaches to better understand how Wolbachia blocks viral growth. In the next 




blocks ZIKV replication, and at which stage of viral infection does competition for 
cholesterol impede viral growth.  
 
 





CHAPTER 4: Wolbachia wStri blocks Zika virus growth at two independent 
stages of viral replication 
4.1 Preamble  
The previous chapter described my work demonstrating that supergroup B 
Wolbachia are capable of limiting ZIKV replication.  Based on these findings I next 
sought to both broaden my understanding of how broad the wStri’s block of virus 
replication is, and when in viral infection does Wolbachia alters virus replication. We and 
others have shown that Wolbachia blocks viral growth early in viral infection at or 
preceding viral genome replication (Rainey et al. 2016, Bhattacharya et al. 2017, Schultz 
et al. 2017). However, an exact block in viral infection and how cholesterol contributes to 
this restriction is unknown.  Additional work has implicated lipid composition or 
cholesterol in DENV inhibition in Wolbachia infected cells (Geoghegan et al. 2017). We 
have previously shown that cholesterol lipid supplementation partially rescues ZIKV 
growth in mosquito cells (Schultz et al. 2017). In this chapter, we aim to isolate the 
stages of viral infection blocked by Wolbachia and determine at which point of infection 
cholesterol is important.  
Here we show that Wolbachia wStri blocks positive sense RNA virus growth at 
two independent stages of viral growth using viral labelling, imaging, and reporter 
constructs for ZIKV in CwStri cells. CwStri cells are an Aedes albopictus (C710) cell line 
that is stably infected with Wolbachia wStri from Laodelphax striatellus. They are a 
powerful in vitro system for investigating the repression of flaviviruses like ZIKV 




positive sense RNA viruses but not negative sense RNA viruses demonstrating that 
Wolbachia blocks viral growth by a virus specific mechanism. Delineating which viruses 
are repressed by Wolbachia and which stages of viral infection are blocks will focus 
future efforts to understand the mechanism by which Wolbachia limits viral growth. 
 
4.2 Wolbachia wStri inhibits positive-sense but not negative-sense RNA viruses 
Following experiments that showed that A. albopictus cells colonized with wStri 
significantly reduced ZIKV replication compared with cells that were wStri-free, we 
investigated the breadth of virus repression in wStri-colonized cells. We chose a broad 
repertoire of viruses, including the positive sense RNA viruses YFV, ZIKV, DENV-2 
(Flaviviridae), CHIKV (Togaviridae), and the negative sense RNA arboviruses Vesicular 
Stomatitis virus (VSV) (Rhabdoviridae) and La Crosse virus (LACV) (Bunyaviridae) for 
this investigation. Wolbachia-free C710 cells (C710 W-) and Wolbachia containing cells 
(C/wStri) were infected with each of these arboviruses at a multiplicity of infection 
(MOI) of 10 and virus accumulation in the media was assessed at three days post 
infection by plaque assay. YFV, DENV, and ZIKV (family Flaviviridae) growth were all 
significantly reduced by Wolbachia wStri (Figure 4.1A, p<0.05, T-test). YFV growth, 
was repressed by approximately four logs from a titer of 5.44 x 106 Plaque forming units 
(PFU)/mL in C710 W- to only 1.67 x 102 PFU/mL in C/wStri (99.99% reduction, Figure 
4.1A).  DENV-2 growth was similarly repressed in the presence of wStri, showing 
growth of 1.99 x 105 Focus forming units (FFU)/mL in C710 W- but just 6.1 x 102 
FFU/mL in C/wStri (99.9% reduction, Figure 4.1A).  Consistent with previous work 




(1.43 x 103 PFU/mL) compared to C710 W- (1.5 x 107 PFU/mL) (Figure 4.1A). Growth 
of CHIKV was significantly reduced (99.99% p<0.05, T-test) in C/wStri cells (1.56 x 102 
PFU/mL) relative to C710 W- (3.67 x 106 PFU/mL) (Figure 4.1A). These data are 
consistent with previous reports of supergroup A Wolbachia repression of positive sense 
RNA viruses and demonstrate the broad range antiviral phenotype for the supergroup B 
Wolbachia wStri. 
 In contrast to the repression of positive sense RNA virus replication in wStri 
containing C710 cells, negative sense RNA virus growth was not inhibited in cells that 
contained Wolbachia (Figure 4.1B). LACV growth in C/wStri cells (3.64 x 107 PFU/mL) 
was slightly higher (not significant) than in C710 W- cells (1.18 x 107 PFU/mL) (Figure 
4.1B). VSV growth was also unaffected (5.58 x 107 PFU/mL in C/wStri compared to 1.69 
x 107 PFU/mL in C710 W-) (Figure 4.1B). These data showed that the restriction of 
positive sense viruses was due to specific actions on positive sense RNA virus replication 
and was not a general restriction of all virus replication. 
 
4.3 Wolbachia conditioned media does not repress Zika virus growth 
 To better understand mechanisms of Wolbachia mediated mosquito protection 
from positive sense arboviruses, we sought to determine how and where virus replication 
is blocked in Wolbachia-infected cells. We focused on ZIKV PRVABC59 because of the 
significant interest in using Wolbachia-infected mosquitos as a ZIKV-control strategy 
and its robust repression (> 4 log) by wStri. We first examined the hypothesis that an 




al. 2016, Rice et al. 2017) was acting to repress viral growth. To test this hypothesis, we 
collected Wolbachia conditioned media from C/wStri cells and conditioned media from 
C710 W- cells assessed virus growth in the presence and absence of media from C/wStri 
cells. Virus growth in the presence of C710 W- media was used as a control. C710 W- 
cells treated with Wolbachia conditioned media grew to 2.80 x 107 PFU/mL which was 
comparable to C710 W- cells treated with C710 W- conditioned media (1.04 x 107 
PFU/mL) (Figure 4.1C) suggesting that Wolbachia does not secrete an inhibitory factor 
that represses viral growth. 
 
Figure 4.1 wStri inhibits Dengue virus and Zika virus but not La Crosse virus or 
Vesicular Stomatitis virus 
 
Wolbachia wStri-infected A. albopictus cells (CwStri) and their uninfected Wolbachia-
free control (C710 W-) cells were infected with DENV-2, ZIKV, YFV 17D, CHIKV, 
LACV, or VSV at a MOI of 10. After three days, virus supernatant was collected and 
infectious virus was assessed by focus forming assay (DENV, YFV) or Plaque forming 
assay (ZIKV, CHIKV, LACV, and VSV). Data shown are means and standard deviation 




sense RNA virus genomes. Viruses shown in (B) Negative sense RNA virus genomes. 
Statistical difference was determined by Student’s t test for each experiment. (C) 
Wolbachia wStri-infected A. albopictus cells (CwStri) and their uninfected Wolbachia-
free control (C710 W-) cells were infected with ZIKV at an MOI of 10. Filtered media 
from spent C710 culture or from spent CwStri culture was added to infected cells. Three 
days post infection, cell supernatants were harvested and viral growth was assessed by 
plaque assay.  * indicates a p-value<0.05 
 
4.4 wStri inhibition of Zika virus is overcome at low Wolbachia infection frequencies 
We then investigated the possibility that cell-cell communication between C/wStri 
and C710 W- cells might influence ZIKV growth. We co-cultured C/wStri and C710 W- 
cells at varying percentages of Wolbachia infection for 24 hours. After cells adhered to 
the plate, they were infected with ZIKV at an MOI of 10. One hour post viral absorption, 
the virus inoculum was removed and fresh media was added to the cells. ZIKV growth 
was determined by plaque assay at 72 hours post infection. Results showed that there was 
a bimodal repression of ZIKV. When 10% or fewer C/wStri cells were plated with C710 
W- cells, ZIKV growth grew to a titer of 4.47 x 107 PFU/mL or higher, similar to growth 
in C710 W- only control. When 50% or more of the plated cells were C/wStri, ZIKV 
growth was strongly repressed (Figure 4.2A, One-way ANOVA, Tukey test p<0.05). 
These data suggest that infected cells do not “signal” to other cells to repress ZIKV 
replication, and that Wolbachia infection frequency across a cell population is a 




From these data it was unclear if Wolbachia infected cells within a mixed 
Wolbachia infected and Wolbachia free cell population were replication sites for ZIKV or 
if they remained uninfected while C710 W- cells produced virus. To understand if ZIKV 
was growing in Wolbachia infected cells, we fixed cells from the above treatment and 
immunolabeled for ZIKV and probed for Wolbachia by fluorescent in situ hybridization 
(FISH). Mean fluorescence of Wolbachia and ZIKV was determined in individual cells 
under each growth condition. ZIKV and Wolbachia concentration by mean fluorescence 
per cell were graphed against one another to determine if high ZIKV density occurs in the 
presence of Wolbachia (Figure 4.2B). When 0% or 1% C/wStri cells were plated with 
C710 W- cells minimal Wolbachia infection and robust ZIKV growth was observed. In 
contrast, when 50% or 100% C/wStri cells were plated with C710 W- cells, minimal 
ZIKV growth and high Wolbachia density is observed. Interestingly, when 10% C/wStri 
cells were plated with C710 W- cells, both ZIKV and Wolbachia were observed in the 
same cells, perhaps due to the high titer of virus (Figure 4.2B). These data suggest that 
Wolbachia infection frequency determines ZIKV growth in vitro but that in cases of 
incomplete penetrance of Wolbachia infection in a cell population that repression is less 





Figure 4.2 wStri inhibition of Zika virus is overcome at low Wolbachia infection 
frequencies 
 
Wolbachia-free (C710 W-) cells were plated with varying quantities of Wolbachia wStri-
infected A. albopictus cells (CwStri) and incubated for 24 hours to allow adherence. Cells 
were infected with ZIKV PRVABC59 at an MOI of 10 and incubated for 3 days. (A) Cell 
supernatant was collected and viral titer was determined plaque forming assay. The data 
shown are means and standard deviations of three independent experiments. Statistical 
difference in infectious virus was assessed by one-way ANOVA followed by Tukey’s test 
for multiple comparisons. Conditions labelled by “a” are statistically different from “b” * 
p-value<0.05 (B and C) Cells were fixed and fluorescent in situ hybridization to the 16S 
ribosomal RNA was used to detect Wolbachia (green) and flavivirus Envelope antibody 
(D11C) was used to detect ZIKV (red). Cells were counterstained with DAPI to for DNA 




in ImageJ. Relative quantities of ZIKV and Wolbachia are shown in (B). Each point is an 
individual cell. Representative images are shown in (C). [AU]: arbitrary units 
 
 
4.5 Wolbachia wStri blocks Zika virus entry  
 Since a secreted effector molecule was not identified, we next investigated 
intracellular mechanisms of Wolbachia’s antiviral phenotype. Several reports have 
suggested that Wolbachia blocks virus replication at an early stage (Rainey et al. 2016, 
Bhattacharya et al. 2017, Schultz et al. 2017). We first tested whether Wolbachia blocked 
at entry. We labelled VSV and ZIKV with BODIPY 650/665 to create a fluorescently 
labeled virus particle that could be tracked in microscopy based assays. When purified 
virus was analyzed by SDS-PAGE, no fluorescently labeled proteins were evident in the 
absence of BODIPY labeling (lane 1, Figure 4.3A and Figure 4.3B). Following BODIPY 
labeling (lane 2, Figure 4.3A and Figure 4.3B), fluorescent bands corresponding to VSV 
Glycoprotein and ZIKV Envelope are observed.  
To test our hypothesis that Wolbachia blocks ZIKV entry, we incubated cells with 
ZIKV-BODIPY labelled virus or VSV-BODIPY labelled virus for 1 hour at 28ºC. 
Unattached virus was then removed and virus attachment and entry were determined by 
immunofluorescence. Resulting images showed that that VSV enters both C710 W- and 
C/wStri cells (Figure 4.3C) yet ZIKV is severely impaired entering C/wStri cells relative 
to C710 W- cells (Figure 4.3D). Mean fluorescence intensity was calculated per cell to 




VSV-BODIPY mean fluorescent intensity in C710 W- cells (26.5 AU) was decreased 
22.2% when compared to C/wStri cells (20.6 AU) (Table 4.1). Although this change was 
statistically significant, it was insufficient to alter VSV growth in C/wStri cells (Figure 
4.1A). ZIKV entry into C/wStri cells (4.7 AU) was reduced by 67.7% relative to C710 
W- cells (14.63 AU) (Figure 4.3F, Table 4.2). These data show that ZIKV entry in 
Wolbachia infected cells is reduced.  
 Cholesterol has previously been implicated in flaviviruses entry (Stiasny et al. 
2003) and has been suggested to mediate Wolbachia repression of DENV (Geoghegan et 
al. 2017).  We have previously shown that cholesterol-lipid supplementation partially 
rescues ZIKV growth in C/wStri cells (Schultz et al. 2017).  To assess if cholesterol-lipid 
addition altered ZIKV entry into C/wStri cells, we supplemented cells with an in vitro 
cholesterol-lipid reagent during viral absorption. Cholesterol-lipid supplementation had 
no significant effect on VSV entry (20.6 AU to 21.3 AU, Table 4.2) (Figure 4.3E) but 
doubled ZIKV entry in C/wStri cells (4.7 AU to 9.9 AU, Table 4.2) (Figure 4.3F). These 
results show that cholesterol and lipids can increase ZIKV entry, but that 






Figure 4.3 Wolbachia wStri blocks Zika virus entry 
 
VSV (A) and ZIKV (B) were pelleted at high speed followed by resuspension in PBS 
buffer. Pelleted virus was labelled with a lysine conjugate, BODIPY 650/665. Virus 
labelling was visualized on a 10% SDS-PAGE gel and imaged at 700 nm to confirm 
BODIPY incorporation in glycoprotein and envelope protein respectively. Lane 1 is 
unlabeled virus. Lane 2 shows labelled virus. (C-F) Labelled virus was incubated with 
cells at an MOI of 10 for 1 hour at 28 ºC. After fixation, cells were mounted in prolong 
gold antifade media with DAPI. (C and D) Representative images of BODIPY-virus 
incorporation. BODIPY-VSV (C) or BODIPY-ZIKV (D) are shown in green. DNA 
stained by DAPI is blue. (E and F) Individual cells were quantified for mean BODIPY 




independent biological replicates. Statistically significant mean fluorescence was 
assessed by one-way ANOVA followed by Tukey’s test for multiple comparisons. * 
indicates a p-value<0.05 
 
Table 4.1 BODIPY labelled VSV entry into Wolbachia infected and Wolbachia free 
mosquito cells 
 Fluorescence intensity [AU] 
 median 
% Change from  
C710 W- 
C710 W- 26.5 0.0 
C710 W- + Cholesterol 28.8 8.6 
CwStri 20.6 -22.2 
CwStri + Cholesterol 21.3 -19.7 
 
 
Table 4.2 BODIPY labelled ZIKV entry into Wolbachia infected and Wolbachia free 
mosquito cells 
 Fluorescence intensity [AU] 
 median 
% Change from  
C710 W- 
C710 W- 14.6 0.0 
C710 W- + Cholesterol 17.7 21.0 
CwStri 4.7 -67.7 







4.6 Wolbachia block viral replication downstream of Zika virus entry 
  To investigate Wolbachia blockade of viral replication downstream of viral entry, 
we tested whether transfected viral genomes were capable of producing infectious virus 
in C/wStri and C710 W- cells. We initially assessed transfection efficiency in C/wStri and 
C710 W- cells using a fluorescently conjugated oligonucleotide. Transfection rates 
determined by confocal imaging (Figure 4.4A) and plate reader (Figure 4.4B) showed a 
similar transfection efficiency in C/wStri and C710 W- cells. We then transfected 0.5 µg 
or 1 µg of purified viral RNA into cells and assessed the production of infectious virus 4 
days post transfection. C710 W- cells produced greater than 1 x 105 PFU/mL when either 
0.5 or 1 µg of RNA was transfected (Figure 4.4C). C/wStri failed to produce any 
detectable infectious virus when transfected with 0.5 or 1µg of viral RNA. These data 
show that a robust block in ZIKV growth occurs post viral entry in Wolbachia wStri 






Figure 4.4 Independent of entry, Wolbachia block viral replication 
 
(A and B) Wolbachia wStri infected (CwStri) and Wolbachia-free (C710 W-) cells were 
transfected with 1ug of ZIKV UTR probe with a 547 Alexafluor conjugate (red) to assess 
transfection efficiency differences. (A) Cells were fixed and counterstained with DAPI 
(DNA, blue). Control cells received probe only without transfection reagent or reagent 




547nm. (C) ZIKV RNA was isolated by Trizol extraction and 0.5 or 1ug of viral RNA 
was transfected into C710 W- or CwStri cells. Four days post transfection, supernatant 
was collected and virus production was quantified by plaque assay. The data shown are 
means and standard deviations of three independent experiments. Statistical significance 
was determined by Student’s T test. * indicates a p-value<0.05 
 
4.7 Wolbachia blocks initiation of viral translation 
 To determine whether a deficiency in viral protein production in C/wStri cells 
contributed to the blockade of ZIKV replication, we generated a reporter construct 
containing the 5’UTR and 3’UTR of ZIKV flanking a luciferase reporter. 1 µg of reporter 
was transfected into C710 W- and C/wStri cells. C/wStri cells produced 68% less 
luminescence than C710 W- cells suggesting ZIKV translation is significantly reduced in 
C/wStri cells (Figure 4.5A, T-test p<0.05).  
These results led us to examine whether this repression was due to a specific 
effect on ZIKV translation or whether Wolbachia infection resulted in a decrease in 
overall translation. We assessed the rate of translation in C/wStri and C710 W- cells by 
pulse-labeling with 35S Methionine. Figure 4.5B shows the pattern of protein synthesis in 
C/wStri cells labeled with 35S methionine for 30 minutes. Total protein measured by 
coomassie staining (Figure 4.5B, right) is shown to confirm equal loading. Under normal 
labeling conditions, a grey background punctuated with several prominently labeled 
bands was observed.  Cycloheximide (CHX) treatment (Lane 2) blocks most protein 




rate in the presence and absence of the eukaryotic protein synthesis inhibitor.  This band 
disappears when cells are treated with tetracycline, revealing that it is likely a Wolbachia 
protein (Wolb*, Figure 4.5B left) that is produced through bacterial protein synthesis. 
Quantitation of these results indicates that Wolbachia protein translation represents 
approximately 1/3 of total protein translation (CHX) while 2/3 of total translation is 
mosquito (TET) in C/wStri cells (Figure 4.5C).  
 There was a remarkable difference in rate of protein synthesis observed when 
C710 W- and C/wStri cells were labeled under similar conditions. As is shown in Figure 
5D, there was significantly more total protein synthesis in C710 W- cells than in C/wStri 
cells for a given amount of total protein present (Figure 4.5E). As expected, CHX ablated 
all translation in C710 W- cells (Figure 4.5D lane 1 compared to lane 2 or 4) and TET did 
not impair mosquito translation (Figure 4.5D lane 1 compared to lane 3). Quantification 
of the difference in protein synthesis (Figure 4.5F) showed that when TET treated C710 
W- cells were compared to TET treated C/wStri cells, host translation was approximately 
66% reduced in C/wStri cells. These data suggest that Wolbachia wStri blocks viral 






Figure 4.5 Wolbachia blocks initiation of viral translation 
 
(A) ZIKV translation reporter construct diagram. The full 5’ and 3’ UTR of ZIKV 
flanking firefly luciferase was constructed in a pCDNA3 vector, amplified with T7 
primers, in vitro transcribed and capped. 1ug of translation reporter was transfected into 
C710 W- and CwStri cells. 24 hours post transfection, cells were lysed and luminescence 
was determined by Nanolight reagent on a Tecan Spark plate reader. Data shown are the 
means of three independent experiments. (B) Quantitation of host translation in CwStri 
cells demonstrates Wolbachia and mosquito translation by 30-minute L-[35S]-Methionine 
pulse post 1 hour methionine starvation. L-[35S]-Methionine incorporation (left) was 
measured by phosphorimager. Total protein was quantitated by coomassie staining (right) 
read at 800nm (infrared Odyssey licor). Lane 1: no treatment, Lane 2: CHX 10uM, Lane 




throughout starvation and L-[35S]-Methionine pulse to block mosquito and Wolbachia 
translation. (C) Translation was quantified by L-[35S]-Methionine incorporation relative 
to total protein. C710 W- translation was compared to CwStri translation by L-[35S]-
Methionine incorporation (D) relative to total protein quantified by coomassie (E) in 
panel F. (D and E) Lanes 1-4 C710 W-, Lanes 5-8 CwStri; Lane 1 & 5: no treatment, 
Lane 2 & 6: CHX 10uM, Lane 3 & 7: TET 22.5uM, Lane 4 & 8: CHX 10uM and TET 
22.5uM. Three independent biological replicates were performed for each experiment. 
Graphical representations show the mean and standard deviation of independent 
biological replicates. Statistical difference was assessed by one-way ANOVA followed 





The data presented here shows that the Wolbachia-mediated inhibition of ZIKV 
replication in mosquito cells occurs by at least two independent mechanisms. A 
schematic depicting these blocks through the virus life-cycle are depicted in Figure 4.6.  
The figure highlights that we observed a significant reduction of ZIKV entry in cells 
infected with wStri, which is likely to be in important cause of decreased ZIKV 
replication. Importantly, complementary experiments showed that if virion-mediated 
entry of ZIKV was bypassed, ZIKV replication was still blocked. This blockade is 
correlated with a reduction in the translation of a ZIKV minigenome reporter construct 




4.6). The finding that there are multiple mechanisms by which Wolbachia mediates viral 
repression is encouraging.  If these multiple mechanisms of virus repression seen in cell 
culture are also active in an intact mosquito infected with Wolbachia, it is less likely that 
viruses will evolve resistance to this strategy of arbovirus control.  
Our work also provides some insight into potential mechanisms for the different 
steps of virus restriction.  We show that cholesterol supplementation partially rescues the 
viral entry defect that we observe in C/wStri cells, which indicates that lower levels of 
cholesterol (known to occur in Wolbachia infected cells (Geoghegan et al. 2017)) limits 
ZIKV entry. While cholesterol lipid supplementation was successful, it is important to 
note that we and others have been unable to rescue entry through methyl beta-
cyclodextrin mediated cholesterol supplementation (Geoghegan et al. 2017). The 
cholesterol lipid supplement used here was insufficient to fully restore C710 W- levels of 
entry in C/wStri cells. This indicates that there is another factor to the entry block.  
Importantly, cholesterol supplementation post entry block did not rescue viral growth 
suggesting cholesterol lipid composition is most important for entry events. These results 
are consistent with our earlier findings (Schultz et al. 2017) that showed cholesterol 
supplementation improved ZIKV replication.   
Our studies also demonstrated that there is a global decrease in protein synthesis 
activity in Wolbachia-infected cells. This global repression alone is a likely candidate for 
the lack of ZIKV protein production observed (Schultz et al. 2017), and is consistent with 
other examinations of the effect of Wolbachia on insect cell homeostasis that have shown 




host amino acids which may contribute somewhat to this decrease in mosquito translation 
(Caragata et al. 2014). Proteomic interrogation of Wolbachia-infected cells has also 
indicated decreases in amino acid metabolism (Baldridge et al. 2017) and translation 
factors (Saucereau et al. 2017) following Wolbachia infection. The observed change in 
protein synthesis as a means of altering ZIKV replication are consistent with other studies 
suggesting a block of flavivirus replication early in viral replication (Rainey et al. 2016, 
Schultz et al. 2017).  
Global dysregulation of methylation patterns in Wolbachia infected cells has 
previously been suggested to interfere with RNA virus replication. RNA methylation has 
been implicated in the translational control of host (Falckenhayn et al. 2016) and viral 
protein production (Lichinchi et al. 2016). Wolbachia disrupts global methylation 
patterns within a cell (Ye et al. 2013). Cytosine methyltransferases such as Dnmt2 have 
been shown to alter translation (Tuorto et al. 2012, Shanmugam et al. 2015, Tuorto et al. 
2015). Dnmt2 is down regulated in Wolbachia infected mosquitos limiting DENV (Zhang 
et al. 2013) yet upregulated limiting Sindbis virus in Drosophila (Bhattacharya et al. 
2017). These studies may suggest a dynamic control of host translation mediated by 
methylation of tRNAs. Alternatively, methylation may directly impact viral replication 
and not be mediated by tRNAs. Dnmt2 has also been shown to directly bind to DCV, a 
positive sense RNA virus in Drosophila (Durdevic et al. 2013). Additional studies are 
needed to delineate how global translation is downregulated in Wolbachia infected cells 




While the global inhibition of translation may strongly effect ZIKV replication, it 
does not act as a universal block to viral growth. Our experiments demonstrate a different 
impact of Wolbachia infection on positive and negative strand RNA virus replication. In 
our experiments, Wolbachia wStri infection only limited the replication of positive sense 
RNA viruses. Our data are consistent with previous studies that Wolbachia infected 
Aedes cells restrict the replication of ZIKV (Aliota et al. 2016, Dutra et al. 2016, Schultz 
et al. 2017), DENV (Lu et al. 2012, Mousson et al. 2012, Frentiu et al. 2014, Ye et al. 
2015, Terradas et al. 2017), and CHIKV (Blagrove et al. 2013, Raquin et al. 2015, Aliota 
et al. 2016). LACV and VSV have not been studied in Aedes mosquito cells in the 
presence and absence of Wolbachia, but the replication of the negative sense RNA 
viruses is not impeded in Wolbachia infected mosquitos. In Culex quinquefasciatus 
mosquitos (a nonnative vector of LACV) LACV was not restricted by Wolbachia wPip 
(Glaser and Meola 2010). In Culex tarsalis mosquitos, a vector of the negative sense Rift 
Valley fever virus, viral growth was also unaffected by Wolbachia (Dodson et al. 2017). 
Thus, our data and recent literature support a broad trend for Wolbachia mediated viral 
repression of positive sense but not negative sense RNA viruses.   
One way in which the protein synthesis block may have an effect on positive 
sense RNA viruses but not negative sense RNA viruses is the difference in replication 
strategies. Positive sense RNA virus genomes are a singular infectious mRNA and must 
be translated by the host to generate a viral polymerase that will make additional mRNAs 
(Fields et al. 2013). Negative sense RNA viruses bring with them a viral polymerase that 




transcription is regulated by the amount of viral protein produced. Under conditions 
where there is a general inhibition of protein synthesis, negative sense RNA viruses 
would be predicted to overproduce mRNAs (Patton et al. 1984) to compensate giving 
them a numerical advantage over host mRNAs. Because positive sense RNA viruses lack 
this mechanism they will be at a disadvantage to host transcripts.  
Our studies also expand the understanding of the performance of the wStri 
Wolbachia strain as a viral antagonist. Cells containing wStri reduced the growth of all 
flaviviruses and alphaviruses (CHIKV) tested. Importantly, wStri blocked YFV, which is 
not repressed by the supergroup A Wolbachia strain wMel (Van Den Hurk et al. 2012). 
These results suggest that Wolbachia wStri has an ability to repress a wider variety of 
positive sense RNA arboviruses and should be investigated in vivo for further 
application. While wMel is the strain currently employed in field trials (Hoffmann et al. 
2014), an understanding of wStri alone or as a superinfection with wMel in vivo may 
strengthen the approach of Wolbachia mediated virus control. 
Our study provides basis for multiple mechanisms of Wolbachia mediated virus 
control and focuses future efforts to delineate molecular interactions which facilitate 
Wolbachia induced viral repression. Additional studies investigating other flaviviruses as 
well as alphaviruses are needed to better understand the uniformity and divergence of 
how Wolbachia block specific viruses. Investigation of wStri repression of viruses in A. 
aegypti cells and whole mosquitos are needed to advance the application of these studies. 














We show a block in ZIKV entry to CwStri cells relative to C710 W- cells. We bypassed 
this robust entry block through transfection to assess if additional blocks occur 
independent of viral entry. We found an independent block in translation using a primary 
translation reporter for ZIKV which we hypothesize is due to the global repression of 





4.9 Future Directions 
This study provides basis for multiple mechanisms of Wolbachia mediated virus 
control and focuses future efforts to delineate molecular interactions which facilitate 
Wolbachia induced viral repression. Additional studies investigating other flaviviruses as 
well as alphaviruses are needed to better understand the uniformity and divergence of 
how Wolbachia block viruses. For example, opposite results from (Zhang et al. 2013) and 
(Bhattacharya et al. 2017) suggest that flaviviruses and alphaviruses may have a different 
mechanism of Wolbachia interference with translation. To better understand this, CHIKV 
or SINV (alphaviruses) alongside ZIKV or DENV (flaviviruses) should be studied in the 
same system. Our system demonstrates strong repression of CHIKV, ZIKV, and DENV 
and is thus a favorable system to address this question. Investigation of wStri repression 
of viruses in A. aegypti cells and whole mosquitos are needed to advance the application 
of these studies. In the next chapter, I will explore the limitations of arbovirus replication 
which may be due to ISV coinfection of A. aegypti cell lines to better understand and 






CHAPTER 5: Dual Insect specific virus infection limits Arbovirus Replication in 
Aedes mosquito cells 
5.1 Preamble  
The previous chapters discuss supergroup B Wolbachia wStri inhibition of viruses 
in A. albopictus cells. However, A. aegypti are a prominent vector of ZIKV and are the 
target for all current Wolbachia field trials. To assess the viability for wStri to block 
pathogens in vivo, wStri needs to be stably transinfected into A. aegypti mosquitos. This 
is accomplished by serial adaptation in A. aegypti cells (McMeniman et al. 2008).  
Few A. aegypti cell lines are broadly available. CCL-125 and Aag2 A. aegypti 
cells can be requested from the ATCC (CCL-125 only) or other researchers (Walker et al. 
2014). ZIKV growth non-permissive in CCL-125 cells (Offerdahl et al. 2017) and is 
variable in Aag2 cells with a peak titer ranging from 104 PFU/mL (Weger-Lucarelli et al. 
2016) to 106 PFU/mL(Fulton et al. 2017, Weger-Lucarelli et al. 2017). Further, peak 
DENV growth in Aag2 cells has been published as low as 102 FFU/mL (Geoghegan et al. 
2017) to 104 FFU/mL(Terradas et al. 2017). The identification or generation of an A. 
aegypti mosquito cell line permissive to a broad array of arboviruses with would benefit 
mechanistic studies of antiviral response in the mosquito. The issue of variability of virus 
growth in A. aegypti cell permissibility has not been extensively studied but one 
hypothesis is that there are opportunistic viruses replicating in some cell culture lines.  
ISV infection of cell culture has been recognized for over 40 years. Cell fusing 
agent virus (CFAV) was first identified in 1975 as an agent is A. aegypti cells which 




Sequencing technologies have since facilitated the discovery of hundreds of ISVs in the 
last ten years (Hall et al. 2016) including the identification of Phasi Charoen like virus 
(PCLV) in mosquitos (Chandler et al. 2014). PCLV is a negative sense segmented RNA 
virus of the family Bunyaviridae and genus Phlebovirus. Since this discovery, RNA-
sequencing of Aag2 cells identified coinfection of CFAV and PCLV infections in an 
Aag2 cell line stock (Schnettler et al. 2016). This raises the possibility that these ISV 
could interfere with the growth of arboviruses being use in the same culture system 
(Bolling et al. 2015)  
We first assessed ZIKV growth in our Aag2 cells with or without supergroup B 
Wolbachia wAlbB or wStri. Recognizing the high variability of growth in these cells, we 
moved on to compare the kinetics of ZIKV growth in two Aedes cells lines. A recent 
report investigating the effect of Wolbachia on ISVs highlighted the presence of CFAV 
and PCLV in the Aag2 cell line. We screened A. aegypti and A. albopictus cells to assess 
the prevalence of CFAV and PCLV infection. We determined the ability of various 
arboviruses to grow in the presence or absence of CFAV-PCLV coinfection to better 
understand mosquito cell lines as a tool for arbovirus studies. We hypothesize that the 
presence of coinfection of CFAV and PCLV in Aag2 cells is responsible for high 
variability of arbovirus growth.  
5.2 Wolbachia wAlbB and wStri infect A. aegypti Aag2 cells 
We infected A. aegypti Aag2 cells with wStri to determine if wStri may be a 
complimentary biocontrol strategy in A. aegypti. We confirmed a stable Wolbachia 




rRNA. We compared the Aag2 wStri infection to an established wAlbB infected Aag2 
cell line obtained from Zhiyong Xi (Lu et al. 2012). wAlbB and wStri have similar strain 
specific infection patterns in Aag2 (A. aegypti) cells and Aa23 (A. albopictus) cells 
(Figure 5.1 compared to Figure 3.2) albeit not all cells are infected. In Aag2wAlbB and 
Aag2wStri cells, approximately 50% of the cells were infected with Wolbachia (Figure 
5.1). In contrast, the A. albopictus cell lines studied had greater than 96% infection 
frequency (Table 3.1). In figure 4.2, we showed that 50% or greater Wolbachia infection 
frequency at the time of arbovirus introduction was required to block arbovirus growth 






Figure 5.1 wStri infects Aag2 cells detected by fluorescent in situ hybridization by 
wStri shown by confocal imaging 
 
 
 Wolbachia wStri was extracted from a confluent 75 cm2 flask. Cells were 
vortexed for five minutes with sterile glass beads and the supernatant was transferred to a 
sterile conical vial. The lysate was pelleted at 2500xg for five minutes to settle cell 
debris. The supernatant was passed through a 5µM filter and then pelleted at 13,000 xg 
for five minutes. The pellet was resuspended in 6mL. Media was removed from a 
confluent 6 well plate (30mm) with Aag2 W-. Wolbachia extract was added to cells and 




were passaged as described in the methods section (Chapter 2). After two passages, Aag2 
cells now infected with wStri (Aag2 wStri) were plated on coverslips alongside Aag2 W- 
and Aag2 wAlbB cells and fixed for fluorescent in situ hybridization as described in 
Chapter 2. 
 
5.3 Wolbachia wAlbB and wStri do not inhibit Zika virus infection in A. aegypti 
Aag2 
We challenged, Aag2 W-, Aag2wAlbB, and Aag2wStri cells with a low MOI 
(0.1) of ZIKV PRVABC59. Six days post infection, we observed variable ZIKV growth 
in Aag2 W- cells as low as 104 FFU/mL (Figure 5.2A) and as high as 106 FFU/mL 
(Figure 5.2, Table 5.1). Wolbachia wAlbB and wStri did not alter viral growth (Figure 
5.2). Previous studies have demonstrated that Wolbachia repression of viral growth is not 
tissue specific (Amuzu and McGraw 2016) indicating that the lack of viral repression 
observed here is likely a factor of Wolbachia infection frequency or density. 
Interestingly, viral growth was highly variable in cells lacking Wolbachia (Table 5.1, W-) 
suggesting an additional variable not identified here. 








1 2 3 4 
 
1 2 3 
W- 3.2E+04 1.0E+03 9.0E+04 2.9E+04 
 
1.1E+03 7.6E+03 9.8E+04 
wAlbB 3.4E+03 2.1E+03 4.5E+05 1.9E+06 
 






Figure 5.2 wAlbB and wStri infected Aag2 cells grow Zika virus determined by 
focus forming assay 
 
 
 Aag2 W-, Aag2wAlbB (A), and Aag2wStri (B) cells were plated in a 12 well 
plate at 1x105cells/well. 24 hours later cells were infected with an MOI of 0.1 of ZIKV 
PRVABC59 for 1 hour at 28ºC. Virus inoculum was removed and replaced with fresh 
media, Schneider’s Drosophila media with 10% FBS. Cells were incubated at 28ºC with 
5% CO2 for six days. Cell supernatant was harvested and assayed by focus forming assay 
for ZIKV infectious virions as described in Chapter 2.  
 
 
5.4 Kinetics of Zika virus growth in A. albopictus Aa23 and A. aegypti Aag2 cells  
We have previously shown that A. albopictus Aa23 cells produce high titers of 
infectious ZIKV (Schultz et al. 2017). However, the kinetics of ZIKV growth in Aa23 
cells has not yet been shown. Since A. albopictus and A. aegypti are established vectors 
for ZIKV, we were interested to determine the kinetics of viral infection in our Aa23 (A. 
albopictus) and our Aag2 (A. aegypti) cell lines. Cells were infected with the African 




incubated for six days. Supernatant was collected for six days and ZIKV RNA was 
assessed by quantitative reverse transcription polymerase chain reaction (qRT-PCR). In 
Aa23 cells, ZIKV MR766 grew along logistic curve peaking in viral RNA titer at six 
days post infection with greater than a 500 fold increase in viral RNA (Figure 5.3A). 
Likewise, in Aa23 ZIKV PRVABC59 replicated to greater than a 500 fold increase along 
a similar growth trend (Figure 5.3B). In contrast ZIKV MR766 (Figure 5.3A) and ZIKV 
PRVABC59 (Figure 5.3B) viral RNA titer increased by only 16 fold in Aag2 cells 
suggesting that virus production was unsuccessful in Aag2 cells. 
To determine viral RNA was representative of ZIKV infectious virus at the peak 
viral RNA titer, viral growth in the supernatant was assessed by focus forming assay at 
six days post infection in independent experiments. There was high variability of viral 
growth spanning two logs variance for ZIKV MR766 and PRVABC59 in Aag2 cells 
(Figure 5.3C and 5.3D). In two independent experiments, ZIKV MR766 growth in Aag2 
cells was below 1.0 x 104 FFU/mL (the initial inoculum of virus) indicating little to no 
virus production (Figure 5.3C). Viral growth was consistently observed in Aa23 cells. 
ZIKV PRVABC59 grew to higher titers than ZIKV MR766 in Aa23 cells suggesting 






Figure 5.3 Growth of Zika virus MR766 and PRVABC59 in Aag2 and Aa23 cells 
 
Aag2 and Aa23 cells infected with ZIKV MR766 (A) and PRVABC59 (B) (MOI 0.1). 
Supernatant was assayed for viral RNA for up to 6 days post infection. Each line is an 
independent biological replicate. Aa23 cells are depicted in purple. Aag2 cells are 
depicted in green. (C-D) Infectious virus production in the supernatant was assayed after 






5.5 Phasi Charoen-like virus and Cell fusing agent virus broadly infect of Aedes cell 
lines  
Following previous studies that have suggested ISV coinfection contributes to 
decreased arbovirus production in mosquito (Hall-Mendelin et al. 2016, Hall et al. 2016) 
and the recent identification of CFAV and PCLV as circulating insect viruses found in 
some cultured insect cells (Schnettler et al. 2016), we screened A. aegypti (Aag2 and 
CCL-125) and A. albopictus (C710, Aa23, C6/36) cell lines for CFAV and PCLV RNA. 
DNase treated RNA was isolated from cell lysates. The presence of mosquito Rps6 
transcripts confirmed successful RNA extraction and reverse transcription polymerase 
chain reaction (RT PCR). CFAV RNA was found in Aa23 and Aag2 cells but not in 
CCL-125, C6/36, or C710 cells (Figure 5.4). Primers designed to amplify the small (S) 
segment were used to probe for the presence of PCLV RNA by RT PCR. A. aegypti cell 
lines Aag2 and CCL-125 each independently obtained from two sources (Table 5.2) were 
positive for PCLV genome (Figure 5.4). Aag2 cells were screened at varying passages 
depending on source. The two sources of CCL125 cells were screened at passage one 
after receipt.  PCLV RNA was detected in CCL-125 and Aag2 cells over multiple cell 
passages. PCLV was not detected in A. albopictus cell lines (C710, Aa23, and C6/36) 
(Figure 5.4). These results suggest that multiple A. aegypti but not A. albopictus cell line 






Figure 5.4 Aedes cell lines are infected with an insect specific flavivirus and 
phasivirus 
 
A. aegypti (lanes 1-2) and A. albopictus (lanes 3-5) cells were screened for PCLV viral 
RNA by RT-PCR visualized on a 1% agarose gel in TAE. 
 
Table 5.2 Cell lines screened for Phasi Charoen like virus  
Cell line Species PCLV detected 
CCL-125 1 A. aegypti Yes 
CCL-125 2 A. aegypti Yes 
Aag2 1 A. aegypti Yes 
Aag2 2 A. aegypti Yes 
Aa23 A. albopictus No  
C6/36 A. albopictus No  







PCLV has previously been reported in A. aegypti mosquitos in Thailand 
(Chandler et al. 2014), Australia, and Brazil (Hall et al. 2016) but has not been reported 
in A. albopictus mosquitos, leaving open the question of whether A. albopictus cells are 
permissive to PCLV infection.  To test this, filtered cell culture media from PCLV RNA 
positive Aag2 cells was diluted 1:10 and added to A. albopictus Aa23 cells.  Six days post 
inoculation, PCLV infection was determined by RT PCR in cell lysates and in cell culture 
media. PCLV was detected in Aa23 cells treated with Aag2 supernatant and in Aag2 cells 
(Figure 5.5A). PCLV was not detected in uninfected Aa23 cells which had been 
incubated with Aa23 spent media as a control for nutrient deprivation (Figure 5.5A). RT 
PCR cannot discern RNA presence from a productive RNA infection. Thus, we 
determined that PCLV grows in Aa23 cells by infecting Aa23 cells with diluted 1:10, 
1:1000, or UV inactivated PCLV from Aag2 supernatant (Figure 5.5B). The 1:10 dilution 
of the PCLV stock from Aag2 cell supernatant grew to greater than a 500 fold increase in 
viral RNA in the supernatant six days post infection in three independent biological 
replicates (Figure 5.5B). The 1:1000 dilution of PCLV grew to a 64 fold increase in viral 
RNA six days post infection. UV-inactivated PCLV (1:10 dilution) did not lead to an 
increase in viral RNA (Figure 5.5B). No cytopathic effect was observed in A. albopictus 
cells infected with PCLV. These data suggest that the PCLV in Aag2 cells is infectious 





Figure 5.5 A. albopictus Aa23 cells are permissive to Phasi Charoen like virus 
growth 
 
(A) Six days post infection with PCLV (1:10 dilution of Aag2 supernatant), Aa23 
cells were DNase treated and assayed for PCLV RNA by RT-PCR visualized on a 1% 
agarose gel in TAE. No RNA was provided in the no input control lane.  (B) Growth 




1:1000 before infecting Aa23 cells. To confirm that PCLV is infectious virus, a 1:10 
dilution of supernatant was UV inactivated. 
 
5.6 Dual insect specific virus infection impedes the growth of flaviviruses  
Upon identifying PCLV in some but not all of our cultured cells stocks we 
became interested in how PCLV and CFAV coinfection might impact the replication of 
different arboviruses. Since PCLV is consistently present in A. aegypti cell lines that are 
variable or non-permissive to ZIKV and not in in the A. albopictus cell lines that are 
established as ZIKV permissive (Aa23 (Schultz et al. 2017), C710 (Schultz et al. 2017), 
and C6/36 (Offerdahl et al. 2017)), we hypothesized PCLV affects the growth of ZIKV. 
To test this hypothesis, we established a persistent infection of PCLV in Aa23 cells and 
challenged cells with arbovirus infection (Figure 5.6A). Aa23 cells are CFAV positive 
and PCLV negative and are permissive to ZIKV infection (Schultz et al. 2017).  We 
challenged Aa23 control cells without PCLV (CFAV only) and PCLV-infected Aa23 
cells (CFAV and PCLV) cells with a low MOI (MOI 0.1) of ZIKV PRVABC59 to 
determine if ISV coinfection confers resistance to ZIKV infection and growth. Six days 
post infection, we observed a significant (p<0.05) 1 log reduction (90%) in ZIKV growth 
in the dual infected (CFAV and PCLV) infected cells assayed by focus forming assay 
(Figure 5.6B).  When Aa23 CFAV only and Aa23 CFAV and PCLV positive cells were 
infected with a high MOI (MOI 10) of ZIKV PRVABC59, we observed a similar 1 log 




Aa23 CFAV only positive cells (Figure 5.6C).  These data suggest dual virus infection 
limits the growth of ZIKV. 
We next wanted to determine if PCLV restriction of viral growth was specific to 
ZIKV. Aag2 cells are more frequently utilized for DENV virus studies (Walker et al. 
2014) and CFAV has previously been shown to promote DENV infection (Zhang et al. 
2017) suggesting that PCLV may have a more mild effect on DENV growth in a 
coinfection setting. We infected Aa23 CFAV only and Aa23 CFAV and PCLV positive 
cells with DENV-2 at an MOI of 0.1 or 10 and assayed DENV-2 growth six or three days 
post infection, respectively, by focus forming assay. Consistent with ZIKV data, we 
observe a one log reduction (90%) of DENV growth in persistently infected Aa23 CFAV 
and PCLV positive cells infected at a low MOI (Figure 5.6D). In contrast, a high 
multiplicity of DENV infection (MOI=10), overcame the effect of PCLV on virus growth 




Figure 5.6 Dual insect specific virus infection limits flavivirus growth in A. 
albopictus cells 
 
(A) Experimental design to investigate tri-infection of A. albopictus Aa23 cells. Cells 
were infected with PCLV (1:10 dilution of Aag2 supernatant). PCLV was allowed 6 days 
to grow in Aa23 cells. Cells were then plated and infected with either ZIKV PRVABC59 
or DENV-2 NGC at a low (MOI 0.1) or high MOI (MOI 10). After 6 days (low MOI) or 
3 days (high MOI), supernatant was collected and the growth of ZIKV and DENV was 
assayed by focus forming assay. (B) ZIKV MOI 0.1 (C) ZIKV MOI 10 (B) DENV MOI 
0.1 (C) DENV MOI 10. All data shown are the combined means and standard deviation 




Test one-tailed, alpha  0.05 on the natural log of FFU/mL accounting for non-normal 
distribution. * indicates p<0.05. Statistical tests were calculated by GraphPad Prism. 
 
5.7 Insect specific virus infection restricts bunyavirus replication 
Since viruses of the same family often require the same host resources, we 
hypothesized a dual ISV infection which includes a negative sense segmented RNA virus 
may have a most pronounced effect on arboviruses with similar genome structure to 
itself. PCLV is in the Bunyaviridae family so we looked for a mosquito-transmitted 
Bunyaviridae family virus to co-infect with PCLV in Aa23 cells. LACV is an arbovirus 
which can be transmitted by Aedes sp. mosquitos (Westby et al. 2015, Bara et al. 2016) 
and grown in A. albopictus cell lines (White 1987). We infected Aa23 CFAV only and 
Aa23 CFAV and PCLV positive cells lines to determine if LACV virus could grow in the 
presence of a PCLV co-infection. Cells were infected at a low MOI of 0.1 and a high 
MOI of 10 with LACV followed by a six or three day incubation, respectively, as 
depicted in Figure 4A. LACV virus growth was undetectable in Aa23 CFAV and PCLV 
positive cells compared to Aa23 CFAV only cells (Figure 5.7A) following a low MOI 
exposure. LACV infection was reduced by 1-3 log (90-99.9%) following high MOI 
infection in Aa23 CFAV and PCLV positive cells (Figure 5.7B). These results show a 






Figure 5.7 Dual insect specific infection limits La Crosse virus growth in A. 
albopictus cells 
      
(A and B)  LACV H78 was grown in Aa23 PCLV-free (CFAV only) or PCLV-infected 
(CFAV & PCLV) cells at either a LACV MOI 0. 1 (A) or LACV MOI 10 (B) by the 
schematic depicted in Figure 4. All data shown are the combined means and standard 
deviation of at least three independent experiments. Statistical significance determined by 
paired T Test one-tailed, alpha  0.05 on the natural log of FFU/mL accounting for non-
normal distribution. * indicates p<0.05. N.D. indicates none detected. Statistical tests 








The data shown here has significant implications for arbovirus interactions with 
ISVs. A. aegypti cell lines, Aag2 and CCL-125, each originating from different mosquito 
isolation approaches (Singh 1971) and different sources were positive for PCLV 
infection. We screened three different A. albopictus cell lines, C6/36, C710, and Aa23, 
and found PCLV was not present in any of these cell lines, demonstrating that infection 
was not universal within laboratory cell lines. This is not due to lack of permissivity, as 
Aa23 cells were readily infected with PCLV present in Aag2 supernatants. We show that 
PCLV grows in Aa23 cells consistent with previous findings that PCLV RNA produces 
protein in Aedes cells (Maringer et al. 2017).  Unlike other reports of ISV infection 
including CFAV (Stollar and Thomas 1975) and Kamiti River virus (Crabtree et al. 2003, 
Sang et al. 2003), we observed no cytopathic effect in CFAV and PCLV co-infected cells 
explaining why co-infection has remained undetected in most stocks. 
Recreating the conditions of Aag2 dual ISV infection are imperfect yet highlight 
the potential ISV-arbovirus interference. PCLV alone from the supernatant of CCL-125s 
(which contained PCLV and not CFAV) did not generate a productive PCLV infection in 
any A. albopictus line tested. This limited our investigation to dual infection with CFAV 
and PCLV rather than PCLV infection alone. We infected Aa23 cells which already had a 
persistent CFAV infection with PCLV from Aag2 supernatants. In this system, CFAV is 
a long established symbiont of the cells and PCLV, although stable, was a relatively 
recent introduction. Our findings demonstrate a reduction of arbovirus growth in dual 




observed in Aag2 cells. This variability may be due to PCLV adaptation to Aag2 cells or 
an alternative variable not yet identified.  
Our findings have relevance for ongoing cell culture work with arboviruses. 
Recently, there has been contradictory data about cell line support of arbovirus 
replication in the two A. aegypti cell lines, CCL-125 and Aag2. A. aegypti cell line CCL-
125 has been reported to be non-permissive to ZIKV (Offerdahl et al. 2017). Separate 
reports have suggested A. aegypti CCL-125 cells are (Wikan et al. 2009) and are not 
(Singh and Paul 1968, Singh 1971) susceptible to DENV.  Limited growth of ZIKV has 
been reported in Aag2 cells (Weger-Lucarelli et al. 2016) although growth in whole 
bodied mosquitos is common. Our data suggest growth of flaviviruses in A. aegypti Aag2 
cell lines is variable and that co-infection of ISVs reduces arbovirus growth. This 
suggests that the low virus growth noted may be in part due to PCLV co-infection. Thus, 
the removal of PCLV or identification of a PCLV-free A. aegypti cell line may improve 
the function of A. aegypti cell culture system for arbovirus studies.  
Previous studies have also suggested that ISVs can limit the growth of arboviruses 
in a co-infection scenario in vitro and in vivo (Bolling et al. 2015). ISVs of the Flavivirus 
genus have been the primary ISVs shown to limit the vector competence studies of other 
flaviviruses. Palm Creek virus restricts the growth of West Nile Virus (WNV) and 
Murray Valley encephalitis virus in vitro by approximately 1-1.5 logs (Hobson-Peters et 
al. 2013). Nhumirim virus has been shown to limit WNV, St Louis encephalitis virus, and 
Japanese encephalitis virus (Kenney et al. 2014). Consistent with the repression caused 




flaviviruses, ZIKV and DENV.  Because CFAV has previously been reported to be 
beneficial to DENV replication (Zhang et al. 2017), it is likely that PCLV or a synergistic 
interaction between PCLV and CFAV causes the observed block in flavivirus replication. 
Perhaps the most striking observation of these studies is the almost complete inhibition of 
LACV replication by CFAV and PCLV coinfection.  Since PCLV and LACV are both 
members of the Bunyaviridae family, we hypothesize this strong repression of LACV by 
PCLV and CFAV coinfection is likely due to similar genetics and lifecycles of LACV 
and PCLV.  
There are many hypotheses about potential mechanisms for arbovirus/ISV 
competition in mosquito cells. One hypothesis, is that ISV mediated suppression is 
caused by superinfection exclusion. Sindbis virus infection has been shown to prevent 
cell line infection with other alphaviruses (Karpf et al. 1997). However, the underlying 
molecular mechanism of this exclusion is unknown. Further, superinfection exclusion is 
thought to drive exclusion of viruses within a family. CFAV and PCLV are in the 
Flaviviridae and Bunyaviridae families, respectively. There is a limited availability of 
antibodies and other molecular tools to investigate the exact mechanism of ISV 
suppression. Thus, expansion of ISV tools would aid our understanding of ISV-arbovirus 
competition.  
ISVs have been suggested for the control of arbovirus transmission (Bolling et al. 
2015) based on their inhibition of arboviruses and wide geographic distribution (Farfan-
Ale et al. 2009, Cook et al. 2012, Vasilakis et al. 2013, Vasilakis et al. 2014).  They are 




al. 2011, Haddow et al. 2013, Yamanaka et al. 2013). Our study is the first report a 
negative sense segmented RNA ISV that shows the possibility of acting as a broad 
reaching tool for arbovirus suppression. If the cell-culture inhibition observed is 
maintained in vivo, PCLV infection could be the basis of bunyavirus exclusion, 
expanding the tools for vector control and arbovirus disease control. PCLV circulation 
has been reported in Thailand and Brazil but not in the United States where LACV cases 
are the highest and is a leading cause of pediatric encephalitis (Westby et al. 2015, 
Bewick et al. 2016, Taber et al. 2017). Further studies investigating the prevalence of 
PCLV and if this virus is co-circulating with LACV would inform efforts to control 
LACV. 
This study provides insight into in vitro arbovirus growth variability caused by 
ISV contaminants. Here, we have surveyed the extent of cell line infection with ISVs 
CFAV and PCLV across A. aegypti and A. albopictus cells showing that both are 
permissive for PCLV, and A. aegypti cells are regularly infected with PCLV. To prevent 
confounding data, we recommend screening for CFAV and PCLV infection in future 
studies. The high prevalence of PCLV in A. aegypti cell lines makes this virus an 
important consideration for in vivo studies and arbovirus control through direct inhibition 




5.9 Future Directions 
This study provides insight into in vitro arbovirus growth variability caused by 
ISV contaminants. Here, we have surveyed the extent of cell line infection with ISVs 
CFAV and PCLV across A. aegypti and A. albopictus cell lines showing that both are 
permissive for PCLV, and A. aegypti cells are regularly infected with PCLV. CFAV and 
PCLV coinfection which interferes with arbovirus growth. To prevent confounding data, 
we recommend screening for CFAV and PCLV infection in future studies. The high 
prevalence of PCLV in A. aegypti cell lines makes this virus an important consideration 
for in vivo studies and arbovirus control through direct inhibition or as an agent for 
paratransgenic approaches.  
Biocontrol strategies of arbovirus replication in Aedes sp. mosquitos are 
promising. However, the strategies discussed above are not sufficiently understood to 
begin field trials or suggest a block of arboviruses in Culex sp. mosquitos. There are no 
publicly available Culex sp. cell lines. Thus, all experiments have been conducted in 
vivo. Transinfection of Wolbachia strain wAlbB into C. tarsalis enhanced WNV titer 
(Dodson et al. 2014) suggesting unforeseen consequences of Wolbachia mediated 
biocontrol. ISVs suggested to block WNV in Culex have been shown to naturally 
circulate in Culex populations where WNV continues to be actively transmitted (Farfan-
Ale et al. 2009, Newman et al. 2011, Ergünay et al. 2017). Thus, a different approach to 
limiting arbovirus spread by Culex mosquitos is needed. In the next chapter, we will 
discuss alternative biocontrol strategies for Culex mosquitos and expand upon the 





CHAPTER 6: Characterization and metabolic profiling of gut microbiota 
isolated from Culex pipiens mosquitos. 
6.1 Preamble  
In the previous chapters, biocontrol of Aedes mosquito transmitted arboviruses 
was discussed. However, there is little evidence that Wolbachia mediated arbovirus 
control strategy will work as well in Culex sp. mosquitos and some evidence that 
Wolbachia may enhance virus growth in Culex mosquitos. Thus, alternative strategies are 
needed to block Culex transmitted arboviruses.  
Recent work has shown that other microbial inhabitants of mosquitos can block 
pathogens, with gut microbiota showing promising results (reviewed by (Dennison et al. 
2014, Hegde et al. 2015). Mosquito gut bacteria are highly variable but not that diverse 
(Osei-Poku et al. 2012, Hegde et al. 2015). The gut microbiota largely contains members 
of the taxon Serratia, Asaia, Pseudomonas, and Enterobacter. There are several 
mechanisms for transmission of these bacteria, including environmental infection, co-
feeding, and vertical transmission. Some of these bacteria, that are typically extracellular 
bacteria, can have an intracellular phase allowing them to colonize important tissues such 
as the salivary gland (Sharma et al. 2014), and the female germline conferring 
transovarial transmission. In the case of Asaia, there is also evidence of paternal 
transmission. The bacterial is sexually transmitted by the males and once present in the 
female they are maternally transmitted to the progeny (Damiani et al.). These 




Gut microbiota may influence arbovirus infection of mosquitos. Arboviruses 
colonize a new mosquito host through invasion of the gut epithelium. Disrupting the 
mosquito microbiota in the gut with an antibiotic cocktail increases DENV transmission 
in A. aegypti mosquitos (Xi et al. 2008). Likewise, a Chromobacterium sp. (Ramirez et 
al. 2014) and bacteria in the genus Proteus and Paenibacillus (Ramirez et al. 2012) 
reduces DENV titers in A. aegypti mosquitos when fed to mosquitos by stimulating the 
innate immune system of the mosquito. However, this inhibition of arboviruses is not 
universal to all bacteria. Serratia odorifera was shown to increases A. aegypti’s ability to 
transmit DENV (Apte-Deshpande et al. 2012). These cultured studies allow for gain and 
loss of function studies to better understand microbial mediated vector competency in 
mosquitos. 
Most gut microbiota studies have focused on Aedes aegypti and the Anopheles 
mosquito (the vector for Plasmodium sp. - the causative agent of malaria). However, 
more recent studies have begun to explore the Culex sp. microbiota. C. quinquefasciatus 
gut microbiota has been studied by culture and 16S sequencing (Pidiyar et al. 2004) yet 
C. pipiens mosquitos have only been studied via cultured independent methods (Chandler 
et al. 2015). To characterize the microbiota of C. pipiens, we first performed 16S rRNA 
profiling to assess the diversity of bacteria in the gut of our lab-reared C. pipiens 
mosquitos. From this information, we determined growth media to culture and isolate the 
bacteria. Gut bacteria were independently cultured and the genomes of each were 
sequenced using the Pacific Biosciences Single Molecule Real Time (PacBio SMRT) 




independently cultured isolates, we characterized the Culex mosquito gut microbiome at a 
species-specific level for the first time. We also show that the presence of Wolbachia 
may have an effect on the composition of Culex gut microbiome. The isolation of these 
species full genomes and Wolbachia manipulation of gut microbiome may serve as a tool 
for further investigations in host-microbe interactions and vector competency studies. 
6.2 Culture independent determination of the C. pipiens gut microbiota 
16S rDNA sequencing was first carried out to first determine which microbes will 
need to be accommodated in culture. C. pipiens mosquitos are frequently infected with 
Wolbachia strain wPip. We considered Wolbachia-infected and Wolbachia-free mosquito 
gut microbiota because Wolbachia infection has previously been shown to alter the gut 
microbiota in a Drosophila host (Simhadri et al. 2017). Wolbachia-free mosquitos were 
generated by five generations of feeding Wolbachia infected mosquitos (genetic 
background W+) with 10ug/mL TET in 10% sucrose. The resulting genetic background 
of these Wolbachia free mosquitos is WT +TET, Figure 6.1. Wolbachia free males were 
back crossed five additional generations with the Wolbachia infected female line to 
homogenize the genetic background of Wolbachia infected and Wolbachia free 
mosquitos (genetic background: F5 backcrossed to WT + TET, Figure 6.1). We 
investigated gut microbiota of surface sterilized adult mosquitos by homogenizing and 
DNA extracting mosquitos to obtain gut microbial DNA. Surface sterilization has been 
shown to successfully remove the microbiome present in the insect cuticle (Simhadri et 
al. 2017)(Chandler et al. 2011) . The second and third variable region of the 16S rRNA 




described (Simhadri et al. 2017). Figure 6.1A shows the schematic of the 16S and the 
primers used for 16S rDNA profiling (27F and 338R).  
The gut microbiota of Wolbachia-infected mosquito appear more diverse than the 
reciprocal Wolbachia-free microbiota. Microbacteriaceae (orange, Figure 6.1) is 
increased by 15-20% in Wolbachia infected females relative to all other samples., 
Wolbachia-infected mosquito microbiota are reported to have a different gut microbial 
composition compared to Wolbachia cured mosquitos after a blood meal (see Fig. 2 in 
Chen et al, 2016). These mosquitos were blood fed weekly. However, blood feeding 
status of each female was not confirmed prior to sequencing. Alternatively, some 
Microbacterium strains are hemolytic (Lee et al. 2014) and thus this increase could be 
due to an increase in blood fed mosquitos in the F5 backcrossed W+ female mosquitos.  
As expected, our data also suggest TET treatment followed by genetic 
background homogenization may also alter gut microbial composition. The Wolbachia 
free mosquito gut microbiota was primarily composed of two organisms: one 
Enterobacteriacae in the genus Serratia and an additional (non-Serratia) species from the 
family Enterbacteriaceae (Figure 6.1B).  Nineteen different genera within eight different 
families were detected across the six samples (Figure 6.1B).  Fifteen bacteria were 
detected in the female F5 backcrossed Wolbachia infected samples while only eleven 
bacteria were detected in wildtype Wolbachia infected female mosquitos. The identity of 
these organisms also differed (Figure 6.1B). These data provide preliminary identities of 










(A) Schematic of 16S rDNA gene and primer location. Black regions represent conserved 
domains. Gray represents hypervariable regions. The 27F and 338R primers were used 
for illumina short read high throughput sequencing. The 8F and 1492R primers were used 
to amplify the full 16S rDNA from isolated gut microbiota followed by Sanger 
sequencing. (B)  Five randomly selected male and five randomly selected females were 
collected from each cage: wild type (WT), WT + TET (TET), and F5 backcrossed to WT 
+ TET. Post surface sterilization, the 16S rDNA was amplified and sequenced by 
Illumina short read sequencing. Percentages represent percent operational taxonomic unit 
(OUT) for each sample. Data provided by Rama Simhadri. 
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6.3 Isolation and culture of Culex microbiota 
Culture isolates for the most abundant OTUs identified in Figure 6.1 were isolated 
and full genome sequence was determined to facilitate future studies with these 
microorganisms. Using the 16S rDNA profiling data, two different agars were selected 
for the growth of mosquito gut microbiota: Tryptic soy agar (TSA) and Brain and Heart 
Infused Agar (BHI). Each agar was prepared with and without 5% defribinated chicken’s 
blood (CB) for the selection of hemolytic bacteria. Surface sterilized female mosquitos 
were homogenized in sterile PBS and serial diluted on TSA, TSA+ CB, BHI, and BHI 
+CB and grown at 25°C. Distinct morphologies were selected and re-plated for isolation. 
A representative image of morphologies observed is shown in Figure 6.2. Consistent with 
the sequencing data, Serratia marcesens (red pigmented bacteria, Figure 6.2) dominated 




isolation, the 16S rDNA was amplified to include all variable regions (Figure 6.1A, 8F, 
1492R). 16SrDNA sequences (Table 6.1) were compared to the NCBI 16S ribosomal 
DNA database to determine genus. Genus and species identification of each organism 
was confirmed by full genome sequencing and metabolic characterization.  





Culex mosquitos were externally sterilized in 10% bleach, homogenized, and plated on 
various agars. Distinct species were identified through morphological differences (black 
arrows) and species identity was determined by sequencing (Table 6.1) and metabolic 
testing (Table 6.3 and 6.4) 
 





















































































































































































































































































The 16S rDNA was sequenced with the 8F and 1492R primer by Sanger sequencing with 
4X coverage. Sequences were aligned using Serial Cloner 6.2.1 
 
6.4 Genome sequencing, annotation, and metabolic modeling of gut commensal 
bacteria of C. pipiens mosquitos 
Gut commensal bacteria were sequenced by PacBio SMRT long read sequencing 
resulting in greater than 100X coverage for each bacterial genome (Table 6.2). Bacterial 
genomes were assembled with HGAP and then submitted to RAST (Overbeek et al. 
2014, Brettin et al. 2015) for annotation. RAST utilizes the SEED database of existing 




Figure 6.3A and 6.3B show genome-wide profiles of the Chryseobacterium sp. and 
Yersinia sp. isolated from our C. pipiens gut.  
Metabolic modeling using the full genome of our bacteria can predict which 
organisms can survive best in different environments. Glycolysis can be initiated through 
the presence of glucose or sugars which can be modified to glucose: Arbutin and Salacin. 
The Chryseobacterium genome lacks the enzymes to convert Arbutin or Salacin to β D 
glucose-6-phosphate where these sugars could enter glycolysis. Enzymes encoded in the 
glycolytic pathway by our Chryseobacterium sp. isolate are highlighted in green (Figure 
6.3A).  This differs in Yersinia sp. The Yersinia sp. isolated has the necessary enzymes to 
convert Arbutin or Salacin to β D glucose-6-phosphate giving it a fitness advantage over 
Chryseobacterium. Indeed, we detected more reads of our Yersinia sp. isolate. A RAST 
metabolic model was generated for each organism and deposited in the RAST online 
database for future studies. 
 
Table 6.2 Genome sequence coverage 
Genus Species Genome size coverage 
Serratia marcesens 5.1MB 175X 
Yersinia frederiksenii 4.2MB 100X 
Comomonas testosteroni 5.8MB 270X 
Chryseobacterium Jejuense 5.3MB 100X 
Leucobacter iarius 3.5MB 225X 
Microbacterium azadirachtae 4.0MB 215X 




Microbial DNA was isolated from pure cultures and sequenced by PAC BIO long read 
SMRT sequencing (see Methods, Chapter 2). Genomes were assembled through HGAP. 
Coverage represents minimal overlapping sequence. 
Figure 6.3 Comparison of glycolytic encoded enzymes by genome modeling of (A) 






Full genomes of each bacterial isolate were submitted to RAST for annotation and 
the production of a metabolic model. KEGG representation of metabolic pathways was 
reviewed for variations across organisms. Yersinia and Chryseobacterium have different 
means of entering glycolysis. Highlighted by the star in (A) and (B), Yersinia encodes 
enzymes to convert Arbutin and Salicin to β D glycose 6 phosphate, yet 
Chryseobacterium lacks these genes. The increased number of sugars which may feed 
into glycolysis may aid Yersinia to colonate the gut of C. pipiens mosquitos. 
 
6.5 Metabolic and physiological characterization of C. pipiens gut microbiota 
In addition to the in silico scale metabolic analysis provided by RAST/SEED, we 
were interested to assess the microbial growth and metabolite utilization. We first 
assessed physiological growth conditions of each organism to determine growth 
conditions at 25ºC. Microbacterium azadirachtae, S. marcesens, and Yersinia 
frederiksenii demonstrated motility in SIM agar while Sphingobacterium multivorum, 
Chryseobacterium jejunese, Leucobacteri iarius, and Comamonas testosteroni were non-
motile after 24 hours (Table 6.3). Y. frederiksenii (Enterobacteriaceae) and S. marcesens 
were facultative anaerobes, perhaps supporting their high abundance in the mosquito gut 
(Table 6.3) (see Chapter 2 methods). L. iarius was also determined have facultative 
anaerobic energy production. All other bacteria tested were strictly aerobic (Table 6.3).  
Metabolic capacity of each bacteria is summarized in Table 6.4. All organisms 
were catalase positive indicating that they can neutralize reactive oxygen species in the 




produced casein and gelatin metabolizing proteases while all others were oxidase 
negative. Only S. marcesens and Y. frederiksenii were able to metabolize tryptophan to 
produce indole and ferment mannitol. S. marcesens and C. testosteroni produced nitrates. 
Only S. marcesens was able to metabolize citrate as a sole carbon source. All organisms 
were negative for phenylalanine deaminase, cysteine reduction (sulfur reduction), and 
lactose fermentation (see Chapter 2 methods). The biochemical tests can inform growth 
of these organisms as well as the metabolic models generated.  
 
Table 6.3 Physiological characterization of Culex gut microbiota 
 gram 
stain 
shape oxygen motility 
Serratia marcesens - rod Facultative + 
Yersinia frederiksenii - rod Facultative + 
Sphingobacterium multivorum - rod Aerobic - 
Chryseobacterium jejunese - rod Aerobe - 
Microbacterium azadirachtae + rod Aerobic + 
Leucobacteri iarius + rod Facultative - 
Comamonas testosteroni - rod Aerobic - 
 
Pure cultures were Gram stained and viewed at 1000X oil immersion to determine wall 
structure and bacteria shape. Oxygen use was determined in an FTM stab 24 and 48 hours 
post inoculation. Motility was determined by SIM agar stab 24 and 48 hours post 
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Substrate utilization and the presence of catalytic enzymes was determined by growth in 





Several factors determine microbial composition in the insect gut. Host innate 
immunity plays an important role. However, interactions within the microbial 
communities can determine the potential for other microbe species to colonize an insect 
gut. This is shown through positive and negative correlations between bacteria across 
hosts. For example, two specific Lactobacillus sp. and Acetobacter sp. have a negative 
correlation in D. melanogaster (Newell and Douglas 2014) and Asaia and Acinetobacter 
sp. are positively correlated in Aedes mosquitos (Minard et al. 2013). Recently, the C. 
tarsalis microbiota of lab reared and wild caught mosquitos was determined by 16S 
rRNA profiling (Duguma et al. 2015).  A high percentage of Enterobacteriaceae, 
Microbacteriaceae, Comamonadacease, and Flavobacterlaceae were found in the wild-
caught or laboratory reared Culex tarsalis (Duguma et al. 2015). Wild-caught Culex 
pipiens from India also have a high presence of Serratia marcesens (Enterobacteriaceae) 
and Microbacterium sp. (Microbacteriaceae) (Chandel et al. 2013). In concordance, we 
also found a high percentage of the same families (Enterobacteriaceae, 
Microbacteriaceae, Comamonadacease, Flavobacterlaceae) in our laboratory reared C. 
pipiens. This cross species similarity potentially suggests an intrinsic gut environment 
supporting specific microbes, although the species of these microbes was not identified 
so no specific metabolic relations were assessed.   
Microbes in the gut provide essential nutrients for metabolic function.  Studies in 
D. melanogaster show that Acetobacter are required for the proper development of flies 




alcohol dehydrogenase activity modulates insulin signaling at key developmental stages 
to help in the progression of development (Shin et al. 2011). The other major gut 
symbiont of D. melanogaster, Lactobacillus plantarum, acts on the Toll pathway to 
stimulate larvae growth in nutrient deprived conditions (Storelli et al. 2011). Gut 
microbiota of the mosquito are also required for proper development of the mosquito 
(Coon et al. 2014). Aseptic mosquitos die during larval development, yet can be rescued 
by nonpathogenic bacteria (Coon et al. 2014). However, very little has been done to 
understand the metabolic state of these non-pathogenic microbes and the array of 
metabolites that are shared with the host.  
Microbial communities in the mosquito gut can prevent pathogen colonization 
through competition for resources, inhibition by metabolites and through the activation of 
host innate immunity. Gut microbial metabolites have been shown to have antiviral 
activity limiting the replication of DENV (Ramirez et al. 2014) and LACV (Joyce et al. 
2011). These metabolites have potential as therapeutic interference for either a human or 
an infected mosquito (Hegde et al. 2015). Gut microbes also stimulate the mosquito 
innate immune response (Xi et al. 2008, Souza-Neto et al. 2009) to prevent viral 
colonization albeit different bacteria species elicit more or less of a host response. An 
increased understanding and the ability to culture C. pipiens gut microbiota may aid in 







CHAPTER 7: Discussion & Future Directions 
7.1 Investigation of Wolbachia-strain specific virus repression in vivo 
 Supergroup B Wolbachia are promising candidates for arbovirus control. We 
investigated two supergroup B Wolbachia and found that supergroup B Wolbachia 
wAlbB and wStri blocked ZIKV growth. The block by wStri is robust limiting the 
replication of all positive sense RNA viruses tested including ZIKV, DENV-2, CHIKV, 
and YFV. Most notably, YFV which is not blocked by wMel is inhibited by wStri 
suggesting the wStri infection alone or superinfection with wMel may be an efficient 
strategy to arbovirus reduction.  
Future investigation is needed to determine if wStri is a viable candidate for 
arbovirus control in vivo. This includes the establishment of wStri in A. aegypti or A. 
albopictus mosquitos. Previous studies have shown that multiple Wolbachia strains can 
superinfect a single host. A. albopictus can be naturally coinfected with two Wolbachia 
strains, wAlbA and wAlbB (Kambhampati et al. 1993). Artificially induced triple 
Wolbachia infections in A. albopictus have also been shown to be stable, promote CI, and 
be beneficial to host fecundity (Fu et al. 2010). Further, superinfection increases total 
Wolbachia density and blocks DENV growth (Joubert et al. 2016). While many A. 
albopictus mosquitos are infected with Wolbachia, they are still competent vectors for 
DENV and other arboviruses, perhaps due to low Wolbachia density (Lu et al. 2012). We 
have demonstrated above that wStri resides at high densities in A. albopictus cells, and 
thus may be a candidate for superinfection in A. albopictus to increase overall Wolbachia 




7.2 Molecular mechanisms of Wolbachia mediated virus suppression  
 We found that Wolbachia wStri blocks ZIKV growth at two independent stage of 
viral replication. Wolbachia limited ZIKV entry into A. albopictus cells to below the limit 
of visualization (68%). Wolbachia infection also reduced ZIKV translation by reducing 
host translation by 67%. These two blocks represent a robust early block in viral 
infection. Although this effort does not rule out that there may be additional late stage 
blocks. The early multilayered block in viral infection by Wolbachia indicates that it is 
unlikely for a virus to adapt and evade Wolbachia’s repression. 
 Wolbachia’s severe dysregulation of host lipids and steroids is a causal factor in 
the block of arbovirus entry. Wolbachia dysregulates lipid metabolism, composition 
(Molloy et al. 2016), trafficking, and available sterols (Caragata et al. 2014, Geoghegan 
et al. 2017). ZIKV entry into Wolbachia infected cells was partially rescued following 
cholesterol-lipid supplementation leading to a partial rescue in the production of viral 
genome copies. Cholesterol-lipid supplement was added at the time of viral infection. A 
time of addition experiment pre-treating cells would clarify if long term cholesterol-lipid 
supplementation would fully Wolbachia infected cells by restoring membrane lipid 
composition. If long term treatment with cholesterol does not fully restore viral entry, 
future investigations should explore if an additional block occurs at viral attachment or 
fusion. 
 Host translation is also reduced in Wolbachia infected cells by greater than 67%. 
Positive sense RNA viruses enter a cell as a singular mRNA message requiring host 




polymerase and cofactors for replication. Thus, a reduction in host translation greatly 
reduces viral translation. Additional studies are needed to better understand how 
Wolbachia interferes with host translation and if this effect is strain specific. Analyzing 
protein synthesis in other cell line systems including Aa23wAlbB, Aag2wAlbB, JW18 
(infected with wMel) and their respective Wolbachia free lines would provide insight on 
the breadth of this mechanism. Wolbachia’s interference with host translation should 
additionally be investigated in vivo. Wolbachia exhibits tissue tropism (Fast et al. 2011, 
Toomey et al. 2013, Toomey and Frydman 2014) in a whole animal suggesting that a 
reduction in translation would not globally effect a mosquito health. Determining if and 
to what extent translation is reduced by a tissue specific will inform the accuracy of the 
A. albopictus-wStri model.  
7.3 Applications of insect specific virus singular or dual infection for arbovirus 
control 
 CFAV and PCLV dual infection in A. albopictus cells reduced ZIKV, DENV, and 
LACV. Future investigation is needed to determine if CFAV and PCLV act in unison or 
if PCLV or CFAV alone is the causative agent of viral antagonism. Because CFAV has 
previously been shown to promote the growth of DENV in A. albopictus cells, it is most 
likely that PCLV alone or PCLV and CFAV together inhibit the growth of the 
arboviruses tested. To facilitate these studies, a purified stock of PCLV in the absence of 
CFAV is needed. PCLV but not CFAV maintains a persistent infection in CCL-125 cells. 
PCLV was collected from CCL-125 cells and infected into C710 cells. However, this 




PCLV is needed for future studies delineating the specific ISV effect on arbovirus 
repression. Additional tools including an antibody for immunolabelling of PCLV and 
CFAV would inform the frequency of ISV infection in A. albopictus and A. aegypti cells. 
Removal of PCLV and CFAV infection from A. aegypti cells by pharmacological 
intervention would improve the use of A. aegypti in vitro model of arbovirus infection.  
 ISV infection in A. albopictus cells greatly reduced LACV infection, especially at 
a low MOI. PCLV and LACV are viruses in the same family: Bunyaviridae. Viruses in 
the same family have similar replication strategies and utilize similar host factors driving 
competition between them. It is likely that PCLV infection outcompeted LACV infection 
in A. albopictus cells. Although bacterial intervention has been suggested (Joyce et al. 
2011), there are no current biocontrol strategies for the reduction of LACV in mosquitos. 
Future studies should address the potential for PCLV to compete with LACV in vivo in 
the invasive A. albopictus and natural vector A. triseriatus mosquito (Thompson and 
Beaty 1977). 
7.4 Strategies for arbovirus control in Culex mosquitos 
 Culex mosquitos are a prominent vector of WNV (Chancey et al. 2015), JEV 
(Mackenzie et al. 2004), and SINV (Adouchief et al. 2016) in the United States and 
across Europe. Wolbachia mediated control of arboviruses in a Culex host requires 
further investigation. Many Culex sp. are naturally infected with Wolbachia. Wolbachia 
wPip infection has been detected greater than 99% of C. pipiens and C. quinquefasciatus 
mosquito populations. Although wPip has been shown to limit WNV in C. 




tarsalis mosquitos do not natively have a Wolbachia infection. However, when a non-
native strain of Wolbachia, wAlbB was introduced to C. tarsalis, WNV infection was 
increased. Future investigations should explore the introduction of alternative strains of 
Wolbachia such as wStri in Culex sp. mosquitos. This may increase Wolbachia density in 
C. pipiens and C. quinquefasciatus to block viral transmission.  
 Alternatively, we have provided additional tools towards the use of gut microbiota 
to block viral transmission in Culex mosquitos. Gut microbial strategies include direct 
pathogen interaction to stimulate an innate immune response or compete for a required 
metabolite. Additional studies to determine which bacteria in the mosquito gut best elicit 
an immune response or directly compete with Culex transmitted arboviruses is needed.  
The bacterial species we have isolated may also be used for paratransgenisis. 
Paratransgenisis is the employment of a bacteria species to deliver a genetic message to a 
host (Hegde et al. 2015). For example, Chromobacterium has been shown to produce an 
antiviral compound, Csp_P (Ramirez et al. 2014). Chromobacterium may have difficulty 
colonizing the C. pipiens gut because it is not a native endosymbiont of the Culex gut 
microbiota. Thus engineering Csp_P into one of the native endosymbionts we have 
identified and cultured may facilitate the delivery of this antiviral compound and block 
the colonization of arboviruses in the C. pipiens gut. There are many applications to the 
knowledge of C. pipiens gut microbiota, their genome, and metabolism. Future studies 
are needed to elucidate which bacteria colonize the gut well, compete with viruses for 






 The work presented here expands the knowledge and available tools to block 
arboviruses in Aedes and Culex sp. mosquitos. We have demonstrated novel repression of 
DENV, ZIKV, CHIKV, and YFV by Wolbachia wStri in Aedes cells and discussed the 
limitations for Wolbachia to block negative sense RNA arboviruses, LACV and VSV.   
This study provides the first identification of specific blocks in viral replication caused by 
Wolbachia infection. Our identification of two blocks in viral growth draws connection 
between the proposed importance of lipids and methylation, which may play a role in 
viral entry and translation respectively. This work focuses future efforts to delineate the 
molecular pathways involved in viral antagonism by Wolbachia.  
 Additionally, we have identified two alternative strategies to arbovirus control 
and provided tools for further investigation. PCLV and CFAV infect A. aegypti and A. 
albopictus cells interfering with arbovirus replication. Together or independently these 
ISVs may be deployed to naturally interfere with arbovirus spread. Second, we have 
characterized the C. pipiens gut microbiota by culture independent and dependent 







Appendix 1 Wolbachia alters insect cell morphology infected 
In vitro culture of insect cells has expanded our understanding of molecular 
mechanisms of cell-cell interactions and microbial interactions. Insect cells grow best in 
dense cultures. Figure A.1 shows C710 and C6/36 (A. albopictus) and JW18DOX (D. 
melanogaster) morphologies and densities of flourishing cultures. JW18DOX is so 
named because it was doxycycline treated to remove its natural Wolbachia wMel 
infection. Up to 40% of all insects are infected with one or more strains of Wolbachia 
(Zug and Hammerstein 2012). Cell lines with native Wolbachia infection have been 
isolated and continue to grow with their respective Wolbachia strain.  Likewise, Aa23 
cells naturally are infected with Wolbachia wAlbB which can also be removed by a 
doxycycline or TET treatment. Wolbachia infected cell cultures have improved our 
understanding of Wolbachia host interactions and arbovirus restriction.  
Wolbachia alters the morphology of its host cell. A. albopictus Aa23 cells with or 
without a wAlbB infection continue to grow at a steady rate. However, these cells appear 
clumped or loosened from the plate. This is more pronounced in a nonnative infection 
whereby wStri, a Wolbachia strain from a leafhopper was transinfected into A. albopictus 
cells (CwStri).  Greater than 50% of CwStri cells are bubbling off of the monolayer 
(Figure A.2). JW18 (Wolbachia wMel infected) cells remain circular and largely in 
suspension while JW18DOX cells lay flat with protrusions (Figure A.2). In contrast to 
the mosquito cells, JW18 and JW18DOX cells grow at different rates. JW18DOX cells 





Figure A.1 Wolbachia free insect cell morphology 
 
 





Appendix 2 Zika virus does not cause a cytopathic effect in mosquito cells 
Mosquitos harbor many virus infections from ISVs to arboviruses. To facilitate 
transmission, arboviruses need to infect and grow in mosquitos without causing damage 
to the host. It is unknown how mosquitos evade arbovirus pathogenesis. Although it has 
been suggested that mosquito cells evade apoptosis cytopathicity through a lack of 
unfolded protein response signaling (Pena and Harris 2011, Hou et al. 2017). A. 
albopictus C6/36 cells are deficient in RNAi and permissive to an array of arboviruses. 
Thus, it is common to use these cells to prepare stocks of arboviruses. We grew our 
ZIKV stocks in C6/36 cells observing minimal to no cytopathic effect of virus infection 
(Figure A.3). After 7 days of infection, cells reached high densities causing them to 
clump or detach from the plate. This is common in uninfected cells which reach 
overconfluency and leads to the demise of a culture. Cells and supernatant were harvested 










C6/36 cells were infected with PRVABC59 at an MOI of 0.01 for 1 hour at 28ºC. 
Virus inoculum was removed and cells were topped off with complete media (MEM with 
10% FBS). Immediately to infection, and 2 days, 3 days, 4 days, and 7 days post 






Without a clear cytopathic effect, a growth curve of viral production was 
necessary determine peak viral titer. The supernatant of infected cells was harvested each 
day and viral RNA was determined by RT-qRTPCR. ZIKV MR766 and PRVABC59 
each peaked in viral titer six days post infection (Figure A.4).  These data were used to 
inform the preparation of virus stocks in C6/36 cells.  
 
Figure A.4 Growth curve of Zika virus infection in C6/36 cells 
 
C6/36 cells were infected with ZIKV MR766 or PRVABC59 at an MOI of 0.01 
for 1 hour at 28ºC. Virus inoculum was removed and cells were topped off with complete 
media (MEM with 10% FBS). At 24 hour intervals, 140 µL of supernatant was collected 
for RNA extraction by QiaAMP Viral RNA extraction. Viral RNA was determined by 








Appendix 3 Drosophila JW18DOX cells are not permissive to Zika virus 
Drosophila cells are an excellent system for high throughput screens because of 
their well annotated genome (Adams et al. 2000) and validated RNAi constructs to 
individually target each gene (DasGupta and Gonsalves 2008). Drosophila S2 cells have 
been used a model to identify host factors important for DENV (Sessions et al. 2009) and 
WNV (Yasunaga et al. 2014) replication in insects. JW18 cells are D. melanogaster cells 
with a natural Wolbachia wMel infection. An RNAi screen coupled with virus infection 
in these cells could identify important factors by which Wolbachia limits viral growth. 
We were interested to establish a system to investigate molecular partners of Wolbachia 
mediated ZIKV repression. However, ZIKV has not been shown to infect and replicate in 
Drosophila cells. We initially infected JW18DOX cells which are JW18 cells treated 
with doxycycline to remove Wolbachia to assess if Wolbachia free Drosophila cells are 
permissive to ZIKV growth. Cells were infected at a high MOI of 100 infectious units of 
ZIKV PRVABC59 per cell. Three days post infection, cell supernatant was collected and 
stored at -80ºC. Cells were fixed and stained for ZIKV by antibody staining (D11C). 
Figure A.5 shows confocal imaging of infected JW18DOX cells. ZIKV infection was 
observed in few cells. Figure A.5 (left) shows perinuclear staining typical of ZIKV 
infection. Figure A.5 (right) shows what may be modest viral spread whereby a single 
cell is robustly infected and neighboring cells have some low level of ZIKV infection 





Figure A.5 Imaging of JW18DOX cells infected at a high multiplicity of infection to 
assess Zika virus entry show no infection. 
 
 
JW18DOX cells were infected with ZIKV PRVABC59 at an MOI of 100. Three days 
post infection cells were fixed and immunolabelled with D11C, a cross-reactive flavivirus 
envelope antibody to detect ZIKV (Red). DNA is counterstained with DAPI.   
 
Serial adaptation of arboviruses to Drosophila has been previously shown to 
promote virus growth (Sessions et al. 2009). We quantified the virus supernatant from the 
first passage (MOI 100) by focus forming assay (Figure A.6). Using this virus, we 
infected a new monolayer of cells with an MOI of 10. After cells grew for 3 days, we 
collected passage 2 supernatant and quantified infectious units by focus forming assay 
(Figure A.6). Again, we infected a new monolayer with this passage 2 stock of virus at an 
MOI of 10. Three days post infection, cell supernatant was again collected and quantified 




virus was detected in passage 3. These data demonstrate a lack of permissivity of 
Drosophila JW18DOX cells.  
 
Figure A.6 Multiple passages of Zika virus in JW18DOX cells results in the 
clearance of virus  
 
 JW18DOX cells were initially infected with ZIKV PRVABC59 at an MOI of 100. 
Three days post infection the supernatant was collected and serially passage through 
nascent JW18DOX cells at an MOI of 10 for passage 2 and passage 3. Virus production 




Appendix 4 Wolbachia dysregulates lipid trafficking genes in CwStri cells 
Lipid droplets are a primary source of lipids in the cell and are trafficked to the 
membrane, endosomes, and endoplasmic reticulum. Lipids are absorbed through a 
lipophorin receptor and then transported in lipid droplets with the help of apolipoprotein 
D, LSD-1, and LSD-2. To free lipids and recycle droplets, phospholipase digests lipids 
releasing fatty acids. Fatty acid synthase facilitates the production of new lipid droplets. 
The roles of these proteins are summarized in Figure A.7 adapted from (Kory et al. 
2015). 
Figure A.7 Lipid droplet factors 
 
 
Proteins involved in lipid absorption, droplet formation, and trafficking. Adapted from 




Lipid trafficking is an important process for viral entry, replication, and egress. 
Flaviviruses required lipid rafts including sphingolipids and sterols for viral attachment 
and fusion (Smit et al. 2011). During replication lipid droplets help to scaffold necessary 
proteins at the rough endoplasmic reticulum to promote viral replication (Samsa et al. 
2009, Filipe and McLauchlan). Lipid trafficking then promotes viral egress through the 
secretory pathway for maturation and release (McLauchlan et al. 2002, Welsch et al. 
2009). 
Wolbachia’s high demand for lipid may cause compeitiive inhibition of viral 
replication. Wolbachia has been shown to alter lipid trafficking proteins including LSD-1 
and LSD-2 (Geoghegan et al. 2017). Wolbachia also alters lipid metabolism (Molloy et 
al. 2016). We assessed the effect of Wolbachia wStri and ZIKV on host lipid droplet 
factors involved in absorption (Lipophorin receptor), trafficking (Apolipoprotein D, 
LSD-1, LSD-2), and recycling (Phospholipase, Fatty acid synthase). Wolbachia wStri 
significantly down regulated lipid trafficking factors but did not significantly dysregulate 
absorption or recycling (Figure A.8A). ZIKV did not signicantly alter any factors. 
However, there was a general trend for increased absorption, trafficking, recycling 












Wolbachia infected (CwStri) and Wolbachia free (C710 W-) cells were infected at an 
MOI of 0.01 with ZIKV PRVABC59 for one hour. Five days post infection cells were 
assayed for transcripts of lipid droplet factors. (A) Mock–virus free cells were compared 
between Wolbachia infected and Wolbachia free cells. Statistical significance was 
determined by student’s t test in Graphpad prism. * indicates p<0.05 n.s is not significant 
p>0.05. (B) ZIKV infected and mock infected C710 W- cells were compared to assess the 






We have shown that short term treatment of Wolbachia wStri infected cells with 
cholesterol lipid supplement during viral entry facilitates ZIKV entry into normally non-
permissive wStri infected cells and that continued provision of cholesterol throughout 
five days of virus infection partially rescures viral replication. Lipid metabolism and 
synthesis are under the transcriptional control of Sterol regulatory element-binding 
proteins (Horton 2002). Thus, a five day supplement with cholesterol lipid supplement 
may transcriptionally increase lipid factors important for viral replication. We assessed if 
transcripts for lipid droplet factors were rescued by cholesterol treatment during viral 
infection in Wolbachia wStri infected cells. Apolipoprotein, LSD-2, Lipophorin receptor, 
and phospholipase D mRNA were all increased in ZIKV infected cholesterol 
supplemented CwStri cells compared to ZIKV infected CwStri cells without cholesterol 
supplementation (Figure A.9). Fatty acid synthase and LSD-1 were not altered by 
cholesterol supplement in ZIKV infected cells. These data suggest that inaddition to its 
effect on viral entry, cholesterol lipid supplement may rescue viral growth through the 






Figure A.9 Cholesterol supplementation upregulated lipid trafficking gene in 







Wolbachia infected (CwStri) and Wolbachia free (C710 W-) cells infected at an MOI of 
0.01 with ZIKV PRVABC59 were assayed five days post infection for transcripts of lipid 
droplet factors. (A) Apolipoprotein D (B) Fatty acid synthase (C)LSD-1 (D) LSD-2 € 
Lipophorin receptor (E) Phospholipase D Mock–virus free cells were compared between 
Wolbachia infected and Wolbachia free cells. ZIKV infected C710 W- cells and CwStri 
cells were compared to assess the effect of on lipid droplet transcripts during viral 
infection. Cholesterol-lipid supplement designed for cell culture was added at 2X 
concentration in complete media (E-5) in the C710 W- and CwStri cells to determine if 
cholesterol lipid supplement rescues lipid droplet factor transcripts in CwStri cells 






Appendix 5 Dnmt2 expression is unchanged in Wolbachia wAlbB and wStri 
infected A. albopictus cells 
DNA methyltransferase 2 (Dnmt2) was named for its high similarity to DNA 
cytosine methyltransferases. However this protein does not methylate DNA. Instead, it 
has a cytoplasmic role methylating small RNAs. Dnmt2 methylates cytosine 38 on 
aspartic acid tRNAs (Goll et al. 2006). Dnmt2 methylation has been shown to be required 
for polypeptide synthesis (Tuorto et al. 2015), and proteins requiring poly-aspartic acid 
residues (Shanmugam et al. 2015) demonstrating broad importance for cellular function.  
In Drosophila, Dnmt2 has also been implicated in the regulation of microbial 
infection. Dnmt2 has also been shown to directly bind to DCV, a positive sense RNA 
virus in Drosophila (Durdevic et al. 2013). Overexpression of Dnmt2 also leads to a 
decrease of Wolbachia titers in Drosophila (LePage et al. 2014) suggesting that Dnmt2 
plays a role in innate immunity. Interestingly, Wolbachia was shown to upregulate Dnmt2 
in Drosophila perhaps self-regulating its own population and repressing RNA virus 
infection (Bhattacharya et al. 2017). Knocking out Dnmt2 in Wolbachia infected flies 
rescued SINV growth (Bhattacharya et al. 2017). However this phenotype may be host 
specific. In A. aegypti mosquitos, Wolbachia down regulates Dnmt2 and DENV 
upregulates Dnmt2 suggesting an inverse role for Dnmt2 in mosquito immunity. We 
determined if Wolbachia wAlbB or wStri alters Dnmt2 transcript levels in A. albopictus 
mosquito cells. Overall there was no significant difference in Dnmt2 levels in Wolbachia 
infected and Wolbachia free cells (Figure A.10). Dnmt2 was modestly downregulated in 




that Wolbachia does not have a robust effect on Dnmt2 transcripts in A. albopictus cells 
(Table A.1). However, it is possible that regulation at the translational level results in 
differential protein expression.  
 





 1x105 Aa23 W-, Aa23wAlbB, C710 W-, and CwStri cells were collected from a 
confluent 75 cm2 flask and RNA extracted by Qiagen RNeasy kit per manufacturer’s 
recommendations. Dnmt2 transcript levels were determined by RT-qRTPCR as described 












1 2 3 Average SD 
Aa23 W- 1.00 1.00 1.00 1.00 0 
Aa23wAlbB 0.74 0.74 1.58 1.02 0.49 
C710 W- 1.00 1.00 1.00 1.00 0 





Appendix 6 Quantitative analysis of negative sense RNA genome copies in 
Wolbachia infected and Wolbachia free cells 
After entering a cell, negative sense RNA viruses undergo primary transcription 
whereby they overproduce mRNA. When sufficient protein has been made from that 
mRNA, a feedback loop redirects the transcription to genome replication to drive forward 
the production of infectious virions. Negative sense RNA viruses are able to overcome 
the global block in translation that we have reported. One hypothesis explaining how 
these viruses can overcome low translation levels is to extend their primary transcription 
phase overwhelming the cell with viral mRNA. Thus, high RNA levels in a cell may be 
indicative of extended primary transcription. We determined VSV and LACV RNA 
levels in Wolbachia free C710 W- cells and Wolbachia infected CwStri cells three days 
post infection with an MOI of 10 of either VSV or LACV, respectively. In both VSV 
(Figure A.11A) and LACV (Figure A.11B), viral RNA levels were upregulated. 
Although this result was not significantly different due to high variability, viral RNA 
levels were consistently upregulated in all biological replicates tested. These data suggest 








Figure A.11 Negative sense RNA viruses produce more viral RNA in wStri infected 





C710 W- and CwStri cells were plated at 2x105 cells per well in a 12 well plate. 24 hours 
later, cells were infected with VSV (A) or LACV (B) at an MOI of 10. One hour post 
inoculation, virus was removed and cells were topped off with complete media (E-5). 
Cells were incubated at 28ºC with 5% CO2 for three days. Cell lysate was extracted and 





Appendix 7 Phasi Charoen like virus phylogeny 
To fully characterize the PCLV variant that was replicating in our cultured cells at 
the genomic level, we sequenced all three segments of the virus using primers based on a 
full genome sequence of PCLV’s three segment genome deposited in NCBI (Accession 
numbers: KU936057.1, KU936056.1, and KU936055.1). Sequencing results showed that 
our PCLV variant was highly similar to this deposited sequence. Phylogenetic analysis 
using MUSCLE alignment and the Tamera Nei model generated a maximum likelihood 
tree demonstrating that our isolate from Aag2 cells is the Bristol strain also identified in 
Aag2 cells (Figure A.12). This finding suggests that PCLV may replicate in many 
laboratory stocks of Aag2 cells. Our PCLV isolate differs most from the PCLV sequences 
obtained from Brazil and Thailand mosquitos in the glycoprotein encoding medium (M) 
segment (Figure A.12). However, this divergence is minimal. The PCLV M reported here 
is 99% identical to the PCLV Bristol sequence and 95% identical PCLV sequences found 
in Thailand mosquitos (Johnson et al. 2008). These data suggest that PCLV may be 
widespread in Aag2 cell lines and demonstrates sequence conservation of PCLV from 






Figure A.12 Phasi Charoen like virus in Aag2 cells is most similar to the Bristol-
strain 
 
The full RNA genome of PCLV was sequenced from filtered supernatant of Aag2 cells 
using primers in Table 2. Sequences from each segment were aligned with the available 
PCLV sequences on NCBI. For each segment, a phylogenetic tree was constructed by the 
Tamera Nei Model in MEGA6 (Tamura et al. 2013) using the full genome of Rift Valley 




polymerase (B) Medium segment encoding the glycoproteins, and (C) Small segment 





Appendix 8 Sterilization technique for seeding the microbiome of C. pipiens 
mosquitos 
The generation of gnotobiotic mosquitos is an important consideration for 
arbovirus intervention involving gut microbiota. Most gut microbiota are transmitted 
transovariolly on the surface of the egg shell called the chorion. Stripping an embryo of 
its chorion effectively reduces vertical transmission of gut microbiota (Coon et al. 2014, 
Simhadri et al. 2017). Drosophila embryos have been sterilized by 10% bleach treatment 
(Simhadri et al. 2017). Aedes embryos have been sterilized by ethanol treatment (Coon et 
al. 2014). Because Culex embryos are less resilient than Aedes embryos, we compared 
the survival of C. pipiens mosquitos post treatment with 10% bleach, 70% ethanol, and a 
combination treatment with sterile deionized (DI) water mock treatment. Egg rafts 
containing 100-400 embryos were collected and exposed to one of the defined treatments 
or DI water for 5 minutes. Chorion removal was evident in ethanol and bleach treated 
eggs by a color change and by the sinking of eggs. C. pipiens eggs are typically dark 
brown to black. Minimal water was kept in wells to keep embryos partially exposed to 
the air for air exchange. Sterilization treatment resulted in transparent embryos. 
Approximately 50% of mock treated eggs survived to adulthood with the largest death 
even occurring between L2 larvae and pupation (Figure A.13). For all sterilization 
treatments, the largest death rate occurred in the embryo stage prehatching (Figure A.13). 
This may be due to an imbalance of air exchange. Ethanol treatment induced high fatality 




conclusion, sterilization of C. pipiens embryos should use bleach and not ethanol 
treatment in minimal water depth to allow air exchange post treatment. 
 
Figure A.13 Survival of sterilized C. pipiens mosquitos 
 
C. pipens egg rafts were collected and photographed to count eggs under high 
magnification. Egg rafts were then treated with 10% bleach, 70% ethanol, both ethanol 
and bleach, or with sterile DI water for 5 minute in a cell strainer in a 6 well plate. Post 
treatment each raft was rinsed three times in DI water and then placed in a container for 
development observation. Four days post hatching L2 larvae pans were imaged and 
cleaned. Mosquitos were fed a non-axenic diet to model the replacement of microbes in a 
gnotobiotic mosquito. Mosquitos were observed daily for pupation and eclosion until no 




Appendix 9 Wolbachia wPip infects the midgut epithelium of C. pipiens mosquitos 
Wolbachia wMel has been shown to colonize the midgut of D. melanogaster 
(Simhadri et al. 2017) but not the midgut of A. aegypti (Amuzu and McGraw 2016). 
Because wMel is a native infection in D. melanogaster, we hypothesized that the native 
Wolbachia wPip would also colonize the midgut of C. pipiens mosquitos. 
Immunolabelled midguts of C. pipiens mosquitos showed modest staining in epithelial 
gut tissues (Figure A.14). The distribution of Wolbachia was not uniform suggesting cell 
type specific tropism as previously reported. Wolbachia in the midgut of C. pipiens 
mosquitos may also then effect the gut microbial species through indirect or direct 
interaction.  
Figure A.14 Wolbachia wPip infected the midgut of C. pipiens mosquitos 
 
Mosquito midguts dissected from wPip infected C. pipiens mosquitos were 




Toomey and Frydman 2014). DNA (blue) and Actin (phalloidin 568) (red) were 





Appendix 10 Full genome sequencing and annotation of microbiota isolated 
from the gut of Drosophila melanogaster 
These genome sequences were previously published as part of (Simhadri et al. 
2017). The full genome of L. plantarum and A. pasteurianus were used to make species 
specific primers for the detection and quantitation of bacteria in D. melanogaster in the 
presence and absence of Wolbachia infection. DNA was extracted from overnight 
cultures of L. plantarum and A. pasteurianus by a modified version of the protocol for the 
Qiagen blood and tissue kit as described above. DNA was sheared with Covaris spin 
tubes (catalog no. 520079). Genome libraries were prepared in accordance with the 
PacBio Template Preparation and Sequencing Guide selecting for approximately 10-kb 
genome fragments. DNA quality and size were confirmed on a Bioanalyzer, followed by 
sequencing with a PacBio RS II sequencer. Raw reads were assembled de novo by SMRT 
analysis software. Manual curation and closing of the genome were carried out by NCBI 
alignment. The A. pasteurianus chromosome (3.12 Mb) and plasmid (140 kb) were 
annotated by using a database of closed Acetobacter strains (CP012111 and NC_013209). 
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